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Rheumatoid arthritis (RA) is a common condition affecting 0.5-1.0% of the pop-
ulation.[1] An EULAR study group assessing risk factors for rheumatoid arthritis 
defined several phases before RA is clinically evident.[2] In the first two phases 
individuals are at risk of RA on the basis of genetic and environmental risk factors. 
In the third phase individuals have systemic auto-immunity associated with RA. In 
the fourth phase, individuals have symptoms without clinically detectable arthritis 
(soft tissue swelling). Lastly, patients have clinically apparent arthritis but do not 
full fill the classification criteria for RA (unclassified arthritis (UA)). An individual 
does not necessarily have to pass all of these phases in the development of RA. 
Additionally, not all patients in the symptomatic phase before arthritis is clinically 
evident, actually progress to clinical arthritis or RA, and similarly not all UA patients 
develop RA.[2]
The earliest phase in which a rheumatologist can identify patients at risk for RA at 
their outpatient clinic is the fourth phase, in this phase patients have symptoms 
without a clinically detectable arthritis.[2] In order to explore the biological pro-
cesses involved in the earliest clinical phase of RA, individuals that are at risk for RA 
have to be identified. In general two approached exist. One approach is to include 
individuals with arthralgia and positive auto-antibodies (rheumatoid factor (RF) 
and anti-citrullinated protein antibody (ACPA)).[3] Another method is to include 
individuals with higher risk on RA-development based on the clinical expertise 
of the rheumatologist.[4] This latter method is used to include individuals in the 
Leiden Clinically Suspect Arthralgia (CSA) cohort. In this cohort, individuals are 
included and followed until clinical arthritis is present, or else for a maximum of 
two years.[5]
Identification of patients in stages preceding that of clinical arthritis and RA might 
also be important from a clinical perspective, since the detection and treatment of 
RA in a very early stage has been associated with better outcomes.[6] It has been 
convincingly shown that early initiation of treatment of RA is associated less severe 
radiographic joint damage, lower disease activity scores (DAS) and a higher chance 




sion.[6,7] An even earlier treatment, that in the phase of CSA, requires accurate 
prediction of progression from CSA to RA.
In previous studies, the prevalence of auto-antibodies is assessed before RA is clin-
ically evident. In these studies it is shown that 46-60% of patients that will develop 
arthritis are RF positive and 43-57% are ACPA positive, depending on inclusion 
criteria (8-10). Furthermore, the specificity of these auto-antibodies is 78-87% for 
RF positivity and 86-98% for ACPA positivity.[8-10] Thus, auto-antibodies have an 
additional value in identifying patients at risk for arthritis development. However, 
auto-antibody status alone is not sufficient as up to 33-41% of individuals who 
are auto-antibody positive do not develop RA and auto-antibody negative patients 
could not be identified.[11,10] Therefore, there is a need for other methods to 
predict RA-development. Imaging might be useful here.
There are several imaging modalities which could have a predictive value for the 
development of RA. In current clinical practice, conventional radiographs are 
widely used. However, conventional radiographs can only depict radiographic joint 
damage (e.g. erosions and joint space narrowing) which is mostly present in later 
stages of RA-development.[12] Therefore, when using conventional radiographs for 
the diagnosis of RA, a window of early treatment could be missed.[6] Ultrasound, 
computed tomography (CT) and magnetic resonance imaging (MRI) can detect 
erosions in an earlier phase compared to conventional radiographs.[12] Ultra-
sound, positron emission tomography (PET), single photon emission computed 
tomography (SPECT) and MRI might play an important role in detecting inflam-
matory processes as an early sign of RA.[12] Of these imaging modalities, MRI is 
of particular interest as MRI does not involve radiation and can detect erosions, 
synovitis, tenosynovitis as well as bone marrow edema (BME). Therefore, MRI is 
well suited to study joint damage and inflammation in the very early phases of RA 
and might therefore attribute to the earlier detection of RA. Especially as currently 
inflammation is measured using C-reactive protein (CRP) levels and the number of 
involved joints with physical examination. These are not sensitive and, with regard 
to physical examination, also evaluator dependent.[13,14] Thus, in the (early) 




mation, such as MRI, may play an important role. MRI could be of value as it is a 
very sensitive technique that can detect local joint inflammation before clinically 
detectable arthritis occurs.[14] The information obtained by MRI might not only be 
useful in the diagnostic process of RA, the information obtained by MRI may also 
improve the understanding of processes which are active within early RA and in the 
phases preceding RA. In this light this thesis explores the value of MRI-detected 
inflammation and erosions in early phases of RA.
Outline of this thesis
This thesis is divided in 2 parts. In the first part we explored to what extend MRI- 
detected features of inflammation and erosions occur in symptom-free persons 
from the general population. In the second part of the thesis we will discuss factors 


















Figure 1  Outline of RA-development and studies depicted in relation to disease 
phase and imaging modality
Schematic overview of this thesis. The grey bars indicate in which phases the studies were performed 
subdivided in imaging modalities. For example, in chapter 6 MRI was used and healthy individuals 




detected on MRI, trying to improve the understanding of the processes which play 
a role in the early phases of RA. See figure 1 for an overview of disease phase in 
which studies were performed.
Part I: MRI-detected inflammation and erosions in the general population
MRI has increasingly been used in the clinical practice of RA. Recent recommenda-
tions of the European League Against Rheumatism (EULAR) suggest that MRI can 
be used to improve the certainty of a RA diagnosis in case of doubt. Furthermore, 
they state that MRI can detect structural damage at an earlier time point compared 
to radiographs.[15] However, these recommendations are mostly based on studies 
that included RA-patients. Since it is unknown to what extent MRI-features occur in 
the general (asymptomatic) population, the role of MRI in the early detection of RA 
is undetermined. We therefore wanted to evaluate the specificity of MRI-detected 
features by assessing the prevalence of MRI-features in asymptomatic persons. 
As a start, we systematically reviewed the medical literature for asymptomatic 
persons with MRI-data of joints commonly affect by RA in chapter 2. In the liter-
ature, a large scale study evaluating MRI-features in a healthy population was 
lacking. Therefore, it was still largely unknown what the occurrence of MRI-detected 
erosions and inflammation in asymptomatic persons was. 
In chapter 3 we therefore assessed the prevalence of MRI-detected erosions and 
inflammation in a large group of asymptomatic volunteers. We also assessed 
whether the frequency of these MRI-features was dependent on factors such as 
age and gender.
Part II:  Association with MRI-detected inflammation and radiographic joint damage
The processes that are active in the (very) early phases of RA are incompletely 
unraveled. Local inflammation in joints may be influenced by factors such as age, 
alcohol consumption or BMI. In subsequent studies, we therefore addressed the 




MRI or with radiographic joint damage. The extent to which bone mineral density is 
decreased in the transition from CSA to RA was studied as well.
The western population is ageing and previous studies suggested that RA-patients 
that are diagnosed at an older age have more radiographic joint damage compared 
to patients diagnosed at younger age.[16-23] We verified in a multi-cohort study 
whether radiographic joint damage is indeed age related and assessed this in 
more detail in chapter 4. Furthermore, we explored factors underlying this associ-
ation based on the general knowledge of risk factors for progressive joint damage. 
Among others, we assumed that older patients present at a later point in time, and 
therefore have more severe radiographic joint damage. Similarly other hypotheses 
were explored including auto-antibody status, clinical measures of joint inflamma-
tion, serological measures of inflammation, and MRI-detected inflammation.
Next to the ageing of the western population, the prevalence of obesity is increas-
ing worldwide.[24] A higher BMI is associated with higher systemic inflammatory 
markers in the general population (25), but also with a higher risk to develop 
RA.[26,27] Counterintuitively, a higher BMI is associated with less joint damage 
in RA-patients, on conventional radiographs.[28-31] As MRI-detected inflammation 
is a precursor of radiographic joint damage, we assessed in chapter 5 whether 
MRI-detected inflammation is also inversely associated with BMI in RA-patients. 
Furthermore, we assessed whether this association differs between patients which 
have an arthritis other than RA and asymptomatic volunteers.
Previous studies suggest that moderate alcohol consumption is associated with 
lower inflammatory markers both in the general population and in RA-patients.
[32,33] Furthermore, moderate alcohol consumption seems to be protective 
against RA-development.[34,35] Thus, we hypothesized that moderate alcohol 
consumption is associated with lower MRI-detected inflammation in RA-patients 




In chapter 7 we evaluated bone mineral density (BMD) loss in patients with CSA. 
BMD-loss is seen as an early sign of RA. Furthermore, BMD-loss is associated with 
progression of radiographic joint damage and predicts development of RA in the 
UA phase.[36,37] Additionally, in the symptomatic phase before arthritis is clin-
ically evident, some biomarkers of bone metabolism are already altered.[38,39] 
Therefore, BMD-loss could be present in the symptomatic phase before arthritis 
is clinically evident, this was assessed in chapter 7. Furthermore, as MRI-detected 
inflammation is associated with the development of bone erosions in RA (8), we 
hypothesized that MRI-detected inflammation was associated with a decrease of 
BMD. Finally, we explored if patients with higher BMD-loss have a higher risk on 
development of arthritis.
Chapter 8 consists of a summary and general conclusions of the studies performed 
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Part I 
MRI-detected inflammation and 
erosions in the general population

Chapter 2: What is the prevalence 
of MRI-detected inflammation and 
erosions in small joints in the general 
population? A collation and  
analysis of published data
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Introduction: MRI sensitively depicts erosions, bone marrow edema (BME) and 
synovitis in rheumatoid arthritis (RA). Recently developed European League 
Against Rheumatism (EULAR) recommendations stated that MRI is valuable to 
improve the certainty of a considered diagnosis and to detect structural damage 
at an early time point. However, these recommendations were mainly based on 
the data of patients with RA; prevalences of MRI-features in the general population 
were not extensively explored. We reviewed the literature on MRI-studies including 
symptom-free persons to assess the occurrence of MRI-features.
Methods: Medical literature databases up to September 2013 were systematically 
reviewed for symptom-free persons with MRI-data on metacarpophalangeal, wrist 
and metatarsophalangeal joints. Data were extracted and summarised. When 
allowed because of comparable scanning and scoring protocols, a mean frequency 
of features was calculated.
Results: Of the 338 articles screened, 31 studies evaluated MRI-findings in symp-
tom-free persons (n = 516 in total). Both the imaging techniques ( < 1/ ≥ 1 T, with/
without contrast enhancement) and the scoring methods (non-validated or RA 
MRI score (RAMRIS)) varied widely, prohibiting direct comparisons of the results 
of many studies. 15 studies scored data according to RAMRIS; combining data of 
similar joint regions showed that erosions (RAMRIS ≥ 1) were present in 33-52% of 
symptom-free persons. Similarly, synovitis was present in 27% and BME in 0-16% 
of symptom-free persons. The prevalence of MRI-detected erosions increased with 
age.
Conclusions: MRI-features, erosions in particular, occur frequently in symptom-free 
persons. Before MRI can be implemented in the diagnostic process, larger studies 
should be conducted determining the degree and combination of MRI-features that 
are disease specific.
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Introduction
Early treatment initiation in rheumatoid arthritis (RA) is associated with less radio-
graphic progression and a higher chance to achieve disease-modifying antirheu-
matic drug-free sustained remission, illustrating the relevance of early diagnosis.
[1-6] To what extent MRI is valuable for early detection of RA is undetermined. 
However, the recently formulated European League Against Rheumatism (EULAR) 
recommendations for the use of imaging in the management of RA suggest that 
MRI can improve the certainty of the diagnosis of RA and detect structural damage 
at an earlier time point than radiographs.[7] Additionally, an imaging task force 
of the American College of Rheumatology recently concluded that, of all imaging 
modalities, MRI serves best to ascertain structural damage in trials.[8] These rec-
ommendations were mainly based on MRI-data of patients with RA; MRI-features 
that are present in the general population were scarcely considered.[7-8]
Furthermore, many studies in RA are currently investigating the preclinical phases 
of the disease because the processes occurring in these phases may influence the 
long-term course of the disease. Potentially very early detection of RA may allow 
intervention in an asymptomatic preclinical disease phase. Indeed, several recent 
studies reported that MRI may play a role in the identification of joint inflammation 
in the phase before it becomes clinically detectable.[9-10] More studies are needed 
to determine the value of novel imaging modalities in the early detection of RA and 
their ability to differentiate patients with the disease from the normal situation.
Thus, to arrive at an evidence-based evaluation on the role of MRI in the diagnostic 
process in the early clinical and preclinical phases of RA, it is necessary to inves-
tigate the occurrence of MRI-features in the general population. In case certain 
MRI-features (to a certain degree) are also present in persons without joint symp-
toms, these lesions are presumably not indicative for RA. No large-scale studies 
have been performed to investigate the prevalence of these features in the general 
population. However, several MRI-studies included symptom-free persons as 
controls.[10-41] We aimed to (1) evaluate the prevalence of MRI-features in symp-
tom-free persons and (2), based on these observations, to make recommendations 





The databases PubMed, EMBASE and Web of Science up until September 2013 
were searched with the assistance of a medical librarian (JWS). Central terms in 
our search were MRI, healthy volunteers, wrist, metacarpal, metatarsal and RA 
(complete details of the search strategy can be obtained by the author). Titles and 
abstracts were screened on whether data on symptom-free persons and MRI of 
hands or feet were available. Subsequently, full-text articles were read and addi-
tional articles were identified through hand searching of reference lists. Articles 
were included when the studies contained (1) symptom-free persons and (2) infor-
mation on MRI-detected erosions, bone marrow edema (BME), synovitis or tenosy-
novitis of hands or feet. Since the symptom-free persons were generally used as 
the control group, the quality of the overall study design was not valued. Further, in 
order to get a comprehensive overview, we decided to include all studies fulfilling 
these two criteria and not to exclude studies based on the quality of the scanner, 
the scan protocol or scoring protocol that was used.
A standardised form was used to extract the following data: (1) study population 
(population size, age, recruitment method, description of study population, 
MRI-scanner, MRI-sequences, joint region scanned and scoring method), (2) 
MRI-features (erosions, BME, synovitis and tenosynovitis) and quantitative aspects 
(number of patients affected, number of joints/bones affected and grading of the 
MRI-features) and (3) relevant characteristics (location of MRI-features, dominant 
or non-dominant hands, age and sex of symptom-free participants). MRI-features 
were present (‘positive’) when recorded as such; studies using the RA MRI score 
(RAMRIS) generally considered a score of ≥ 1 for that feature as positive.[10,27-40] 
Data were extracted and reported such as done by the authors: either by present-
ing the prevalence of a feature or by presenting summary measures of continuous 
RAMRIS. According to RAMRIS, the range per bone/joint of erosion, BME and syno-
vitis scores are 0-10, 0-3 and 0-3, respectively; scoring of the metacarpophalangeal 
(MCP) region and wrist region involved evaluation of 8 and 15 bones and 4 and 3 
joints (radioulnar joint, radiocarpal joint and intercarpal-carpometacarpal joint), 
respectively, evaluation of the 5 metatarsophalangeal (MTP) joints involved eval-
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uation of 10 bones. In case the same joint regions were assessed using similar 
scan protocols (ie, either with or without use of contrast enhancement) and similar 
scoring methodology (RAMRIS), it was considered acceptable to combine the 
results of different studies. Then mean frequencies (with 95% CIs) were calculated. 
Since it is known that contrast enhancement increases the reliability of assessment 
of synovitis,[42] studies evaluating synovitis and tenosynovitis with and without 
contrast enhancement were not combined but analysed separately.
Results
Selection of studies
The literature search yielded 338 studies; five additional articles were found 
by hand searching of reference lists (figure 1). After screening, 61 articles were 
selected. Two studies were excluded because of a language other than English. Of 
the remaining articles, 33 were eligible for inclusion. One article was excluded as 
it concerned a population that was used in two articles. Consequently, data were 
extracted of 32 articles. Whereas 31 studies provided data on patient level ( joint 
region), one study analysed the data only on individual bone/joint level; therefore, 
this study was only used when analyzing results on bone/joint level.[41]
Study description
The 31 included studies contained information on 3-42 (range) symptom-free 
persons per study; in total, 516 symptom-free persons were studied (table  1). 
Descriptions of the recruitment method is given in only seven studies.
[12,23,24,26,31,32,36] Most of these studies are reported to have studied hospital 
staff. Methods to exclude the target disease were described in 26 articles; four 
studies did not include this information and described their symptom-free persons 
as ‘healthy volunteers’[11] or ‘healthy controls’[14,37,38] and one study was 
described to have performed MRIs of ‘healthy volunteers’ and persons with wrist 
instability.[26] The methods of excluding target disease differed. Thirteen studies 




[15-17,19-22,24,28-30,36,39] Twenty studies mentioned that there were no current 
musculoskeletal/ joint symptoms.[10,12,13,18,20,21,23-25,27-34,36,39] In four 
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Excluded because data was 
only presented on bone/joint 
level (n=1)
Figure 1  Overview of literature research
       # Articles identified by hand searching of reference lists. 
    * Articles were excluded when no data on symptom-free persons or MRI-features of hands or feet were  
      described. 
    ¶ Articles were excluded when no data were presented on erosions, BME, synovitis or tenosynovitis  
       in symptom-free persons.  
    ^ The data of the 31 included studies provided data on patient level.
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studies, persons underwent clinical assessment by a rheumatologist,[24,27,29,36] 
and in two studies laboratory investigations were done and persons were excluded 
in case they were rheumatoid factor positive or had increased C reactive protein 
levels.[32,33]
Of the 31 included studies, 19 used an MRI with ≥ 1 T, 11 with an < 1 T MRI and one 
study used two different scanners (one with 1 T and one with 0.6 T).[34] Contrast 
enhancement was used in 17 of the 31 studies.
Sixteen studies did not use a validated scoring method; evaluations were done by 
experienced radiologists (in 12 studies), an experienced rheumatologist (1 study) 
and an ‘observer’ (2 studies), and in one study no information was provided. In 
15 studies, MRIs were scored according to RAMRIS.[43] MRI-scoring was done 
blinded for clinical status in 18 of the 31 studies. In seven studies, scoring of 
patients and controls was not performed blindly [10,15,20,23,27,34,40] and in six 
studies (140 symptom-free persons) only symptom-free persons were evaluated.
[22,23,28,30,32,36]
Prevalence of erosions
The studies that did not use a validated scoring method reported a lower prevalence 
of erosions than did the studies using RAMRIS (table 2). A wrist was scanned on 
one or both sides and assessed using RAMRIS in 69 and 44 persons, respectively. 
When combining data of the wrist, a total RAMRIS erosion score ≥ 1 was reported in 
52.2% (mean, 95% CI 40.6 to 63.5, unilateral wrist) [27,34,37] and 40.9% (95% CI 
27.7% to 55.6%, both wrists) [35,36] of symptom-free persons, respectively. Unilat-
eral MCP joints were evaluated in 97 persons and revealed erosions in 33% (95% 
CI 24.4% to 42.9%).[27,34,38,39] No studies described the prevalence of erosions 
when using higher cut-offs for positivity for instance, a total RAMRIS erosion score 
of ≥ 2).
Prevalence of BME
The recorded prevalence of BME was higher in the studies using RAMRIS than in 
the studies using other methods. Combining the data of the 63 persons in whom 




score ≥ 1) of 15.9% (95% CI 8.7% to 27.0%).[27,34] Similarly, BME was present in 
9.5% (95% CI 4.1% to 19.6%) [27,34] of persons in whom unilateral MCPs were 
evaluated. Combining studies assessing unilateral wrist and MCPs showed a mean 
frequency of BME of 0.0% (95% CI 0.0% to 6.8%).[29,30] No studies categoried 
BME features with higher cut-off values.
Prevalence of synovitis and tenosynovitis
Synovitis was assessed without contrast enhancement in 8 studies and with con-
trast in 13 studies. In the studies that used no validated scoring method, synovitis 
was present in 0-4.8% (range) of persons when no contrast was used13-15 20 and 
0-44.4% (range) when contrast was used.[11,16-19,22,26] In the studies that were 
scanned with contrast enhancement and scored according to RAMRIS, synovitis was 
present (total synovitis score ≥ 1) in 26.7% (95% CI 15.8% to 41.2%); these studies 
assessed wrist and MCP joints together.[29,30] Data on the studies that provided 
results of wrist or MCP joints separately were not combined due to differences in 
scanning or scoring protocols. Tenosynovitis was assessed infrequently (table 2).
Continuous RAMRIS-scores
Three studies did not report categorised data but reported continuous RAMRIS, 
incorporating a semi-quantitative evaluation of the severity of the features.
[10,27,28] The mean RAMRIS for erosions and BME were low ( ≤ 3.2 and 0.9, respec-
tively, table  3). For synovitis, contrast enhancement was used in one study;[28] 
this study revealed higher mean RAMRIS synovitis scores than did the two studies 
without contrast (mean synovitis scores > 3 vs < 1, respectively; table 3).[10,27]
Prevalence of lesions at the bone and joint level
In the aforementioned studies, total scores per joint region were evaluated. Several 
studies evaluated the prevalence of MRI-features on the level of individual bones 
and/or joints, all defining a RAMRIS of ≥ 1 as positive.[24,29-32,36,39,41] Erosions 
were analysed in six studies; among the 4696 bones evaluated, 161 showed ero-
sions 3.4% (95% CI 2.9% to 4.0%).[30-32,36,39,41] BME was analysed in only two 
studies; among the 1182 bones evaluated, five were positive for BME 0.4% (95% CI 
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0.2% to 1.0%).[24,32] Three studies analysed 471 joints on synovitis and reported 
the prevalence of synovitis in 42 joints 8.9% (95% CI 6.6% to 11.9%).[29,30,41]
The severity of the individual lesions was scarcely reported. Three studies con-
tained information on the severity of erosions and reported that 80.8% (mean, 
95% CI 72.8% to 86.9%) of the recorded erosions had a score of 1.[31,32,36] None 
of the studies reported on the severity of BME or tenosynovitis at the local level. 
Two studies described the synovitis scores in more detail; 21 joints had a RAMRIS 
of 1 (95.5%), a RAMRIS synovitis score of 2 was seen in 1 joint (4.5%) and no joints 
had a RAMRIS of 3.[29,30]
With regard to the location of the MRI-features, erosions and synovitis were more 
often observed in the wrist than in the MCP joints.[20,31,32] The locations of 
erosions were evaluated in seven studies at the bone level; most erosions were 
observed in the carpal bones; however, there was no clear agreement on which 
carpal bones showed erosions most frequently.[30,32,35,36,41] Erosions were 
rarely scored on the metacarpal-1 and trapezium (bones that might also be affected 
by osteoarthritis).[30-32,35,36] Locations of BME and synovitis were not clearly 
reported.
Relevant characteristics
We next evaluated to what extent differences in the scanner or differences in 
persons’ characteristics influenced the results. No different prevalences were 
observed when comparing extremity-MRI [10,12,13,27,31-33,35] with whole-body 
MRI.[11,14-26,28-30,36-40] When comparing the prevalence of MRI-features in 
studies that used MRI-scanners with < 1 Tesla (T) [12,13,16,20,31-33,35-38] and those 
with > 1 T, [10,11,15,17,18,23,24,26,28,29,39,40] a higher prevalence of erosions 
was detected with < 1 T scanners (mean 38% vs 24%). Owing to the heterogeneity 
between studies, no summary results can be provided with regard to the prevalence 
of MRI inflammatory features in relation to the field strength of the MRI. When com-
paring the studies that evaluated the MRIs blindly versus those that scored the MRIs 
knowing that the persons were symptom-free, no differences in the prevalences of 




The dominant and non-dominant hands were evaluated in two studies and no sig-
nificant differences were observed.[31,36] Differences in the frequency of features 
between sexes were also not detected.[32] Four studies compared the prevalence 
of MRI-features between age categories and showed a non-significant tendency to 
[27,32] or a significant [31,36] higher prevalence of MRI erosions in older persons. 
Synovitis and BME were less frequently studied in relation to age, although a signif-
icant difference in two studies was observed with higher prevalences at older age.
[31,36] No information was provided on the location or the grading of the erosions 
and the inflammatory features observed in symptom-free persons of different age 
categories.
Discussion
MRI is an imaging method that is very sensitive in detecting inflammation and 
also bone erosions. This makes MRI an interesting tool to measure the course of 
the disease in randomised clinical trials and this suggests that MRI may also be 
useful in the diagnostic process. When MRI would be implemented in practice in 
the diagnostic workup of joint symptoms, it is crucial to consider the prevalence 
of MRI-features in the general population to prevent false-positive findings due 
to positive labelling of features that are (also) present in the normal situation. We 
reviewed the literature systematically to get an overview of the reported prevalence 
of features in symptom-free persons. The large majority of these studies were not 
designed to determine the frequencies of MRI-features in the general population 
but used symptom-free persons as the control group. In addition, there were con-
siderable differences in methodology of the selection of volunteers, MRI-protocols 
and MRI-scoring. This resulted in heterogeneous data. Indeed, considerable differ-
ences in the frequencies of MRI-features in symptom-free persons were observed 
in the different studies. We combined the data of the studies that had similar scan-
ning and scoring protocols and, based on the data available, we observed that all 
MRI-features studied were present regularly and that MRI-detected erosions were 
present most frequently (in 33-52% of symptom-free persons).
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Most studies described their findings at the patient/ joint region level and not at 
the level of individual bones or joints. However, studies that did include evaluation 
at the bone level showed that most lesions were mild (RAMRIS of 1). Furthermore, 
we noted a lower prevalence of all MRI-features (erosions in particular) in studies 
not using RAMRIS than in those using the RAMRIS method. This may possibly 
reflect that the RAMRIS method is sensitive and that radiologists evaluating the 
MRIs using clinical experience may more often report an MRI as normal. Addition-
ally, most of the studies that did not use the RAMRIS method were done when 
MRI-techniques were less developed.[11,12,14-22,24,25,44]
Of all MRI-features, the prevalence of synovitis varied the most between studies. 
This cannot be explained only by the absence or presence of contrast enhancement 
that may increase the sensitivity and specificity of identifying MRI-detected syno-
vitis as both types of studies were evaluated separately.[42,45,46] The reasons for 
these differences between studies are unclear to us.
The most important limitation of this review is the heterogeneity of the data col-
lected, which is a result of the methods with which data were collected in the 
individual studies. For instance, in many studies the symptom-free persons were 
used as the control-group and information on how the symptom-free persons were 
recruited was missing. Some studies included symptom-free persons only and did 
not use the symptom-free persons as controls.[22,23,28,30,32,36] A consequence 
of this latter approach is that the evaluators per definition were aware that they had 
evaluated scans of symptom-free persons. Hypothetically, awareness of the clin-
ical status may affect the scoring with lower scores being given to symptom-free 
individuals. In addition, the methodology to rule out rheumatic diseases differed 
between the studies. A difficult issue is to what extent osteoarthritis was ruled out; 
joint space narrowing or other osteoarthritic features were not assessed in these 
studies, so no definite conclusions can be drawn as to what extent the presence of 
asymptomatic osteoarthritis has affected the results. Furthermore, recent studies 
indicated that ACPA can affect the bone in the absence of clinically apparent 
arthritis and that subclinical inflammation may precede clinical arthritis.[9,10] In 




studies the symptom-free persons were even followed (for 1-5 years); none of these 
persons developed RA.
Another important limitation relates to the issue when it is allowed to combine 
the results of different studies. We combined results of studies that used similar 
scan protocols (same joints and uniformity in contrast enhancement) and similar 
scoring protocols. Still, the summary measures that we provided should be inter-
preted with care as the readers of the different studies were not trained together 
and inter-reader differences and other causes of heterogeneity most likely exist. 
Nevertheless, this review gives a first impression of the MRI-features present in 
the general population. It can be argued that more stringent quality criteria should 
be applied before it is acceptable to combine the results of different studies. For 
instance, the following quality criteria might be reasonable: (1) the recruitment 
method was described, (2) appropriate methodology was used to exclude persons 
with joint symptoms or joint disease, (3) the field strength of the MRI was ≥ 1 T and 
(4) scans were scored according to the RAMRIS method. None of the 32 studies 
included in this review fulfilled all these four criteria. This underlines that large, 
Box 1  Recommendations for high-quality studies, formulated based on the 
findings of this review
Recommendations for future studies
Include a large number of symptom-free persons 
Include persons of different age categories
Apply population based recruitment methods 
Describe the recruitment methodology
Apply thorough anamnesis and physical examination to exclude the presence of joint symptoms  
or signs of joint disorders.
Perform similar MRI-scans in all persons
MRI strength of ≥ 1 Tesla
Use contrast-enhancement
Score the MRIs according to RAMRIS
Include also MRIs of persons with joint diseases (eg RA) and score the MRIs blinded to the  
clinical status
Preform analyses stratified for age
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high quality studies on this subject are needed. Recommendations for the set-up 
of such studies are proposed in box 1.
Furthermore, several questions still have to be answered. More detailed studies 
are needed on the prevalence of MRI-detected erosions, BME, synovitis and teno-
synovitis in the symptom-free persons in relation to age. Furthermore, the location 
and the co-occurrence of erosions and inflammation (BME, synovitis or tenosyno-
vitis) could be important for differentiation. In none of the studies was it reported 
whether the erosions were accompanied by inflammatory lesions, which may also 
be relevant to differentiate early disease from normal variants, as disease-specific 
erosions might presumably more often be accompanied by measures of inflamma-
tion. Also the extent or severity of the lesions may be useful to take into account. 
Ultimately, comparing a large number of MRI-scans of healthy persons and early 
RA-patients will reveal which combination of features are disease specific and will 
allow MRI criteria specific for early disease to be defined.
In conclusion, MRI-features, erosions in particular, occur frequently in symp-
tom-free persons and are more prevalent with increasing age. Before MRI can be 
implemented in the diagnostic process of arthritis, further evaluation of these 
features in symptom-free persons is required. Preferentially, this is done in large 
studies, ensuring homogeneity in the scan-protocol and scoring method, by eval-
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Table 1-a Characteristics of the 31 selected studies




Male MRI Contrast Area scanned Uni/bilateral Score Method Blinded †
Scored without a validated method
Wrist+MCP summed
Nakahara et al, 1996 [11] 10 NP NP 5/5 1.5T Gd + Wrist+MCP NP Described +
Lindegaard et al, 2001 [12] 3 Hospital staff 46 (34-55) 1/2 0.2T Gd + Wrist+MCP Unilateral Described +
Yoshioka et al, 2006 [13] 13 NP 34.1 (22-48) 5/8 0.21T Gd - Wrist+MCP+PIP Bilateral NP +
Offidani et al, 1998 [14] 12 NP NP NP 1.0T Gd - Wrist+MCP+IP NP Described +
Wrist
Beltran et al, 1987 [15] 6 NP NP NP 1.5T Gd - Wrist NP Described NP
Jorgensen et al, 1993 [16] 4 NP 30 2/2 0.5T Gd + Wrist NP NP +
Yanagawa et al, 1993 [17] 10 NP NP 7/3 1.5T Gd + Wrist NP NP +
Østergaard et al, 1995 [18] 3 NP 30 (28-31) NP 1.5T Gd + Wrist NP NP +
Tonolli-Serabian et al, 1996 [19] 10 NP 59 (46-71) 5/5 1.0T Gd + Wrist Bilateral Described +
Pierre-Jerome et al, 1997 [20] 42 NP 42.1 42/0 0.5T Gd - Wrist Bilateral Described NP
Valeri et al, 2001 [21] 12 NP 31 8/4 1.0T Gd - Wrist Bilateral Described NP
Partik et al, 2002 [22] 18 NP 30,8 (24-34) 9/9 1.0T Gd + Wrist NP NP NP
Robertson et al, 2006 [23] 30 Hospital staff & 
contacts
31 (22-49) 17/13 1.5T Gd + Wrist Unilateral Described NP
MCP 
McGonagle et al, 1999 [24] 31 Hospital staff 48 (28-62) 18/13 1.5T Gd - MCP Unilateral Described +
Klarlund et al, 1999 [25] 3 NP 31 (24-33) NP 1.0T Gd + MCP Unilateral Described +
Vlychou et al, 2013 [26] 5 2 volunteers & with 
3 wrist instability
41.2 ± 3.2 3/2 3.0T Gd + MCP+PIP+DIP Unilateral Described +
Scored according to RAMRIS (see table 1-b on the next pages) 
* Description of recruitment of symptom-free persons.
†  Scoring was done blind for the status (patient/symptom-free person) described, articles that do  
describe their scoring method but not according to the RAMRIS method; 
DIP, distal interphalangeal joint; 
Gd, gadolinium; 
IP, interphalangeal joint; 
MCP, metacarpophalangeal joints; 
MTP, metatarsophalangeal; 
NP, Not provided; 
PIP, proximal interphalangeal joint; 
T, tesla.
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Klarlund et al, 1999 [25] 3 NP 31 (24-33) NP 1.0T Gd + MCP Unilateral Described +
Vlychou et al, 2013 [26] 5 2 volunteers & with 
3 wrist instability
41.2 ± 3.2 3/2 3.0T Gd + MCP+PIP+DIP Unilateral Described +
Scored according to RAMRIS (see table 1-b on the next pages) 
* Description of recruitment of symptom-free persons.
†  Scoring was done blind for the status (patient/symptom-free person) described, articles that do  
describe their scoring method but not according to the RAMRIS method; 
DIP, distal interphalangeal joint; 
Gd, gadolinium; 
IP, interphalangeal joint; 
MCP, metacarpophalangeal joints; 
MTP, metatarsophalangeal; 
NP, Not provided; 





Table 1-b Characteristics of the 31 selected studies




Male MRI Contrast Area scanned Uni/bilateral Score Method Blinded †
Scored without a validated method (see table 1-a on the previous pages)
Scored according to RAMRIS 
Wrist+MCP data
Brown et al, 2006 [29] 17 NP 38 12/5 1.5T Gd + Wrist+MCP Unilateral RAMRIS +
Ejbjerg et al, 2004 [30] 8 NP 47 (24-67) 20/8 1.0T Gd + Wrist+MCP Unilateral RAMRIS NP
Olech et al, 2010 [31] 40 Hospital staff 36.7 (20-64) 29/11 0.2T Gd - Wrist+MCP Bilateral RAMRIS +
Parodi et al, 2006 [32] 23 Healthy relatives  59 (25-86) 16/7 0.2T Gd - Wrist+MCP+PIP Bilateral RAMRIS NP
Ejbjerg et al, 2005 [33] 9 NP NP NP 0.2T Gd - Wrist+MCP+MTP Bilateral RAMRIS +
Duer-Jensen et al, 2011 [34] 24 NP 46 (21-71) 17/7 0.6T(12), 1.0T(12) Gd + Wrist+MCP+PIP Unilateral RAMRIS NP
Wrist
Cimmino et al, 2011 [35] 13 NP 71 (57-86) NP 0.2T Gd - Wrist Bilateral RAMRIS +
Palosaari et al, 2009 [36] 31 Hospital staff 49 (32-64) 18/13 0.23T Gd+ (10/31) Wrist Bilateral RAMRIS NP
Døhn et al, 2008 [37] 4 NP 36 (34-57) 3/1 0.6T Gd - Wrist Unilateral RAMRIS +
MCP
Døhn et al, 2006 [38] 4 NP 35.5 (34-57) 3/1 0.6T Gd - MCP Unilateral RAMRIS +
Tan et al, 2003 [39] 28 NP 40 19/9 1.5T Gd + (8/28) MCP Unilateral RAMRIS +
Miese et al, 2012 [40] 13 NP 51 ± 12 (25-66) 10/3 3T Gd + MCP (dig 2&3) Unilateral RAMRIS NP
Mean grading (Wrist+MCP)
Xie et al, 2008 [27] 14 NP 25 ± 5 (19-33) 4/10 1.0T Gd - Wrist+MCP Bilateral RAMRIS NP
Xie et al, 2008 [27] 27 NP 62 ± 7 (49-74) 22/5 1.0T Gd - Wrist+MCP 24/27 Bilateral RAMRIS  NP
Krabben et al, 2013 [10] 19 NP 46.2 ± 11.8 15/4 1,5T Gd - Wrist+MCP+MTP Unilateral RAMRIS NP
Rastogi et al, 2013 [28] 10 NP (24-40) 7/3 3T Gd+ Wrist Unilateral RAMRIS NP
* Description of recruitment of symptom-free persons.
†  Scoring was done blind for the status (patient/symptom-free person) described, articles that do  
describe their scoring method but not according to the RAMRIS method; 
DIP, distal interphalangeal joint; 
Gd, gadolinium; 
IP, interphalangeal joint; 
MCP, metacarpophalangeal joints; 
MTP, metatarsophalangeal; 
NP, Not provided; 
PIP, proximal interphalangeal joint; 
T, tesla.
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Table 1-b Characteristics of the 31 selected studies




Male MRI Contrast Area scanned Uni/bilateral Score Method Blinded †
Scored without a validated method (see table 1-a on the previous pages)
Scored according to RAMRIS 
Wrist+MCP data
Brown et al, 2006 [29] 17 NP 38 12/5 1.5T Gd + Wrist+MCP Unilateral RAMRIS +
Ejbjerg et al, 2004 [30] 8 NP 47 (24-67) 20/8 1.0T Gd + Wrist+MCP Unilateral RAMRIS NP
Olech et al, 2010 [31] 40 Hospital staff 36.7 (20-64) 29/11 0.2T Gd - Wrist+MCP Bilateral RAMRIS +
Parodi et al, 2006 [32] 23 Healthy relatives  59 (25-86) 16/7 0.2T Gd - Wrist+MCP+PIP Bilateral RAMRIS NP
Ejbjerg et al, 2005 [33] 9 NP NP NP 0.2T Gd - Wrist+MCP+MTP Bilateral RAMRIS +
Duer-Jensen et al, 2011 [34] 24 NP 46 (21-71) 17/7 0.6T(12), 1.0T(12) Gd + Wrist+MCP+PIP Unilateral RAMRIS NP
Wrist
Cimmino et al, 2011 [35] 13 NP 71 (57-86) NP 0.2T Gd - Wrist Bilateral RAMRIS +
Palosaari et al, 2009 [36] 31 Hospital staff 49 (32-64) 18/13 0.23T Gd+ (10/31) Wrist Bilateral RAMRIS NP
Døhn et al, 2008 [37] 4 NP 36 (34-57) 3/1 0.6T Gd - Wrist Unilateral RAMRIS +
MCP
Døhn et al, 2006 [38] 4 NP 35.5 (34-57) 3/1 0.6T Gd - MCP Unilateral RAMRIS +
Tan et al, 2003 [39] 28 NP 40 19/9 1.5T Gd + (8/28) MCP Unilateral RAMRIS +
Miese et al, 2012 [40] 13 NP 51 ± 12 (25-66) 10/3 3T Gd + MCP (dig 2&3) Unilateral RAMRIS NP
Mean grading (Wrist+MCP)
Xie et al, 2008 [27] 14 NP 25 ± 5 (19-33) 4/10 1.0T Gd - Wrist+MCP Bilateral RAMRIS NP
Xie et al, 2008 [27] 27 NP 62 ± 7 (49-74) 22/5 1.0T Gd - Wrist+MCP 24/27 Bilateral RAMRIS  NP
Krabben et al, 2013 [10] 19 NP 46.2 ± 11.8 15/4 1,5T Gd - Wrist+MCP+MTP Unilateral RAMRIS NP
Rastogi et al, 2013 [28] 10 NP (24-40) 7/3 3T Gd+ Wrist Unilateral RAMRIS NP
* Description of recruitment of symptom-free persons.
†  Scoring was done blind for the status (patient/symptom-free person) described, articles that do  
describe their scoring method but not according to the RAMRIS method; 
DIP, distal interphalangeal joint; 
Gd, gadolinium; 
IP, interphalangeal joint; 
MCP, metacarpophalangeal joints; 
MTP, metatarsophalangeal; 
NP, Not provided; 





Table 2-a Frequency of erosions, BME, synovitis and tenosynovitis in symptom-free persons
First author, year of publication N = healthy Uni/bilateral Erosions BME Synovitis Tenosynovitis
Scored without a validated method
Wrist+MCP 
Nakahara et al, 1996 [11] 10 NP NP 0.0% 0.0% 0.0%
Lindegaard et al, 2001 [12] 3 Unilateral 0.0% NP NP NP
Yoshioka et al, 2006 [13] 13 (+PIP) Bilateral 0.0% NP 0.0% 0.0%
Offidani et al, 1998 [14] 12 (+IP) NP 0.0% NP 0.0% 0.0%
Wrist 
Beltran et al, 1987 [15] 6 NP 0.0% NP 0.0% 0.0%
Jorgensen et al, 1993 [16] 4 NP 0.0% NP 0.0% 0.0%
Yanagawa et al, 1993 [17] 10 NP NP NP 0.0% NP
Østergaard et al, 1995 [18] 3 NP NP NP 0.0% NP
Tonolli-Serabian et al, 1996[19] 10 Bilateral 0.0% NP 0.0% NP
Pierre-Jerome et al, 1997 [20] 42 Bilateral 35.7% * 0.0% 4.8% Fl: 9.5% Ext: 7.1%
Valeri et al, 2001 [21] 12 Bilateral NP NP NP 0.0%
Partik et al, 2002 [22] 18 NP NP 0.0% 44.4% NP
Robertson et al, 2006 [23] 30 Unilateral NP 13.3% NP NP
MCP
McGonagle et al, 1999 [24] 31 Unilateral 25.8% 9.7% NP NP
Klarlund et al, 1999 [25] 3 Unilateral 0.0% NP NP NP
Vlychou et al, 2013 [26] 5 (+PIP, DIP) Unilateral 0.0% 0.0% 0.0% 0.0%
Scored according to RAMRIS (see table 2-b on the next pages) 
0% is noted when no erosions are found or an abnormality is described in the patient group and the 
healthy control group is only described as ‘no abnormalities’ with no further specification.
Italics: studies in which contrast was used to score synovitis and tenosynovitis. 
* Contradicting data in original article, with 35.7% erosions in the table and 14.3% erosions in the text.
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Table 2-a Frequency of erosions, BME, synovitis and tenosynovitis in symptom-free persons
First author, year of publication N = healthy Uni/bilateral Erosions BME Synovitis Tenosynovitis
Scored without a validated method
Wrist+MCP 
Nakahara et al, 1996 [11] 10 NP NP 0.0% 0.0% 0.0%
Lindegaard et al, 2001 [12] 3 Unilateral 0.0% NP NP NP
Yoshioka et al, 2006 [13] 13 (+PIP) Bilateral 0.0% NP 0.0% 0.0%
Offidani et al, 1998 [14] 12 (+IP) NP 0.0% NP 0.0% 0.0%
Wrist 
Beltran et al, 1987 [15] 6 NP 0.0% NP 0.0% 0.0%
Jorgensen et al, 1993 [16] 4 NP 0.0% NP 0.0% 0.0%
Yanagawa et al, 1993 [17] 10 NP NP NP 0.0% NP
Østergaard et al, 1995 [18] 3 NP NP NP 0.0% NP
Tonolli-Serabian et al, 1996[19] 10 Bilateral 0.0% NP 0.0% NP
Pierre-Jerome et al, 1997 [20] 42 Bilateral 35.7% * 0.0% 4.8% Fl: 9.5% Ext: 7.1%
Valeri et al, 2001 [21] 12 Bilateral NP NP NP 0.0%
Partik et al, 2002 [22] 18 NP NP 0.0% 44.4% NP
Robertson et al, 2006 [23] 30 Unilateral NP 13.3% NP NP
MCP
McGonagle et al, 1999 [24] 31 Unilateral 25.8% 9.7% NP NP
Klarlund et al, 1999 [25] 3 Unilateral 0.0% NP NP NP
Vlychou et al, 2013 [26] 5 (+PIP, DIP) Unilateral 0.0% 0.0% 0.0% 0.0%
Scored according to RAMRIS (see table 2-b on the next pages) 
DIP, distal interphalangeal joint; 
Ext, extensor tendons; 
Fl, flexor tendons; 
IP, interphalangeal joint; 
MCP, metacarpophalangeal joints;
MTP, metatarsophalangeal; 
NP, Not provided;  




Table 2-b Frequency of erosions, BME, synovitis and tenosynovitis in symptom-free persons
First author, year of publication N = healthy Uni/bilateral Erosions BME Synovitis Tenosynovitis
Scored without a validated method (see table 1-a on the previous pages)
Scored according to RAMRIS
Wrist+MCP (2-5)
Brown et al, 2006 [29] 17 Unilateral NP 0.0% 17.6% 5.9%
Ejbjerg et al, 2004 [30] 28 Unilateral NP 0.0% 32.1% NP
Olech et al, 2010[31] 40 Bilateral 65.0% 17.5% 42.5% NP
Parodi et al, 2006 [32] 23 (+PIP) Bilateral 26.0% 8.7% NP Fl: 17.4% xt: 4.3%
Ejbjerg et al, 2005 [33] 9 (+MTP) Bilateral 55.6% NP NP NP
Combined data [29,30] 0/45 Unilateral BME mean 0% (95% CI 0.0-6.8)
Combined data [29,30] 12/45 Unilateral Synovitis mean 26.7% (95% CI 15.8-41.2)
Wrist
Cimmino et al, 2011 [35] 13 Bilateral 30.8% 30.8% 0.0% 30.8%
Palosaari et al, 2009 [36] 31 Bilateral 45.2% NP 60.0% NP
Døhn et al, 2008 [37] 4 Unilateral 25.0% NP NP NP
Duer-Jensen et al, 2011† [34] 24 Unilateral 45.8% 4.5% 81.8% 0.0%
Xie et al,2008 ‡ [27] 14 Age 25 ± 5 Unilateral 0.0% 0.0 0.0% NP
27 Age 62 ± 7 Unilateral 88.9% 33.3% 3.7% NP
Combined data [35,36] 18/44 Bilateral Erosions mean 40.9% (95% CI 27.7-55.6)
Combined data [27,34,37] 36/69 Unilateral Erosions mean 52.2% (95% CI 40.6-63.5)
Combined data [27,34] 10/63 § Unilateral BME mean 15.9% (95% CI 8.7-27.0)
MCP (2-5) 
Døhn et al, 2006 [38] 4 Unilateral 0.0% NP NP NP
Tan et al, 2003 [39] 28 Unilateral 32.1% NP NP NP
Miese et al, 2012 [40] 13 MCP 2&3 Unilateral NP 0.0% 0.0% NP
Duer-Jensen et al, 2011† [34] 24 Unilateral 45.8% 4.5% 45.5% 0.0%
Xie et al,2008 ‡ [27] 14 Age 25 ± 5 Unilateral 0.0% 14.3% 0.0% NP
27 Age 62 ± 7 Unilateral 44.4% 11.1% 14.8% NP
Combined data [27,34,38,39] 32/97 Unilateral Erosions mean 33.0% (95% CI 24.4-42.9)
Combined data [27,34] 6/63 § Unilateral BME mean 9.5% (95% CI 4.1-19.6)
0% is noted when no erosions are found or an abnormality is described in the patient group and the 
healthy control group is only described as ‘no abnormalities’ with no further specification.
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Table 2-b Frequency of erosions, BME, synovitis and tenosynovitis in symptom-free persons
First author, year of publication N = healthy Uni/bilateral Erosions BME Synovitis Tenosynovitis
Scored without a validated method (see table 1-a on the previous pages)
Scored according to RAMRIS
Wrist+MCP (2-5)
Brown et al, 2006 [29] 17 Unilateral NP 0.0% 17.6% 5.9%
Ejbjerg et al, 2004 [30] 28 Unilateral NP 0.0% 32.1% NP
Olech et al, 2010[31] 40 Bilateral 65.0% 17.5% 42.5% NP
Parodi et al, 2006 [32] 23 (+PIP) Bilateral 26.0% 8.7% NP Fl: 17.4% xt: 4.3%
Ejbjerg et al, 2005 [33] 9 (+MTP) Bilateral 55.6% NP NP NP
Combined data [29,30] 0/45 Unilateral BME mean 0% (95% CI 0.0-6.8)
Combined data [29,30] 12/45 Unilateral Synovitis mean 26.7% (95% CI 15.8-41.2)
Wrist
Cimmino et al, 2011 [35] 13 Bilateral 30.8% 30.8% 0.0% 30.8%
Palosaari et al, 2009 [36] 31 Bilateral 45.2% NP 60.0% NP
Døhn et al, 2008 [37] 4 Unilateral 25.0% NP NP NP
Duer-Jensen et al, 2011† [34] 24 Unilateral 45.8% 4.5% 81.8% 0.0%
Xie et al,2008 ‡ [27] 14 Age 25 ± 5 Unilateral 0.0% 0.0 0.0% NP
27 Age 62 ± 7 Unilateral 88.9% 33.3% 3.7% NP
Combined data [35,36] 18/44 Bilateral Erosions mean 40.9% (95% CI 27.7-55.6)
Combined data [27,34,37] 36/69 Unilateral Erosions mean 52.2% (95% CI 40.6-63.5)
Combined data [27,34] 10/63 § Unilateral BME mean 15.9% (95% CI 8.7-27.0)
MCP (2-5) 
Døhn et al, 2006 [38] 4 Unilateral 0.0% NP NP NP
Tan et al, 2003 [39] 28 Unilateral 32.1% NP NP NP
Miese et al, 2012 [40] 13 MCP 2&3 Unilateral NP 0.0% 0.0% NP
Duer-Jensen et al, 2011† [34] 24 Unilateral 45.8% 4.5% 45.5% 0.0%
Xie et al,2008 ‡ [27] 14 Age 25 ± 5 Unilateral 0.0% 14.3% 0.0% NP
27 Age 62 ± 7 Unilateral 44.4% 11.1% 14.8% NP
Combined data [27,34,38,39] 32/97 Unilateral Erosions mean 33.0% (95% CI 24.4-42.9)
Combined data [27,34] 6/63 § Unilateral BME mean 9.5% (95% CI 4.1-19.6)
§ Duer-Jensen only assessed 22 patients for BME.
DIP, distal interphalangeal joint; Ext, extensor tendons; Fl, flexor tendons; IP, interphalangeal joint; 
MCP, metacarpophalangeal joints; MTP, metatarsophalangeal; NP, Not provided;  




Table 3 Mean RAMRIS score in symptom-free persons
First author, 
year of 
publication N = healthy
Uni/
bilateral Erosions BME Synovitis
Teno-
synovitis
Xie et al,2008 
[27]
14 
Age 25 ± 5
Bilateral 0 Pt Dom MCP: 0.14 0 Pt NP
27 
Age 62 ± 7
24/27 
Bilateral
Dom MCP: 1.51 
Dom Wr: 3.11
Dom MCP: 0.29 
Dom Wr: 0.85
Dom MCP: 0.29 
Dom Wr: 0.03
NP
Krabben et al, 
2013 [10]
19 (+MTP) Unilateral MCP/PIP: 0.1 
Wrist: 0.7
MCP/PIP: 0.1 # 
Wrist: 0.9
NP
Rastogi et al, 
2013 * [28]
10 Unilateral T0: 0.8 ± 1.3 
T12: 0.4 ± 0.7 
T24: 0.4 ± 0.7 
T52: 1.4 ± 1.9
T0: 0.6 ± 0.7 
T12: 0.2 ± 0.5 
T24: 0.2 ± 0.4 
T52: 0.3 ± 0.6
T0: 3.5 ± 2.6 
T12: 3.3 ± 1.6 
T24: 3.7 ± 2.0 
T52: 4.5 ± 1.7
NP
Italics: studies in which contrast was used to score synovitis and tenosynovitis. 
Erosions were scored on a scale from 0-10 for each location; BME and synovitis were scored from 0-3 
for each location.
Erosions and BME were scored in 23 locations in the hand and 10 in the foot; synovitis was scored in 
7 locations in the hand and 5 in the foot. 
† Krabben summed the BME and the synovitis into an inflammation score.
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Introduction. The use of magnetic resonance imaging (MRI)-detected inflammation 
and joint damage in the diagnosis of rheumatoid arthritis is recommended by a 
European League Against Rheumatism imaging task force. This recommendation is 
based on the sensitivity of MRI and not on specificity. Knowledge of the prevalence 
of MRI-detected features in symptom-free persons, however, is pivotal when con-
sidering MRI for diagnostic purposes.
Methods. From November 2013 to December 2014, 196 symptom-free persons of 
different ages were recruited from the general population. Inclusion criteria were 
no history of inflammatory arthritis, no joint symptoms during the previous month, 
and no clinically detectable arthritis on physical examination. Contrast-enhanced 
MRIs of the dominant metacarpophalangeal (MCP), wrist, and metatarsophalan-
geal (MTP) joints were obtained using a 1.5T scanner and scored by 2 readers for 
synovitis, bone marrow edema, tenosynovitis, and erosions. For analyses at the 
joint level, MRI-detected inflammation was considered present if both readers 
scored the image as positive.
Results. Of 193 persons scanned (ages 19-89 years), only 28% had no single 
inflammatory feature and 22% had no erosions. Primarily low-grade features were 
observed. All MRI-features were positively correlated with age (P < 0.001). Preferential 
locations for synovitis were MCP2, MCP3, the wrists, and MTP1. Bone marrow edema 
was frequently present in MCP3, the scaphoid, and MTP1. Tenosynovitis was infre-
quent, except for in the extensor carpi ulnaris. Preferential locations for erosions were 
MCP2, MCP3, MCP5, the distal ulna, MTP1, and MTP5. Tables with age-, location-, and 
inflammation type-dependent frequencies were constructed. Simultaneous colocal-
ized presence of synovitis, bone marrow edema, tenosynovitis, or erosions occurred.
Conclusion. MRI-detected inflammation and erosions are prevalent in symp-
tom-free persons from the general population, especially at older ages and at 
preferential locations.
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Introduction
Magnetic resonance imaging (MRI) findings are increasingly used as outcome mea-
sures in clinical trials in rheumatoid arthritis (RA). According to a European League 
Against Rheumatism (EULAR) imaging task force, MRI is also helpful in the diagno-
sis of RA.[1] The first recommendation of this task force states that MRI can be used 
to improve the certainty of a diagnosis when there is doubt. This recommendation 
is largely based on the fact that MRI is more sensitive than physical examination for 
detecting local inflammation.[1-3] As such, MRI may increase the ability to identify 
arthritis or RA very early.
Computed tomography may be more sensitive than MRI for the detection of ero-
sions,[4] but if MRIs are obtained to evaluate local inflammation, erosive lesions 
can also be detected. An imaging task force of the American College of Rheumatol-
ogy concluded that MRI assesses structural damage more sensitively than other 
imaging modalities.[5] The EULAR imaging task force also recommended that MRI 
be considered for detecting local damage at an earlier time point if conventional 
radiographs do not show damage.[1] Similar to the recommendation regarding 
using MRI for the detection of inflammation, this recommendation is based on 
MRI-studies of RA-patients, which thus assessed the sensitivity of the method.
The specificity of MRI-findings has not yet been determined, because the preva-
lence of MRI-detected inflammation and erosions in the general population has not 
been explored extensively. Recently, we reviewed the literature for studies of MRI 
in healthy subjects.[6-12] Taken together, the findings of those studies suggested 
that erosions, synovitis, and bone marrow edema occur regularly in the general 
population. However, the available studies had some limitations. They included 
few symptom-free persons, recruitment methods were often not reported or not 
entirely population based, and age was not taken into account. Furthermore, spe-
cific locations were not assessed because analyses were mostly done at the level 
of the person but not at the level of individual bones.
Currently available data, therefore, do not allow a description of the prevalence 
of MRI-detected inflammation and erosions in the general population. Before 




on their specificity is required. In this light, we aimed to address the following ques-
tions: 1) What is the occurrence of different MRI-features (synovitis, bone marrow 
edema, tenosynovitis, and erosions) in symptom-free persons? 2) Is the frequency 
of these MRI-features dependent on anatomic location, sex, or age? 3) Do different 
MRI-features occur simultaneously at the same joint in symptom-free persons?
Subjects and methods
Participants
This cross-sectional study was performed between November 2013 and December 
2014 in Leiden, The Netherlands. Symptom-free individuals were recruited via 
advertisements in local newspapers and web sites. Inclusion criteria were: age 
18 years or older, no history of RA or other inflammatory rheumatic diseases, no 
joint symptoms during the previous month, and no clinically detectable arthritis 
on physical examination. Persons who volunteered were screened for these criteria 
by telephone and a subsequent visit at the outpatient clinic. At inclusion, informa-
tion was collected on age, sex, weight, height, dominant hand, smoking history, 
alcohol consumption, comorbidity, and medical history. Physical examinations 
of the hands and feet were performed to exclude the presence of arthritis and to 
evaluate the presence of asymptomatic Heberden’s nodes or Bouchard’s nodes or 
hallux valgus. We decided not to exclude persons with these asymptomatic signs 
of osteoarthritis (OA), since prior exclusion would result in a “too healthy” study 
population.
The presence of these signs was recorded, allowing subanalyses excluding these 
individuals. At the second visit, MRI was performed. After the 2 visits, participants 
received a voucher for e20 as compensation for their time and travel costs. Partici-
pants did not receive a report of their MRI-findings. The study was approved by the 
local medical ethics committee, and written informed consent was obtained from 
all subjects.
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MRI-protocol and scoring
MRI of the metacarpophalangeal (MCP) joints, wrist joints, and metatarsopha-
langeal (MTP) joints on the dominant side was performed within 15 days after the 
screening visit. Sequences acquired were coronal precontrast T1-weighted fast 
spin-echo (FSE) and coronal and axial postcontrast T1-weighted FSE with frequen-
cy-selective fat suppression. Further details on the scan protocol are provided in 
the Supplementary Methods, available on the Arthritis & Rheumatology website.
MRI-scoring was done independently by 2 trained readers (LM and HWvS). In an 
attempt to exclude observer bias introduced by knowing that persons had no 
symptoms, the MRIs of symptom-free individuals were mixed with MRIs of RA-pa-
tients and patients with arthralgia without clinical synovitis (total n = 99).[13,14] 
The readers were blinded with regard to any personal or clinical data. Scoring of 
synovitis, bone marrow edema, and erosions was performed following the Rheu-
matoid Arthritis Magnetic Resonance Imaging Scoring (RAMRIS) method (see Sup-
plementary Methods). Tenosynovitis in the MCP and wrist was scored according to 
the method described by Haavardsholm et al.[15,16] The total MRI inflammation 
score was calculated by summing the scores for all inflammatory features, includ-
ing the synovitis, bone marrow edema, and tenosynovitis scores in the MCP and 
wrist joints and the synovitis and bone marrow edema scores in the MTP joints.
The within-reader intraclass correlation coefficient (ICC), based on 40 MRI-scans, 
was 0.99 for reader 1 and 0.98 for reader 2, and the interreader ICC, based on 
193 MRI-scans, was 0.96. When evaluating the inflammation or erosion scores at 
the subject level, the mean scores of both readers were studied. When performing 
analyses at the joint level evaluating MRI-features at specific locations, the data 
were categorized. In the case of disagreement between the 2 readers, the lower 
score was used. For instance, when 1 reader scored a feature as 1 and the other 
reader scored the same feature as 0, the final score for that feature at that location 
was 0. Differences between readers in scores at individual locations of > 1 did not 





Frequencies were assessed. Comparisons between sexes were conducted using 
the Mann-Whitney U test. Correlations of MRI-findings with age were determined 
using Pearson’s correlation coefficient. SPSS V20.0.0 was used.
Results
Characteristics of the participants
Of 199 volunteers screened between November 2013 and December 2014, 196 
fulfilled the inclusion criteria. Three individuals were excluded because of hand 
symptoms. After inclusion, 3 others did not undergo MRI and were excluded 
because of personal problems, vasovagal response to intravenous puncture, and 
anxiety, respectively. Consequently, MRIs for 193 persons (ages 19-89 years) were 
obtained. Baseline characteristics of the subjects are presented in Table  1. On 
clinical examination, signs of OA (e.g., Heberden’s nodes, Bouchard’s nodes, and 
hallux valgus) were observed in 68 persons (33 participants ages 40-59 years and 
35 participants older than 60 years). No clinically relevant incidental findings were 
observed.
Presence of MRI-detected inflammation and erosions
The median total MRI inflammation score was 2 (interquartile range (IQR] 0.5-4.5). 
For synovitis, bone marrow edema, tenosynovitis, and erosions, the median total 
scores were 0.5 (IQR 0.0-2.0), 1.0 (IQR 0.0-2.0), 0.0 (IQR 0.0-0.0), and 2.0 (IQR 
1.0-4.0), respectively. Forty-two participants (22%) had no erosions, and 54 partici-
pants (28.0%) had a total MRI inflammation score of 0 (see Supplementary Table 1, 
available on the Arthritis & Rheumatology website). A total synovitis score of ≥ 1 
was recorded for 48.2% of the subjects, a total bone marrow edema score of ≥ 1 for 
57.5%, and a total tenosynovitis score of ≥ 1 for 16.6%. Hence, tenosynovitis was 
less prevalent than the other features.
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Location of MRI-detected inflammation and erosions
Next, we assessed the 3 different joint regions (MCPs, wrist, and MTPs). The highest 
total inflammation score was obtained in the wrist (median 1.0 [IQR 0.0-2.5]). The 
median total inflammation score at the MCP and MTP joints was 0.0 (IQR 0.0-1.0) 
and 0.0 (IQR 0.0-1.0). Synovitis, bone marrow edema, tenosynovitis, and erosion 
scores of ≥ 1 in the wrist were present in 33.2%, 45.1%, 9.3%, and 68.4% of the 
participants, respectively; these percentages were higher than those for the MCP 
and MTP joints (Supplementary Table 1).
We next assessed the MRI-features at the individual joint level. At the level of the 
MCP joints, synovitis, bone marrow edema, and erosions were most frequently 
present in MCP3 (in 11.4%, 3.6%, and 14.5% of the subjects, respectively) and 
MCP2 (in 8.8%, 2.6%, and 17.1% of the subjects, respectively). Flexor tenosynovitis 
was most frequently present in MCP3 (in 4.7% of the subjects) (see Supplementary 
Table 2, available on the Arthritis & Rheumatology website).
In the 3 wrist joints, synovitis was frequently observed (in the distal radioulnar joint 
in 8.3%, in the radiocarpal joint in 17.1%, and in the intercarpal carpometacarpal 
[CMC] joint in 15.5% of the subjects). In the carpal bones, bone marrow edema was 
most frequently present in the lunate, scaphoid, and distal ulna (in 19.2%, 8.8%, 
and 5.2% of the subjects, respectively). Erosions were frequently found in the cap-
itate (in 23.3% of the subjects), lunate (in 21.8% of the subjects), and distal ulna 
(in 11.9% of the subjects). Tenosynovitis was almost absent in the wrist, with the 
exception of the extensor carpi ulnaris tendon (extensor compartment VI), which 
showed tenosynovitis in 7.3% of the subjects (Supplementary Table 2).
At the level of the MTP joints, inflammation preferentially occurred in MTP1, with 
synovitis in 10.4% of the subjects and bone marrow edema in 17.1% of the sub-
jects; erosions were present in MTP1 in 18.1% of the subjects. Erosions were also 
frequently present in MTP5 (in 7.8% of the subjects) (Supplementary Table 2).
The anatomic location of the MRI-detected erosion and the cortical break was 
studied in detail for several bones that were frequently affected (Figures 1A-D). The 
erosions were more frequently seen in the proximal side of the joint than in the 





Association between sex and MRI-features
We next investigated whether men and women had different MRI scores. The 
median total inflammation score for men was 2.0 (IQR 1.0-4.5) and that for women 
was 2.0 (IQR 0.5-4.4), showing no difference between the sexes (P = 0.36). Simi-
larly, the total synovitis, bone marrow edema, tenosynovitis, and erosion scores 
were compared and showed no differences (P = 0.79, P = 0.14, P = 0.41, and P = 0.11, 
respectively).
Association between age and MRI-features
We next investigated whether age was correlated with MRI-detected inflammation. 
We observed that older age was positively correlated with a higher total inflamma-
tion score (r = 0.57, P < 0.001) (Figure 2A). This positive correlation with older age 
was also found for synovitis, bone marrow edema, tenosynovitis, and erosions 
separately (r = 0.55, r = 0.51, r = 0.28, and r = 0.69, respectively) (all P < 0.001) 
(Figures 2B-E).
To explore the possibility that these correlations were caused by the presence of 
asymptomatic OA, the prevalence of which also increases with age, we performed 
subanalyses. First, subjects with any sign of (asymptomatic) OA at physical exam-
ination were excluded. The correlations between age and the total inflammation 
score and between age and the erosion score remained similar to those obtained 
Figure 1  (Next page) Schematic overview of observed RAMRIS defined erosions.  
Schematically depicted are the locations of cortical breaks in MCP-2 
and MCP-3 (A), MCP-5 (B), distal ulna (C), and MTP-1 (D) in coronal 
and axial plane, and an MRI example of erosions (arrows) at these 
locations. MR sequences include coronal T1 FSE and axial T1 FSE with 
fat suppression after contrast enhancement.
Figure 1:  (Next page) The grey dots present the location of the cortical breaks; when more cortical 
breaks are present at the same location the dots have a darker shade of grey.
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before exclusion of these subjects (r = 0.53, P < 0.001 and r = 0.66, P < 0.001, respec-
tively). When anatomic locations that are included in the RAMRIS method but also 
Figure 2  Correlations between age and total inflammation-score(A.1.), total 
synovitis-score(B.), total BME-score(C.), total tenosynovitis-score(D.) 
and total erosions-score(E.1.) in all 193 symptom-free persons, and 
correlations between age and total inflammation and total  
erosion-scores after exclusion of persons with Heberden’s nodes, 
Bouchards nodes, or hallux valgus (n = 68) and CMC-1 and MTP-1 joints 
(A.2., E.2.)





















































































































Correlation coefficient of age with (A.1.) inflammation-score was r = 0.57, (A.2.) inflammation-score 
r = 0.52, (B.) synovitis-score was r = 0.55, (C.) BME-score was r = 0.51, (D.) tenosynovitis-score was 
r = 0.28, (E.1.) erosion-score r = 0.69, and (E.2.) erosion-score r = 061, all p < 0.001.
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are known to be predilection sites for OA (CMC1 and MTP1) were removed from the 
analysis, the correlation coefficient for the association of inflammation with age 
was r = 0.55 (P < 0.001), and the correlation coefficient for the association of erosions 
with age was r = 0.62 (P < 0.001). Finally, these individuals and anatomic locations 
were both excluded from the data set, after which the correlation of inflammation 
score with age was still observed (r = 0.52, P < 0.001) (Figure  2A). Similarly, age 
remained correlated with the erosion score (r = 0.61, P < 0.001) (Figure 2E).
Generation of tables with age-, location-, and feature-dependent 
prevalence of MRI-detected inflammation and erosions.
The data presented thus far indicate that the prevalence of MRI-findings in the 
symptom-free population is dependent on the age of the individual, the anatomic 
location, and the feature assessed. Therefore, we constructed tables that incor-
porate these 3 characteristics. These tables present the frequency of synovitis, 
bone marrow edema, tenosynovitis, and erosions per joint per age category ( < 40, 
40-59, and ≥ 60 years) and per grade of severity (Tables 2-4). As Tables 2-4 show, in 
general MRI-detected inflammation was rare in individuals younger than 40 years. 
Furthermore, features were very rarely assigned scores of 2 or 3.
At the MCP joints, synovitis was present in MCP2 in 8% and in MCP3 in 14% of 
the participants ages 40-59 years and in MCP2 in 19% and in MCP3 in 17% of the 
participants age 60 years or older (Table 2). Flexor tenosynovitis at MCP2-4 was 
present in 6-12% of the participants age 60 years or older.
At the wrist, grade 1 synovitis of the distal radioulnar, radiocarpal, and intercarpal 
CMC joints was frequent in persons age 40 years or older (Table 3). Bone marrow 
edema was prevalent in the scaphoid and lunate, and the prevalence increased 
with older age. In the bones forming the CMC1 joint (proximal metacarpal 1 and 
trapezium), inflammation occurred more frequently at older ages. (The frequencies 
of bone marrow edema at proximal metacarpal 1 in the 3 age categories were 0%, 
3%, and 8%.) Tenosynovitis seldom occurred in the wrist, with the exception of the 
extensor carpi ulnaris tendon in persons age 40 years or older (9% and 12% in the 




At the MTP joints, the highest prevalence of MRI-detected inflammation was seen 
at MTP1. For instance, 23% of the subjects age 60 years or older had bone marrow 
edema of grade 1 in MTP1. Bone marrow edema and synovitis each occurred in 
MTP5 in 4% of the symptom-free persons age 60 years or older (Table 4).
When MRI-detected erosions were evaluated, similar patterns were seen. The 
prevalence of erosions at joints that are known as predilection sites for OA (CMC1 
and MTP1) increased with age, but the same was observed for locations that are 
not considered typical for OA, such as MCP2 and MCP3 (Tables 2-4). Examples of 
MRI-detected inflammation and erosions observed in the symptom-free partici-
pants are shown in Supplementary Figure 1, available on the Arthritis & Rheuma-
tology website.
Co-occurrence of several MRI-detected inflammatory features at the 
same joint
It is known that simultaneous occurrence of synovitis, bone marrow edema, and/or 
tenosynovitis is frequent in arthritis and RA (2). If different inflammatory features 
do not occur simultaneously at the same joint in symptom-free persons, this might 
be a characteristic differentiating patients from age-matched controls.
At the MCP joints, bone marrow edema, synovitis, and tenosynovitis were studied. 
Although predominantly only one inflammatory feature was present, synovitis and 
bone marrow edema or synovitis and tenosynovitis were also regularly simulta-
neously present. Of 29 persons with any sign of inflammation in MCP3, 10 had 
colocalization of ≥ 2 features. Similarly, of 22 persons with inflammation in MCP2, 
3 had ≥ 2 inflammatory features at this joint (see Supplementary Table 3A, available 
on the Arthritis & Rheumatology website). At the wrist, synovitis in the radiocarpal 
joint was evaluated in relation to bone marrow edema in the surrounding bones 
(scaphoid, lunate, triquetrum, pisiform, distal ulna, and distal radius). Likewise, 
synovitis of the intercarpal CMC joint was studied in relation to bone marrow 
edema of the proximal metacarpals 2-5 and all carpals. Both analyses showed 
that in almost one-third of the participants with any type of inflammation in these 
wrist joints, synovitis and bone marrow edema were both present (Supplementary 
Table 3B).
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At the level of the MTP joints, bone marrow edema and synovitis frequently occurred 
together in MTP1 (Supplementary Table 3C). Taken together, these data show that 
MRI-detected synovitis, bone marrow edema, and tenosynovitis can be present 
simultaneously in the same joint in symptom-free persons.
Co-occurrence of MRI-detected inflammation and erosions
Similarly, we investigated to what extent MRI-detected erosions were seen at loca-
tions that also showed inflammation. These analyses revealed that the parts of the 
joints with erosions also showed inflammation. For example, of the 33 MCP2 joints 
with an erosion, 9 also showed inflammation, and of these 9 joints, 3 joints even 
had ≥ 2 inflammatory features. Of the 23 symptom-free persons with erosions at the 
distal ulna, 6 also had bone marrow edema (see Supplementary Table 4, available 
on the Arthritis & Rheumatology website).
Number of joints or bones affected
Finally, the prevalence of MRI-features in ≥ 2 joints was studied. Twenty-two % of 
the subjects had synovitis in ≥ 2 joints, 23% had bone marrow edema in ≥ 2 bones, 
4% had tenosynovitis in ≥ 2 tendons, and 50% had erosions in ≥ 2 bones. This 
shows that inflammation or erosions can occur at several locations within the same 
symptom-free person.
Discussion
MRI is a promising tool because of its high sensitivity for the detection of local 
inflammation of Joints.[1,2] In addition, MRI depicts erosions. When using MRI for 
diagnostic purposes, the specificity of the findings should be considered. This 
study revealed that MRI-detected inflammation and erosions are prevalent in 
symptom-free persons, especially at specific joints or bones and at older ages. We 
also observed the simultaneous occurrence of different inflammatory features in 




abnormality since the persons studied had no arthritis, no joint symptoms, and no 
previous inflammatory rheumatic disease.
This is the first large-scale study of MRI in symptom-free persons. Even after strat-
ifying for age, the 3 different strata each contained more than the total number 
of healthy controls in previous MRI-studies.[6-12] Furthermore, the use of con-
trast-enhanced MRI obtained using a 1.5T scanner allowed sensitive assessment 
of MRI-features. Another strength is that our recruitment method is different from 
previous studies that mostly evaluated hospital staff, which harbors a risk of a “too 
healthy” population.[6] We recruited volunteers via advertisements in local news-
papers and web sites; hence, people could in no way feel forced to participate. To 
prevent selection bias due to inclusion of persons who would personally benefit 
from participating, participants did not receive MRI-results and were only partly 
compensated for travel costs. A completely random selection would entail actively 
approaching (randomly selected) individuals; we did not have ethics permission 
for such recruitment. We have not followed up the persons who were studied.
In our view, knowledge of clinical status (being healthy) might result in underscor-
ing. To avoid this, the scans of the symptom-free persons were blinded and mixed 
with scans of patients. Hence, the readers were unaware of clinical status.
According to the scoring method used, imaging artifacts and normal structures 
should not be scored. The MRIs were scored accordingly.[17,18] We acknowledge 
that at several carpalia (e.g., the capitate and lunate) it can be difficult to differ-
entiate erosions from physiologic indentations due to enlarged insertion areas of 
interosseous ligaments or vascular channels. The availability of serial MRIs might 
make this differentiation easier, but in the present study persons were scanned 
once. Differentiation of erosions from anatomic variants was performed by experi-
enced readers (each reader had read > 500 scans), and readers were instructed not 
to score an erosion in case of doubt. Furthermore, we used 2 readers and applied 
a very conservative method for analysis when categorizing the data. A joint could 
only be scored as 1 if both readers had scored it as 1. When readers disagreed, 
erosions were not considered to be present. If a different method had been used 
(e.g., a third adjudicator), it is likely that more erosions and inflammatory features 
would have been found.
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The RAMRIS method was developed to sensitively follow the level of inflammation 
in RA-patients in clinical trials and was not designed for diagnostic purposes. If 
MRI is to be used for diagnostics, data on symptom-free persons are relevant to 
consider. Evaluation methods other than RAMRIS may be more accurate or more 
feasible, but this was beyond the scope of the present study.
A challenging question is what processes underlie the occurrence of MRI-detected 
inflammation and erosions in symptom-free persons. First, the MRI-findings 
observed could be degenerative in nature. Persons with symptomatic OA were 
not studied. To prevent recruiting a “too healthy” study population, symptom-free 
persons with Heberden’s nodes, Bouchard’s nodes, or hallux valgus were not 
excluded beforehand. Excluding these persons gave similar results. MRI-features 
were also present at locations that are not specific to OA (such as MCP2 and the 
distal ulna). Erosions were located marginally at the joint surface, which is unlike 
OA. In sum, the observation of more MRI-detected inflammation and erosions at 
older ages is not solely caused by the inclusion of persons with asymptomatic OA 
(as identified by physical examination), but it is possible that degenerative pro-
cesses have contributed. Some observed preferential locations (MCP2, MCP3, and 
the distal ulna) are also known as preferential locations for arthritis and destruction 
in RA.[19] This might suggest that findings at these locations are partly mediated by 
mechanical strains. Furthermore, immunosenescence may also play a role, result-
ing in asymptomatic subclinical inflammation at older ages. Further studies are 
needed to identify the underlying mechanisms. Of note for bone marrow edema, it 
is possible that bone marrow edema in symptom-free persons relates to biologic 
processes that are different from those in RA-patients.
This observational study does not allow interpretation regarding the biologic 
nature of the findings. This limitation is inherent to imaging/MRI. However, this 
does not diminish the value of having a good reference when using MRI for diag-
nostic purposes.
The findings may be relevant if MRI is used to identify subclinical inflammation in 
patients with arthralgia without clinical arthritis who are presumed to be at risk for 
RA. In this setting it is relevant to prevent false-positive findings. If MRI is used for 




in Tables 2-4 could be used as a reference. For instance, a prevalence of < 5% in 
the general population could be used as a cutoff to define a joint with abnormal 
MRI-detected inflammation.
In conclusion, this study showed that MRI-detected inflammation and erosions 
are prevalent in symptom-free persons, especially at older ages. The prevalence 
differed for the different MRI-features and also depended on the joint, bone, or 
tendon studied. Individual lesions were all assigned low grades. Interestingly, the 
joints that had the highest prevalence of MRI-features in symptom-free persons are 
similar to the joints that are frequently affected in RA.
Supplementary material
Supplementary material is published on the website of arthritis and rheumatology.
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Table 1 Characteristics of the 193 symptom-free participants
Total n = 193
Age in years, mean (sd) 49.8 (15.8)
 < 40 years, n (%) 51 (26.4)
40-60 years, n (%) 90 (46.6)
 ≥ 60 years, n (%) 52 (26.9)
Female, n (%) 136 (70.5)
Weight (kg), median (IQR) 71 (64-82)
Smoking
Yes, present, n (%) 17 (8.8)
Yes, in past, n (%) 70 (36.3)
No, n (%) 106 (54.9)
Alcohol use †, n (%) 135 (69.9)
If yes, units per week, median (IQR) 7 (4-14)
Recent (less than 1 year) trauma ‡, n (%) 0 (0)
Comorbidity
Hypertension, n (%) 13 (6.7)
Ischemic heart/cerebral disease, n (%) 4 (2.1)
Thyroid disease (current or past), n (%) 8 (4.1)
Diabetes mellitus, n (%) 1 (0.5)
Patient reported migraine, n (%) 6 (3.1)
Mood disorders (current or past), n (%) 10 (5.2)
Malignancies (current or past), n (%) 4 (2.1)
Other diagnoses, n (%) 53 (27.5)
Any sign of osteoarthritis of small joints 
at physical examination §, n (%)
68 (35.2)
Heberden nodes DIP, n (%) 55 (28.5)
Bouchard nodes PIP, n (%) 7 (3.6)
CMC-1 osteoarthritis, n (%) 2 (1.0)
Hallux valgus, n (%) 25 (13.0)
IQR = interquartile range; CMC-1 = carpometacarpal joint 1. 
† Information on alcohol consumption was missing for 1 person.
‡ Trauma occurring ,1 year prior to magnetic resonance imaging.
§  The percentage of participants with signs of asymptomatic osteoarthritis in this study was similar to 




Table 2  Frequencies of synovitis, bone marrow edema (BME), tenosynovitis, 
and erosions in the MCP joints of symptom-free participants
 < 40 years n = 51  
Grade 1/Grade 2
40-59 years n = 90 
Grade 1/Grade 2
 ≥ 60 years n = 52  
Grade 1/Grade 2
Synovitis    
MCP-2 0 / 0 8 / 0 19 / 0
MCP-3 0 / 0 14 / 0 17 / 0
MCP-4 0 / 0 2 / 0 4 / 0
MCP-5 0 / 0 1 / 0 6 / 0
BME*    
MCP-2 2 / 0 2 / 0 4 / 0
MCP-3 2 / 0 3 / 0 6 / 0
MCP-4 0 / 0 0 / 0 0 / 0
MCP-5 0 / 0 2 / 0 0 / 0
Tenosynovitis    
Extensor MCP-2 0 / 0 0 / 0 0 / 0
Extensor MCP-3 0 / 0 1 / 0 0 / 0
Extensor MCP-4 0 / 0 0 / 0 0 / 0
Extensor MCP-5 0 / 0 0 / 0 0 / 0
Flexor MCP-2 0 / 0 1 / 0 6 / 0
Flexor MCP-3 0 / 0 3 / 0 12 / 0
Flexor MCP-4 0 / 0 3 / 0 6 / 0
Flexor MCP-5 0 / 0 1 / 0 2 / 0
Erosions*    
MCP2 6 / 0 13 / 0 33 / 2
MCP3 8 / 0 12 / 0 17 / 6
MCP4 0 / 0 2 / 0 8 / 0
MCP5 2 / 0 6 / 0 21 / 0
Values are the percent of participants with Rheumatoid Arthritis Magnetic Resonance Imaging Scoring 
(RAMRIS) grade 1 or grade 2 features in the indicated joints. RAMRIS grade 3 features rarely occurred; 
only 1% of participants ages 40-59 had a grade 3 erosion in metacarpophalangeal joint 3 (MCP3). 
*  Bone marrow edema and erosions were scored in the proximal and distal MCP bones separately. The 
scores for the 2 bones are summed into 1 score; therefore, the possible range of scores is 0-6 and 
0-20, respectively. For MCP2, 1 bone had an erosion score of 2 (scores of 1 in both the proximal and 
distal bone); for MCP3, 4 bones had an erosion score of ≥ 2 (3 participants had a score of 2 or 3 in the 
proximal bone and 1 had a score of 1 in both the proximal and distal bone).  
65
MRI in symptom-free persons
3
Table 3-a  Frequencies of synovitis, bone marrow edema (BME), tenosynovitis, 
and erosions in the wrist joints of symptom-free participants
 < 40 years n = 51  
Grade 1/Grade 2
40-59 years n = 90  
Grade 1/Grade 2
 ≥ 60 years n = 52  
Grade 1/Grade 2
Synovitis    
Intercarpal-CMC joint 4 / 0 16 / 0 27 / 0
Radio-carpal joints 0 / 0 17 / 0 35 / 0
Distal radio-ulnar 
joint
0 / 0 8 / 0 17 / 0
BME    
Metacarpal-1 basis 0 / 0 3 / 0 8 / 2
Metacarpal-2 basis 4 / 0 1 / 0 2 / 0
Metacarpal-3 basis 0 / 0 0 / 0 2 / 0
Metacarpal-4 basis 0 / 0 0 / 0 2 / 0
Metacarpal-5 basis 0 / 0 0 / 0 0 / 0
Trapezium 0 / 0 0 / 0 4 / 4
Trapezoid 2 / 0 1 / 0 6 / 0
Capitate 6 / 2 3 / 0 4 / 0
Hamate 0 / 0 3 / 0 8 / 0
Scaphoid 2 / 0 7 / 0 19 / 0
Lunate 6 / 0 19 / 1 27 / 4
Triquetrum 2 / 0 6 / 0 2 / 0
Pisiform 0 / 0 0 / 0 0 / 0
Distal radius 0 / 0 0 / 0 0 / 0
Distal ulna 0 / 0 7 / 0 8 / 0
Frequencies of Tenosynovitis and Erosions see table 3-b on the next page
Values are the percent of participants with Rheumatoid Arthritis Magnetic Resonance Imaging Scoring 
(RAMRIS) grade 1 or grade 2 features in the indicated joints. RAMRIS grade 3 features rarely occurred; 





Table 3-b  Frequencies of synovitis, bone marrow edema (BME), tenosynovitis, 
and erosions in the wrist joints of symptom-free participants
 < 40 years n = 51  
Grade 1/Grade 2
40-59 years n = 90  
Grade 1/Grade 2
 ≥ 60 years n = 52  
Grade 1/Grade 2
Frequencies of Synovitis and BME see table 3-a on the previous page
Tenosynovitis    
I extensor 0 / 0 0 / 0 0 / 2
II extensor 0 / 0 0 / 0 0 / 0
III extensor 0 / 0 0 / 0 0 / 0
IV extensor 0 / 0 0 / 0 2 / 0
V extensor 0 / 0 0 / 0 0 / 0
VI extensor 0 / 0 9 /0 12 / 0
1 flexor 0 / 0 0 / 0 0 / 0
2 flexor 0 / 0 0 / 0 0 / 0
3 flexor 0 / 0 0 / 0 0 / 0
4 flexor 2 / 0 0 / 0 2 / 0
Erosions    
Metacarpal-1 basis 0 / 0 8 / 0 23 / 2
Metacarpal-2 basis 0 / 0 2 / 0 2 / 0
Metacarpal-3 basis 0 / 0 1 / 0 4 / 0
Metacarpal-4 basis 0 / 0 0 / 0 2 / 0
Metacarpal-5 basis 0 / 0 1 / 0 0 / 0
Trapezium 2 / 0 2 / 0 31 / 0
Trapezoid 4 / 0 11 / 0 17 / 0
Capitate 18 / 0 24 / 0 27 / 0
Hamate 0 / 0 4 / 0 13 / 0
Scaphoid 4 / 0 18 / 0 37 / 0
Lunate 8 / 0 19 / 0 40 / 0
Triquetrum 2 / 0 19 / 0 23 / 0
Pisiform 0 / 0 0 / 0 6 / 0
Distal radius 0 / 0 2 / 0 2 / 0
Distal ulna 6 / 0 9 / 0 23 / 0
Values are the percent of participants with Rheumatoid Arthritis Magnetic Resonance Imaging Scoring 
(RAMRIS) grade 1 or grade 2 features in the indicated joints. RAMRIS grade 3 features did not occur.
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Table 4  Frequencies of synovitis, bone marrow edema (BME), tenosynovitis, 
and erosions in the MTP joints of symptom-free participants
 < 40 years n = 51  
Grade 1/Grade 2
40-59 years n = 90 
Grade 1/Grade 2
 ≥ 60 years n = 52  
Grade 1/Grade 2
Synovitis    
MTP-1 4 / 0 11 / 0 13 / 2
MTP-2 0 / 0 1 / 0 0 / 0
MTP-3 0 / 0 1 / 0 0 / 0
MTP-4 0 / 0 0 / 0 0 / 0
MTP-5 0 / 0 0 / 0 4 / 0
BME *    
MTP-1 10 / 0 12 / 1 23 / 8
MTP-2 2 / 0 0 / 1 0 / 0
MTP-3 0 / 0 1 / 0 0 / 0
MTP-4 0 / 0 1 / 0 0 / 0
MTP-5 0 / 0 1 / 0 4 / 0
Erosions *    
MTP1 2 / 0 14 / 0 37 / 4
MTP2 0 / 0 1 / 0 0 / 0
MTP3 0 / 0 0 / 0 2 / 0
MTP4 0 / 0 0 / 0 0 / 0
MTP5 2 / 0 10 / 0 10 / 0
Values are the percent of participants with Rheumatoid Arthritis Magnetic Resonance Imaging Scoring 
(RAMRIS) grade 1 or grade 2 features in the indicated joints. RAMRIS grade 3 features rarely occurred; 
only 1% of the participants ages 40-59 years had bone marrow edema in metatarsophalangeal joint 3 
(MTP3).
*   Bone marrow edema and erosions were scored in the proximal and distal MTP bones separately. 
The scores for the 2 bones are summed into 1 score; therefore, the possible range of scores is 0-6 
and 0-20, respectively. For MTP1, 5 bones had a bone marrow edema score of 2 (4 participants had 
a score of 1 in both the proximal and distal bone and 1 participant had a score of 2 in the proximal 
bone). For MTP2 and MTP3, 2 bones had a bone marrow edema score of ≥ 2 (both had a bone marrow 
edema score of 2 or 3 in the proximal bone). For MTP1, 2 bones had an erosion score of 2 (2 persons 
with an erosion score of 1 in both the proximal and the distal bone).
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Introduction: The western population is ageing. It is unknown whether age at diag-
nosis affects the severity of Rheumatoid Arthritis (RA), we therefore performed the 
present study.
Method: 1,875 RA-patients (7,219 radiographs) included in five European and 
North-American cohorts (Leiden-EAC, Wichita, Umeå, Groningen and Lund) were 
studied on associations between age at diagnosis and joint damage severity. In 
698 Leiden RA-patients with 7-years follow-up it was explored if symptom duration, 
anti-citrullinatedpeptide- antibodies (ACPA), swollen joint count (SJC) and C-re-
active-protein (CRP) mediated the association of age with joint damage. Fifty-six 
other RA-patients of the EAC-cohort underwent baseline MRIs of wrist, MCP and 
MTP-joints; MRI-inflammation (RAMRIS-synovitis plus bone marrow edema) was 
also evaluated in mediation analyses. Linear regression and multivariate normal 
regression models were used.
Results: Analysis on the five cohorts and the Leiden-EAC separately revealed 1.026-
fold and 1.034-fold increase of radiographic joint damage per year increase in age 
(β = 1.026, 1.034, both p < 0.001); this effect was present at baseline and persisted 
over time. Age correlated stronger with baseline erosion-scores compared to joint 
space narrowing (JSN)-scores (r = 0.38 versus 0.29). Symptom duration, ACPA, SJC 
and CRP did not mediate the association of age with joint damage severity. Age was 
significantly associated with the MRI-inflammation-score after adjusting for CRP 
and SJC (β = 1.018, p = 0.027). The association of age with joint damage (β = 1.032, 
p = 0.004) decreased after also including the MRI-inflammation-score (β = 1.025, 
p = 0.021), suggesting partial mediation.
Conclusion: RA-patients presenting at higher age have more severe joint damage; 
this might be partially explained by more severe MRI-detected inflammation at 
higher age.
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Introduction
The western population is ageing. Consequently, the number of patients with 
rheumatoid arthritis (RA) presenting at an older age is increasing.[1, 2] Ageing is 
associated with alterations and remodelling of the innate and adaptive immune 
system immunosenescence).[3-5]
It is unclear to what extent ageing or age-associated changes in function of immune 
cells influence the severity of RA. If RA-severity differs for patients diagnosed at 
different age categories, this is relevant for clinical practice. Some previous studies 
suggest that older patients with RA have more joint damage [6-11], whereas other 
studies observed no difference [12, 13] or observed less joint damage in older 
patients with RA.[14] Most studies performed analyses at a single time point [7-10, 
13, 14] and all studied patients categorized as younger or older.[6-14] The first aim 
of the present study was to explore the association between age and severity of 
joint damage in more detail. Patients with RA included in one North-American and 
four European longitudinal cohorts were studied for severity of joint damage at 
disease presentation and during the course of the disease. We analysed age as a 
continuous variable to obtain optimal insight into the effects of age.
Second, no studies have explored processes underlying the association between 
age at disease onset and radiographic joint damage. First, because joint damage 
measures such as the Sharp-van der Heijde (SHS)-score assess bone erosions and 
joint space narrowing (JSN),
JSN may occur not only due to RA but also reflect degeneration. An increase in total 
SHS-severity at older age could therefore be due to a disproportional increase in 
JSN. Additionally, based on general knowledge of risk factors for progressive joint 
damage in RA (longer symptom duration, presence of RA-related auto-antibodies, 
higher numbers of swollen joints and elevated acute-phase reactants are all asso-
ciated with more severe damage), we made several other hypotheses. We assumed 
that older patients present at a later point in time, and therefore have more severe 
joint damage. In addition, as the prevalence of RA-related auto-antibodies in the 
general population increases with increasing age, we hypothesized that patients 




or anti-citrullinated peptide antibodies (ACPA)-positive and therefore have more 
severe disease.[8, 11-13, 15-20] Likewise we postulated that inflammation at diag-
nosis is more severe at older age resulting in more joint damage. Inflammation was 
evaluated using traditional measures (swollen joint count (SJC), C-reactive protein 
(CRP)) and using magnetic resonance imaging (MRI), which is more sensitive in 
detecting local inflammation.[21, 22] We also aimed to explore these hypotheses.
Thus the first aim of this study was to explore the association of age with joint 
damage severity in more detail and, second, we aimed to increase the understand-
ing of the processes underlying the association between age of disease onset and 
the severity of the disease course.
Methods
Study population
To determine the association between age at diagnosis and severity of joint damage, 
patients with RA included in five longitudinal inception cohorts were studied. In 
total this comprised 1,875 patients with 7,219 sets of radiographs made at baseline 
and during follow up. Patients were included in cohorts of the Leiden early arthritis 
clinic (EAC), Groningen (both the Netherlands), Wichita (USA), Umeå and Lund 
(both Sweden). All patients with RA fulfilled the 1987 criteria for RA except for the 
Lund cohort where the 1958 criteria were used. The age at diagnosis was recorded 
in all cohorts. For all studies the regional ethics committee approved the study 
and all participants gave their written informed consent. Extensive descriptions 
of these cohorts are presented elsewhere [23-26], short descriptions are provided 
below.
Leiden early arthritis clinic (EAC) cohort
Patients with early RA (n = 698) between 1993 and 2006 were included.[23] From 
these patients 3,643 sets of radiographs of the hands and feet were obtained during 
7 years of follow up. Follow-up visits, including radiographs, were done yearly. All 
radiographs were chronologically scored by an experienced reader, blinded to the 
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clinical data, according to the SHS-method. The intra-reader intra-class correlation 
coefficient (ICC) was 0.91. The applied treatment strategies changed over time, as 
described elsewhere [27]; the inclusion periods were used to adjust for differences 
in applied treatments. The data for these patients were used for the mediation 
analyses as they contained most radiographs and extensive data on clinical and 
serologic variables. A second study population of patients with RA was included 
in the EAC in 2010-2012. In addition to the general EAC-protocol including radio-
graphs, these consecutively included patients had contrast-enhanced 1.5 T MRI 
of unilateral metacarpophalangeal (MCP), wrist and metatarsophalangeal (MTP) 
joints at baseline. Patients who had 1-year follow up, including radiographs, were 
selected (n = 56). The MRI (ONI-MSK-Extreme 1.5 T MRI (GE, WI, USA)) was per-
formed at inclusion, on the most symptomatic side or the dominant side in the case 
of equally severe symptoms. Scanning was done according to the RA MRI score 
(RAMRIS), with contrast enhancement. The scan protocol is described in Additional 
file 1. MRI-scoring was done by two trained readers blinded to any clinical data.
[28-30] The within-reader ICCs were 0.98 and 0.83, and the inter-reader ICC 0.82. 
The mean score of both readers was studied.
Wichita
This North-American cohort consisted of 293 patients that were diagnosed between 
1963 and 1999.[24] In this cohort 1,062 radiographs were made during 15 years of 
follow up. All radiographs were chronologically scored by an experienced reader 
using the SHS (ICC 0.98).[31]
Umeå
The third cohort consisted of 459 patients included between 1995 and 2010.[6] 
These patients had radiographs at baseline and 2 years: 868 radiographs were 
obtained and were scored by two trained rheumatologists according to the Larsen 
score.[32, 33] Treatment strategies differed between 1995 and 1999, 2000 and 






This dataset included 278 patients with RA who were diagnosed between 1945 
and 2001. During 14 years of follow up 865 radiographs were obtained that were 
chronologically scored according to the SHS by one of two readers (intra-reader 
ICC > 0.90 inter-reader ICC 0.96).[34] Joint destruction was less severe after 1990, 
which coincides with the introduction of treatment with disease-modifying 
anti-rheumatic drugs (DMARDs).
Lund
This cohort consist of 147 patients recruited from primary care units in the area of 
Lund from 1985-1989 [26]: 781 radiographs were obtained during 5 years of follow 
up. These radiographs were scored according to the Larsen score (ICC 0.94).[32, 35] 
All results for age in all datasets in this study represent the age of the patient at the 
time of diagnosis. At the baseline visit, the date of birth or age itself was recorded.
Analyses
First, the associations between age at diagnosis and the severity of joint damage 
were evaluated for each cohort separately. A multivariate normal regression model 
for longitudinal data [27] was used with radiographic scores as the outcome and age 
as the continuous independent variable. The radiographic scores were log10-trans-
formed (log10 (score+1)) to approximate a normal distribution. In all cohorts the 
residuals of the models were normally distributed around zero, indicating a good 
fit of the models (Additional file 2: Figure S1). This repeated measurement anal-
ysis takes the correlation between repeated measurements within patients into 
account. A heterogeneous first-order autoregressive (ARH1) correlation structure 
was used, assuming a stronger correlation for measurements taken in a shorter 
period of time than for those over a longer period. As described elsewhere in detail 
[27] this model is able to test for two effects: first the model can be used to analyse 
whether patients with a risk factor have more severe joint damage at any point in 
time; this reflects a constant effect size over time.
Second, the model can be used to analyse whether patients have more severe 
radiographic progression over time; this present the steepness of the curve of joint 
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damage over time (risk factor*time). In the evaluated cohorts, the radiographic 
data were plotted (before starting with statistical analysis); this suggested an 
effect that is constant over time and not a progression effect. Therefore analy-
ses were focussed on the constant effect and all results presented (effect sizes, 
p-values) were those of a constant effect, thus, this concerns a difference in joint 
destruction that was equally present at every time point. In all datasets, analyses 
were adjusted for gender. In the cohorts that included patients in periods with dif-
ferent treatments strategies (EAC, Umeå and Groningen) an additional adjustment 
was made for the inclusion period (as proxy for treatment strategy) as radiographic 
joint damage varied between different inclusion periods. As the analyses were 
performed on the log-scale, the resulting effect estimates were back-transformed 
to the normal scale and indicated the fold increase in joint damage per year of 
increase in age at diagnosis. Thus, this outcome indicates a relative increase 
in joint damage and is unit-free. This allowed us to enter the effects of the five 
different cohorts in an inverse-weighted meta-analysis. This method weights the 
results with a low standard error stronger than results with a higher standard error, 
preventing over-representation of the less precise data on the overall outcome. 
A random-effect model was used.
To explore whether the increase in total SHS at increasing age was explained by 
a disproportionate increase in JSN, possibly reflecting age-related degenerative 
changes, the total SHS at baseline of the 698 Leiden RA-patients was split into 
erosion score and JSN-score. Pearson’s correlation coefficients were determined 
and equality/ inequality of the two correlation coefficients was assessed using the 
corcor command. Similarly, the total SHS was split for separate locations; predi-
lection locations for primary osteoarthritis (proximal interphalangeal (PIP)- joints, 
carpometacarpal-1 (CMC-1)-joints and MTP-1 plus interphalangeal-1 joints were 
compared to other joints.
Mediation analyses were used to identify potential mechanisms underlying 
the association between age at disease onset and radiographic joint damage. 
Mediation analyses were performed according to Baron and Kenny (Fig.  1).[36] 
First (step 1), the mediator variables were regressed on the independent variable 




Second (step 2), regression analysis of the dependent variable (radiographic joint 
damage) on the independent variable (age) was done. In this analysis the inde-
pendent variable must significantly affect the dependent variable. Third (step 3), 
the dependent variable was regressed on the independent and mediator variable. 
When mediation occurs, the mediator variable significantly affects the dependent 
variable and the effect of the independent variable on the dependent variable 
decreases (partial mediation) or disappears completely (full mediation). Symptom 
Age
(Independent Factor)












Figure 1  Schematic overview of the causal paths that were studied using 
mediation models as described by Baron and Kenny
The figure illustrates two causal paths that lead to an outcome. A direct path from independent to 
dependent variable (B) and an indirect path from an independent to a dependent variable through a 
mediator variable (A,C). To test mediation 3 test have to be performed according to Baron and Kenny.
[36] First, the mediator variables were regressed on the independent variable (A), the independent 
variable should significantly affect the mediator variables. Secondly, regression analysis of the 
dependent variable on the independent variable was done,(B) in this analysis the independent 
variable must significantly affect the dependent variable. Thirdly, the dependent variable was 
regressed on the independent and mediator variable (B and C). When mediation occurs the mediator 
variable significantly affects the dependent variable and the effect of the independent variable on 
the dependent variable is closer to zero. In this study we tested whether different mediators could 
influence the effect of age on radiographic joint damage. The tested mediators were symptom 
duration at diagnosis, swollen joint count (SJC), tender joint count (TJC), C-reactive protein (CRP), 
anti-citrullinated protein antibody (ACPA), rheumatoid factor (RF), and inflammation detected on MRI. 
SHS = Sharp-van der Heijde score.
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duration at baseline, ACPA (anti-CCP2), IgM-RF, CRP, SJC and TJC were assessed 
as mediators. Linear or logistic regression was used as appropriate for step 1. For 
steps 2 and 3 the multivariate normal regression model was used as described.
Analyses were performed with SPSS V20.0.0; the meta-analysis and the equality of 
the correlation test were performed using STATA/SE V12.1.
Results
Age at diagnosis and severity of radiographic joint damage
First, the association between age and severity of joint damage observed on radio-
graphs was explored separately in each cohort. Baseline characteristics of these 
patients are presented in Table 1. In all cohorts an increase in age at diagnosis was 
associated with more severe joint damage at baseline and this effect persisted 
over time. Combining all five cohorts in a meta-analysis revealed that patients had 
1.026-fold more joint damage observed on radiographs per year increase in age at 
any point during the disease course (β = 1.026, p < 0.001, Fig. 2a). For illustration, 
the predicted severity of joint damage per group of patients according to different 
age categories is depicted in Fig. 2b, based on 698 patients with RA included in the 
Leiden-EAC. Data for the other cohorts are depicted in Additional file 3: Figure S2. 
Here joint damage increased 1.034-fold per year increase in age; this effect was 
constant over time (β = 1.034, p < 0.001).
Correlation of age with erosion score and JSN-score
The SHS at disease onset in patients with RA included in the Leiden EAC were 
split into total erosion scores and total JSN-scores to explore whether age-related 
degenerative changes explain the association between age and total SHS score, 
and we assessed whether the correlation between age and JSN-score was stronger 
than the correlation between age and the erosion score. Age at diagnosis was sig-
nificantly correlated with both the erosion and JSN-scores (r = 0.38, p < 0.001 and 
r = 0.29, p < 0.001 respectively, Fig. 3) at baseline. The correlation coefficient of the 






































Figure 2  Association of age at diagnosis with joint damage severity in five 
longitudinal cohorts summarized in a meta-analysis (A) and depicted for 
RA-patients included in the Leiden EAC for different age categories (B)
(A) Age was entered as continuous variable in the multivariate normal regression analysis, because 
the plots of the raw data suggested no interaction of age with time. The meta-analysis (inverse 
weighted meta-analysis with a random-effect model) summarizes the effects of age of the different 
cohorts. An effect size of 1.034 represents a 1.034-fold increase in joint damage per year increase in 
age. Because these effect sizes were unit-free they could be compared in meta-analysis. (B) Although 
age was analyzed as continuous variable, in order to illustrate the data the predicted SHS per 
age-categories were plotted. Presented are the SHS predicted by the multivariate normal regression 
analysis. SHS = predicted Sharp van der Heijde score.
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Figure 3  Correlation between age and Sharp-van der Heijde erosion (A) and 
joint-space narrowing scores (B) at baseline
JSN = Joint space narrowing,  




















































Figure 4  'Sharp-van der Heijde erosion score (A) and joint space narrowing 
score (B) over time for patients with rheumatoid arthritis from the 
Early Arthritis Clinic, categorized by age at diagnosis'
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association between age and erosion and JSN-score over time was also assessed, 
and older age was associated with higher erosion scores and higher JSN-scores at 
all points in time (β = 1.030, p < 0.001, and β = 1.020, p < 0.001, respectively) (Fig. 4).
The total SHS score is also the sum of the scores of different joints. We hypothesized 
that some joints (predilection locations for primary osteoarthritis in particular, 
such as CMC-1) are more frequently affected by age-related degeneration. There-
fore the total SHS score at baseline was split for several regions and correlations 
between the SHS score per region and age were determined. This revealed that the 
correlation of CMC-1 was comparable to that of the wrist (r = 0.26 and r = 0.23, both 
p < 0.001). The correlation of the other locations was also comparable (r = 0.20, 0.31 
and 0.39 for MTP + IP-1, MCP joints and PIP joints, all p < 0.001), only in the MTP2−5 
joints the correlation of the SHS score with age was lower (r = 0.08, p = 0.03, Addi-
tional file 4: Figure S3). Together these results suggest that degenerative changes 
at older age may contribute to more severe joint damage in patients presenting at 
older age but are clearly insufficient to explain the total effect.
Age and symptom duration at first presentation
Because it is known that prolonged symptom duration at first presentation is 
associated with more severe radiographic progression [37, 38], we hypothesized 
that older persons present with a longer symptom duration, hence mediating the 
association with joint damage. Although longer symptom duration was associated 
with more joint damage (β = 1.003, p < 0.001), symptom duration was inversely 
associated with age, (β = 0.99, p < 0.001), hence older age was associated with 
shorter symptom duration. Therefore, symptom duration did not mediate the effect 
of age on joint damage (Table 2).
Age and RA-related auto-antibodies
The presence of ACPA and RF were strong risk factors for radiographic progression 
(β = 1.37, p < 0.001 and β = 1.30, p < 0.001, respectively). These auto-antibodies can 
mediate the association between age and joint destruction if age is associated 
with a higher prevalence of these auto-antibodies. We observed no significant 




p = 0.09). The prevalence of ACPA was lower when RA was diagnosed at an older 
age (OR = 0.98, p < 0.001). Therefore, these auto-antibodies did not mediate the 
association between age and joint damage (Table 2).
Age and clinical measures of joint inflammation
Next we explored whether the extent of joint inflammation, measured using the 
SJC and TJC at baseline, was a mediator. Age at diagnosis was not associated with 
the number of joints involved (β = 1.00, p = 0.11 and β = 1.00, p = 0.55 for SJC and 
TJC, respectively). The SJC and TJC were also not associated with radiographic joint 
damage (β = 1.00, p = 0.23 and β = 1.00, p = 0.76); therefore these clinical measures 
of local inflammation were not mediators (Table 2).
Age and serological measures of inflammation
Subsequently it was explored whether CRP, a measure of systemic inflammation, 
was a mediator. CRP-levels increased significantly with age (β = 1.016, p < 0.001), 
indicating that with every year increase in age the CRP increased by 1.6%. CRP-lev-
els were also associated with severity of joint damage (β = 1.003, p = 0.003). In the 
third step of the mediation analysis, the association between age and joint damage 
was studied after adjustment for CRP. This revealed a very slight decrease in effect 
size, from 1.034 to 1.033 (Table 2), based on which it was concluded that also CRP 
was not a mediator. Similar results were seen when erythrocyte sedimentation rate 
(ESR) was studied (data not shown).
Age and local inflammation measured by MRI
It is known that MRI of the extremities measures local inflammation more sensi-
tively than physical examination and CRP.[21, 22, 39] To explore local inflammation 
in more detail, additional mediation analysis was performed in another group of 
patients with RA who underwent MRI of the extremities at baseline (Table 3). The 
MRI synovitis and bone marrow edema (BME) scores were summed, yielding the 
MRI inflammation scores. Also in this group of patients, an increase in age was 
associated with more joint damage at baseline; also here the effect was constant 
over time. (β = 1.032 p = 0.004). All subsequent analyses were adjusted for SJC and 
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CRP to ensure that the results for MRI-detected inflammation were not explained 
by these traditional measures of inflammation. It was observed that patients 
presenting at older age had higher MRI inflammation scores (β = 1.018, p = 0.027) 
and that higher MRI inflammation scores were associated with radiographic joint 
damage at any point in time evaluated (β = 1.026, p = 0.018). Then in step 3 of the 
mediation analysis there was a decreased effect size of age with structural damage 
when additionally adjusting for the MRI inflammation score (β = 1.032 p = 0.004 to 
β = 1.025 p = 0.02), suggesting that MRI-detected inflammation is a partial media-
tor for the effect of age on radiographic joint damage.
Discussion
The western population is ageing. Consequently the number of patients with RA 
diagnosed at an older age is rising.[1, 2] It is generally hoped that the additional 
years of life are spent in good health. RA, however, is associated with decreased 
functioning and quality of life. Previous studies on age and RA-severity have 
contrasting results.[6, 7, 9, 40, 41] The present study of patients with RA, which 
included five longitudinal cohorts, showed that older patients had more severe 
joint damage at diagnosis and this effect remained present during the disease 
course. We evaluated several hypotheses to increase the understanding of the 
processes driving the observations of the influence of age. We observed that the 
effect was partially and modestly mediated by MRI-detected inflammation with 
increasing age.
Longitudinal data from five cohorts were studied on the effect of age on the sever-
ity of joint damage. Because of the presence of serial radiographic measurements 
multivariate normal regression analysis was used (this model is similar to a linear 
mixed model, only no random effect is added). For reasons of consistency this 
model was also used in the mediation analysis in the second part of the manu-
script. However, the effect of joint damage was already present at baseline and 




outcome. Repeating the mediation analysis with baseline SHS as the outcome 
indeed revealed similar results (data not shown).
Interestingly, some variables assessed in the mediation analyses were inversely 
correlated with age. The symptom duration at the time of diagnosis was shorter 
at older age, indicating that older patients had less delay in getting access to 
rheumatologic care. Thus, although we hypothesized that older patients presented 
with more severe damage due to having longer duration of disease, older patients 
had a shorter period of symptoms at first presentation, hence arguing against this 
hypothesis. Also the prevalence of ACPA decreased at older age in 1,987-crite-
ria-positive patients with RA, which is in contrast to the prevalence of ACPA in the 
general population [15], but a lower frequency of ACPA amongst older patients with 
RA has been described before.[6] Several studies have observed higher CRP-levels 
in older patients with RA [11, 16, 17], and we also observed this. However, the effect 
size of the association between age and severity of joint damage decreased very 
little after adjusting for CRP, therefore CRP was not considered an evident mediator.
MRI of the extremities is sensitive in detecting local inflammation and subclinical 
inflammation observed on MRI has been found to be relevant for radiographic pro-
gression of RA.[21, 22] The present data showed that patients with RA presenting 
at an older age have more MRI-detected inflammation. Ageing is associated with 
an increase in pro-inflammatory status and a decline in both T cell and B cell func-
tion.[3-5] Potentially, changes in the immune system are underlying the current 
observation of more severe inflammation on MRI at an older age. Earlier studies 
have shown that the severity of MRI-detected inflammation is associated with the 
severity of radiographic joint damage and that this effect is independent of the 
effects of CRP and SJC on radiographic progression.[22, 39] The present data also 
show that MRI-detected inflammation is associated with severity of joint damage, 
independent of other measures of inflammation. Hence in the last two steps of the 
mediation analysis, adjustments for CRP and SJC were made. The finding that the 
effect size of age decreased after additional adjustment for MRI-detected inflam-
mation suggests that the effect of more severe joint damage at higher age is partly 
mediated by the presence of more severe MRI-detected inflammation at an older 
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age. In other words, it suggests that MRI-inflammation acts in the so-called causal 
path.[36]
Interestingly, some recent evidence suggested that older age might also be associ-
ated with presence of more MRI-detected inflammation in symptom-free persons.
[42] More studies are needed to determine the validity of these results, and to 
differentiate disease-related inflammation on MRI from variations that are present 
in the general population. Nonetheless, in our view this does not affect the validity 
of the present results. If MRI-detected inflammation also occurs at an older age 
in people without RA, this most likely does not affect the mediation analyses in 
RA and does not influence the decrease in the beta value for age between steps 2 
and 3.
We explored whether the higher SHS scores at older age were due to age-related 
degeneration. We have tried to detangle these effects by evaluating JSN-scores and 
erosion scores separately and predilection locations for degenerative changes sep-
arately. Although these comparisons do not allow us to make conclusions about 
the causality, degenerative changes at an older age appear insufficient to explain 
the observed association between age and severity of joint damage.
Similarly, it can be questioned whether more severe MRI-detected inflammation 
is RA-specific or age-specific. This is even more difficult to discriminate as the 
RAMRIS was derived for RA; degenerative features such as JSN and osteophytes 
were not included; also the locations assessed by RAMRIS are specific for RA. 
The CMC-1 joint is included but is known to be affected by degeneration as well. 
When we evaluated the BME-scores in the base of metacarpal-1 and trapezium (the 
two bones together forming CMC-1), the correlation with age was not significant 
(ρ = 0.24, p = 0.07) whilst the BME-score obtained in other bones in the wrist was 
positively correlated with age (ρ = 0.41, p = 0.002). This suggests that the higher 
MRI scores seen in patients with RA at higher age were not primarily due to degen-
eration (in the process of osteoarthritis).
Degeneration in the light of osteoarthritis may be different from the more global 
effects of wear and tear. We cannot exclude that part of the effect of greater MRI-de-
tected inflammation at an older age is due to wear and tear. Part of the observation 




to wear and tear. If this is true, hand and foot radiographs of healthy people at 
older ages would also show erosions according to the SHS method. To the best of 
our knowledge, radiographic studies on the hands and feet of healthy persons of 
different age categories have not been done.
It has been suggested that older patients are treated differently in comparison to 
younger patients [43-46], but others have argued against this.[47] The majority of 
patients studied here were included in periods when early, tailored, treatment and 
use of biologic agents were uncommon. Importantly, treatment most likely does 
not affect the results of our study as differences in radiographic joint damage were 
already present at baseline. The differences were already present before the start 
of treatment, so treatment was not a likely mediator.
Analyses were adjusted for gender to account for differences in male/female ratios 
at different ages. Additionally, women have hormonal changes during their lifetime. 
When repeating the mediation analyses in men only, no differences were observed 
(data not shown), suggesting that gender was not a confounder.
The strength of this study is that five cohorts with longitudinal data were studied. 
The cohorts used different inclusion criteria, but despite these differences, all 
cohorts had more radiographic joint damage with older age at disease onset. This 
replication supported the validity of the association between age and severity of 
joint damage. A limitation is that the mediation analyses were performed using data 
from one cohort only. However, data on the complete set of potential mediators 
were not available for the other datasets. Another limitation is the relatively small 
number of patients with RA with baseline MRI-data and 1-year follow up in relation 
to the large cohorts of patients with radiographic data. This is due to the fact that 
in our setting MRI was not available until a few years ago. Notably, the effect size 
of age on radiographic joint damage in this small patient group of patients with RA 
was almost similar to that of the larger RA datasets.
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Conclusions
The present study convincingly showed that patients with RA diagnosed at an 
older age already have more joint damage on disease presentation, and this effect 
remains during the disease course. This effect might be partially explained by more 
severe local inflammation at an older age. Future studies are needed to elucidate 
the biological mechanisms determining inflammation severity and RA-severity and 
changes during the patient’s lifetime.
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Table 1  Characteristics of patients with rheumatoid arthritis included in the 
longitudinal cohorts studied
EAC Part 1 EAC Part 2 
(MRI)
Wichita Umeå Groningen Lund
Total n of patients 698 56 293 459 278 147
Total n of radiographs 3.643 105 1.062 868 865 781
Mean n of radiographs  
per patient (SD)
5.2 (2.1) 1.9 (0.3) 3.6 (2.0) 1.9 (0.3) 3.1 (1.4) 5.3 (0.8)
Year of diagnosis 1993-2006 2010-2012 1963-1999 1995-2010 1945-2001 1985-1989
Radiographic follow-up  
in years
7 1 15 2 14 5
Method of scoring SHS SHS SHS Larsen SHS Larsen
Age
Mean (SD) 56.6 (15.6) 55.9 (14.2) 48.8 (14.2) 53.9 (14.5) 49.3 (12.6) 50.7 (11.5)
Median (IQR) 58 (46-68) 59 (46-65) 49(39-60) 56 (45-64) 50 (40-59) 51 (43-59)
Range 17.1-92.4 21.5-77.8 16.0-83.0 17.0-83.0 18.3-76.3 18.0-78.0
Female sex (%) 474 (67.8) 31 (55.4) 226 (77.1) 321 (69.2) 196 (70.5) 98 (66.7)
Symptom duration  
in weeks (IQR)
19 (11-37) 18 (11-32) NA NA NA 43 (29-62)
TJC (IQR) 8(5.0-12.0) 7(4.-10.5) NA NA NA NA
SJC (IQR) 8(4.0-14.0) 5(3.5-10.0) NA NA NA NA
BSE (IQR) 33(19-54) 25(10-41) NA NA NA NA
CRP (IQR) 17(8.0-40.0) 11(3.0-20.5) NA NA NA NA
ACPA positivity (%) 365(53.7) 33 (63.5) 238 (82.1) 339 (73.1) 162 (79.4) 114 (80.3)
RF positivity (%) 405 (58.2) 36 (64.3) NA NA 259 (93.8) 115 (80.3)
Age, symptom duration, TJC, SJC, ESR, CRP, ACPA and RF were assessed at baseline.
EAC, Early Arthritis Clinic;
MRI, magnetic resonance imaging;
TJC, tender joint count;
SJC, swollen joint count; CRP, C-reactive protein;
ESR, erythrocyte sedimentation rate;
ACPA, anti-citrullinated peptide antibodies;
RF, rheumatoid factor;
SHS, Sharp-van der Heijde.
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Table 2  Mediation analysis in 698 patients with rheumatoid arthritis from the 
Leiden Early Arthritis Clinic, with radiographic severity of joint damage 
over 7 years as the outcome variable
Effect (β)1 95% CI p-value
Step 1: Effect of age on possible mediators
SJC 1.00 1.00-1.01 0.11
TJC 1.00 1.00-1.01 0.55
Symptom duration 0.992 0.988-0.996  < 0.001
CRP 1.016 1.011-1021  < 0.001
RF 0.99 0.98-1.00 0.09
ACPA 0.98 0.97-0.99  < 0.001
Step 2: Effect of age on radiographic joint damage
Ageing 1.034 1.029-1.040  < 0.001
Step 3: Effect of age and possible mediator on radiographic joint damage
SJC 1.00 0.99-1.00 0.23
Ageing 1.035 1.029-1.040  < 0.001
TJC 1.00 0.98-1.01 0.76
Ageing 1.037 1.030-1.044  < 0.001
Symptom duration 1.003 1.002-1.005  < 0.001
Ageing 1.035 1.029-1.040  < 0.001
CRP 1.003 1.001-1.005 0.003
Ageing 1.033 1.027-1.038  < 0.001
ACPA 1.37 1.16-1.60  < 0.001
Ageing 1.035 1.030-1.040  < 0.001
RF 1.30 1.10-1.52 0.002
Ageing 1.034 1.029-1.039  < 0.001
The effect size (β) of swollen joint count (SJC), tender joint count (TJC), symptom duration and 
C-reactive protein (CRP) reflect the increase per year increase of age. For example, the β for CRP is 
1.016 this means that for every year increase in age there is 1.016-fold increase in CRP. A β of 0.992 
indicates an increase 0.992- fold, hence actually a decrease. The effect size of anticitrullinated protein 
antibody (ACPA) and rheumatoid factor (RF) reflect the odds ratio. Step 1, 2 and 3 of the mediation 
analyses are explained in Fig. 1. In step 1 a linear or logistic regression was used, in step 2 and 3 a 
multivariate normal regression analysis was used.[27] Also here the effects are per unit. For example, 
the β for age on joint damage is 1.034/year this means that for every year increase in age there is an 
increase of 3.4% this is equal to an increase of 95.2% every 20 years (1.034^20). All features (SJC, TJC, 




Table 3  Mediation analysis in 56 patients with rheumatoid arthritis from the 
Leiden Early Arthritis Clinic, with radiographic severity of joint damage 
as the outcome variable
Effect (β) 95% CI p-value
Step 1: Effect of age on possible mediators
MRI inflammation 1.018 1.002-1.034 0.027
Synovitis 1.011 1.00-1.024 0.092
BME 1.021 1.00-1.043 0.052
Step 2: Effect of age on radiographic joint damage
Ageing 1.032 1.010-1.055 0.004
Step 3: Effect of age and possible mediator on radiographic joint damage
MRI inflammation 1.026 1.004-1.047 0.018
Ageing 1.025 1.004-1.047 0.021
Synovitis 1.069 0.97-1.17 0.15
Ageing 1.029 1.007-1.051 0.011
BME 1.039 1.011-1.067 0.007
Ageing 1.026 1.005-1.047 0.014
Step 1, 2 and 3 are explained in Fig. 1.
In step 1 a linear regression is used, in step 2 and 3 a multivariate normal regression analysis is used.[27]
The effects are per unit increase, for example per point increase in rheumatoid arthritis magnetic 
resonance imaging score (RAMRIS) and per year increase in age; for further explanation see legend of 
Table 2.
MRI, magnetic resonance imaging;
BME bone marrow edema 
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Chapter 5: Body mass index and extent 
of MRI-detected inflammation: opposite 
effects in rheumatoid arthritis versus 












Introduction: In the population a high body mass index (BMI) has been associated 
with slightly increased inflammatory markers. Within rheumatoid arthritis (RA), 
however, a high BMI has been associated with less radiographic progression; this 
phenomenon is unexplained. We hypothesized that the phenomenon is caused by 
an inverse relationship between BMI and inflammation in hand and foot joints with 
RA. To explore this hypothesis, local inflammation was measured using magnetic 
resonance imaging (MRI) in early arthritis patients presenting with RA or other 
arthritides and in asymptomatic volunteers.
Methods: A total of 195 RA-patients, 159 patients with other inflammatory arthriti-
des included in the Leiden Early Arthritis Clinic, and 193 asymptomatic volunteers 
underwent a unilateral contrast-enhanced 1.5 T MRI-scan of metacarpophalangeal, 
wrist, and metatarsophalangeal joints. Each MRI-scan was scored by two readers 
on synovitis, bone marrow edema (BME), and tenosynovitis; the sum yielded the 
total MRI inflammation score. Linear regression on log-transformed MRI-data was 
used.
Results: A higher BMI was associated with higher MRI inflammation scores in 
arthritides other than RA (β = 1.082, p < 0.001) and in asymptomatic volunteers 
(β = 1.029, p = 0.040), whereas it was associated with lower MRI inflammation 
scores in RA (β = 0.97, p = 0.005). Evaluating the different types of inflammation, a 
higher BMI was associated with higher synovitis, BME, and tenosynovitis scores in 
arthritides other than RA (respectively β = 1.084, p < 0.001, β = 1.021, p = 0.24, and 
β = 1.054, p = 0.003), but with lower synovitis and BME-scores in RA (respectively 
β = 0.98, p = 0.047 and β = 0.95, p = 0.002).
Conclusions: Increased BMI is correlated with less severe MRI-detected synovitis 
and BME in RA. This might explain the paradox in RA where obesity correlates with 
less severe radiographic progression.
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Background
The prevalence of obesity is increasing worldwide. It has become evident that 
adipose tissue is an active organ, producing proinflammatory cytokines and adipo-
cytokines. A population-based study has shown that a high body mass index (BMI) 
is associated with increased inflammatory markers, such as C-reactive protein 
(CRP).[1] Obesity is also associated with an increased risk for several diseases, 
among which is cardiovascular disease, in which low-grade inflammation is part 
of the pathogenesis. Furthermore, recent data have revealed that obesity is also 
associated with an increased risk for rheumatoid arthritis (RA).[2]
Interestingly, however, although obese persons have a higher risk to develop 
RA, the presence of obesity within RA has been shown advantageous. Several 
studies have observed and replicated that a higher BMI is associated with less 
severe radiographic joint progression in RA.[3-6] The mechanisms underlying this 
observation are unknown. Data from a recent clinical trial in RA, evaluating drug 
efficacy with magnetic resonance imaging (MRI) to measure the disease outcome, 
suggested that patients with a higher BMI have less severe bone marrow edema 
(BME) on MRI.[3] BME is strongly associated with erosive progression [7], which 
may explain the finding of BMI and radiographic progression in RA. Together these 
observations prompted us to study the association between BMI and MRI-detected 
joint inflammation in more detail.
This cross-sectional study investigated the association between BMI and inflam-
mation in hand and foot joints detected by MRI at disease presentation; we 
hypothesized that a higher BMI is associated with less severe local inflammation in 
RA. Because an advantageous effect of BMI has only been observed thus far in RA, 
we also evaluated the association between BMI and MRI-detected inflammation 
differed in RA-patients compared with patients with other inflammatory arthritides 






Three groups were studied. Firstly, RA-patients who were consecutively included 
in the Leiden Early Arthritis Clinic (EAC) cohort between August 2010 and October 
2014. Secondly, early arthritis patients with other inflammatory diagnoses who 
were included in the same cohort in the same time period. Thirdly, asymptomatic 
volunteers who were recruited from the general population.
The EAC-cohort is an inception cohort of early arthritis patients presenting with 
clinically detected arthritis of ≥ 1 joint and symptom duration < 2 years.[8] At base-
line, questionnaires were filled, physical examination was performed (including 
weight and height), blood samples were obtained, and MRI was performed. RA was 
defined as fulfilling the 1987 ACR criteria during the first year of follow-up.
The asymptomatic volunteers were recruited between November 2013 and Decem-
ber 2014.[9] Volunteers were recruited via advertisements in local newspapers and 
websites. The volunteers had no history of RA or other inflammatory rheumatic 
diseases, no joint symptoms during the last month, and no clinically detectable 
arthritis at physical examination. Participants received a voucher of €20 to com-
pensate for their time and travel costs and did not receive a report of the MRI- 
results. Therefore, volunteers had no/limited benefit from participating.
MRI-protocol and scoring
On an ONI-MSK-extreme 1.5 T extremity MRI machine (General Electric, WI, USA), 
imaging was performed of the unilateral metacarpophalangeal (MCP) 2-5 joints, 
wrist joints, and metatarsophalangeal (MTP) 1-5 joints. In patients the most painful 
side was scanned or, in case of equally severe symptoms on both sides, the dom-
inant side. In asymptomatic volunteers, the dominant side was scanned. Accord-
ing to the protocol, the MRI-scan was performed before the 2-week visit in which 
patients receive their diagnosis, and the median time between the first visit and the 
MRI-scan was 8 days. Furthermore, patients were asked to stop NSAIDS 24 hours 
prior to the MRI-scan. The following sequences were acquired: T1 fast-spin echo 
(T1), T2-weighted fat saturated (T2), and, after intravenous contrast administration 
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(gadoteric acid, 0.1 mmol/kg; Guerbet, Paris, France), T1 fast-spin echo with fat 
saturation (T1 Gd). A detailed scan protocol is provided in Additional file 1. Scoring 
was carried out according to the RAMRIS for synovitis and BME in the MCP, wrist, 
and MTP joints and according to Haavardsholm et al. for tenosynovitis in the MCP 
and wrist.[10, 11] The total MRI inflammation score was calculated by summing the 
synovitis, BME, and tenosynovitis scores. MRI-scoring of the arthritis patients was 
done independently by two trained readers (WPN and ECN) and the asymptomatic 
volunteers were scored independently by two trained readers (HWvS and LM). All 
readers were trained before the start of this project. Readers were blinded for any 
clinical data. MRI images of asymptomatic volunteers were blinded and mixed with 
MRI images of RA-patients and patients with arthralgia without clinical synovitis 
(n = 99), to exclude observer bias scoring introduced by knowledge that persons 
had no symptoms. The within-reader intraclass correlation coefficients (ICC) for the 
readers who scored the arthritis patients were 0.98 and 0.93, and for the readers 
who scored the asymptomatic volunteers these were 0.98 and 0.99. The between-
reader ICC of the four readers were all above 0.91 (Additional file 2). The mean 
scores of two readers were used for the analyses.
Analyses
Associations between MRI-detected inflammation and BMI were assessed using 
univariable and multivariable linear regression analyses. The MRI inflammation 
scores were log10-transformed (log10(score + 1)) to approximate a normal distri-
bution. Thereafter, BMI was divided into three categories according to the World 
Health Organization (WHO) definition: low-normal weight ( < 25 kg/m2), overweight 
( ≥ 25 to < 30 kg/m2), and obese ( ≥ 30 kg/m2). The Kruskal-Wallis test, Mann-Whitney 
U test, linear regression models, and Spearman rank correlation coefficient were 
used as appropriate. SPSS V23.0.0 was used.
In RA-patients treated in a trial, an association between BMI and BME was 
observed [3]. We sought to compare our findings in an unselected RA population 
at disease presentation with these results. In order to do so, we performed a 
multivariable ordinal logistic regression model in which BME was categorized into 






In total, 202 RA-patients and 170 early arthritis patients with other inflammatory 
diagnoses were consecutively included in the Leiden EAC. Five RA-patients and 
eight other arthritis patients had no information on height or weight and, respec-
tively, two and three patients had an MRI-scan without contrast enhancement and 
were excluded. Therefore, 195 RA-patients and 159 arthritis patients with other 
inflammatory diagnoses were evaluated.In addition, 196 asymptomatic volunteers 
were recruited, as already described, three of whom did not receive an MRI-scan 
due to personal problems (n = 1), vasovagal collapse at intravenous puncture 
(n = 1), and anxiety (n = 1).
Baseline characteristics of all participants are presented in Table 1. Seventy-nine 
(41%) RA-patients were overweight (BMI > 25 to < 30 kg/m2) and 41 (21%) were obese 
( ≥ 30 kg/m2); in other arthritis patients these percentages were respectively 44% 
(n = 70) and 14% (n = 23), and in asymptomatic volunteers these percentages were 
32% (n = 61) and 9% (n = 17) respectively.
BMI and MRI-detected inflammation
The median MRI inflammation score in RA-patients was 14.5 (IQR = 7.0-26.5), in 
other arthritis patients the median was 6.0 (IQR = 2.0-15.0), and in asymptomatic 
volunteers the median was 2.0 (IQR = 0.5-4.5, p < 0.001), showing that RA-patients 
had the highest MRI inflammation scores.
In RA-patients, a higher BMI was associated with lower MRI inflammation scores 
(β = 0.97, p = 0.024). A β value of 0.97 indicates that for every point increase in BMI 
there is a 0.97-fold increase in MRI inflammation score; thus higher BMI was asso-
ciated with less severe MRI inflammation. In contrast, in other arthritis patients and 
in asymptomatic volunteers, a higher BMI was associated with higher MRI inflam-
mation scores (respectively β = 1.082, p < 0.001 and β = 1.029, p = 0.040; Fig.  1). 
When BMI was categorized into three groups (low-normal weight, overweight, and 
obese), similar results were obtained. Obese RA-patients had significantly lower 
MRI inflammation scores (median = 10.0, IQR = 6.5- 18.0) compared with low-nor-
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Figure 1  The association between BMI (both when presented on a continuous 
scale or categorized) and MRI-detected inflammation is different in 
early RA-patients (A) compared to early arthritis patients with other 
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    
 
Total inflammation score were log transformed for regressions. Regression coefficients presented are 
back-transformed (10^β and 10^95%CI). In RA-patients the back-transformed regression coefficient is 
0.97 (95%CI 0.94-1.00; A.1.). In arthritis patients with other diagnoses the coefficients is 1.082 (95%CI 
1.041-1.13; B.1.) and in asymptomatic volunteers it was 1.029 (95%CI 1.001-1.057; C.1.), The lines 




mal weight RA-patients (median = 19.5, IQR = 7.5-29.0, p = 0.005) and overweight 
RA-patients (median = 14.5, IQR = 7.0-28.0, p = 0.046). Within the group of other 
early arthritis patients, obese patients had higher total MRI inflammation scores 
(median = 8.5, IQR = 5.0-13.5) compared with patients with a low-normal weight 
(median = 2.5, IQR = 0.5-9.5, p = 0.002). Similarly, overweight was also associated 
with higher total MRI inflammation scores (median = 8.0, IQR = 3.5-22.0, p < 0.001). 
Within asymptomatic volunteers a tendency towards higher inflammation scores 
was seen in obese persons (median = 3.5, IQR = 1.0-5.5) compared with low-normal 
weight persons (median = 1.5, IQR = 0.5-3.5, p = 0.064) and overweight persons 
(median = 2.0, IQR = 1.0-4.5, p = 0.24; Fig. 1).
Thereafter, the association between BMI (measured continuously) and MRI- 
detected inflammation was adjusted for age and gender, also showing that a 
higher BMI was associated with higher inflammation scores in other early arthritis 
patients (β = 1.036, p = 0.054) and asymptomatic volunteers (β = 1.022, p = 0.040) 
but with lower inflammation scores in RA-patients (β = 0.96, p = 0.005; Table 2 (for 
nonback-transformed β values, see Additional file 3)). After additional adjustments 
for CRP and anti-citrullinated protein antibody (ACPA) the results remained similar 
(β = 0.96, p = 0.003 for RA-patients and β = 1.039, p = 0.043 for other early arthritis 
patients).
The group of early arthritis patients with diagnoses other than RA was divided into 
the following six subgroups: inflammatory osteoarthritis (n = 38), spondyloarthritis 
with peripheral arthritis and psoriatic arthritis (n = 40), systemic lupus erythemato-
sus/mixed connective tissue disease and other systemic disease (n = 20), reactive 
arthritis and lyme arthritis (n = 17), gout and pseudogout (n = 19), and other dis-
eases (n = 25). These subgroups were studied to assess whether the association 
was more pronounced in a particular disease group. However, the directionality of 
the effect was similar in all subgroups (Additional file 4).
BMI and different types of MRI inflammation
The total MRI inflammation score is composed of the synovitis, tenosynovitis, and 
BME-scores. To assess whether synovitis, BME, and tenosynovitis have different 
associations with BMI, these types of inflammation were assessed separately. The 
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synovitis score showed a negative association with BMI in RA-patients (β = 0.98, 
p = 0.047) and a positive association in other arthritis patients and in asymptom-
atic volunteers (β = 1.084, p < 0.001 and β = 1.031, p = 0.006 respectively). A higher 
BMI was associated with lower BME in RA-patients (β = 0.95, p = 0.002). In other 
arthritis patients and in asymptomatic volunteers, BMI was not associated with 
BME-scores (respectively β = 1.021, p = 0.24 and β = 1.003, p = 0.79). Within other 
arthritis patients and in asymptomatic volunteers there was a positive associa-
tion between BMI and the tenosynovitis score (β = 1.054, p = 0.003 and β = 1.021, 
p = 0.003 respectively), whereas BMI was not associated with tenosynovitis in RA 
(β = 0.98, p = 0.21; Additional file 5).
Further analyses in BMI and BME
Recently, an inverse association between BMI and BME was shown in RA-patients 
who were treated in a trial.[3] The median BME-scores of patients included in 
this trial and who were low-normal weight, overweight, and obese patients were 
Figure 2  Association of overweight and obesity with BME compared to low-nor-
mal weight in RA-patients included the EAC-cohort and the GO-BEFORE 
trial[3] summarized.













BMI was categorized in three groups, low-normal weight ( < 25 kg/m2), overweight ( ≥ 25 to < 30 kg/m2)  




respectively 9 (IQR 2.5-19), 6.3 (IQR 2.5-13), and 4.8 (IQR 1.5-9.8).[3] We wished 
to compare these recent results with our findings obtained in an unselected set of 
RA-patients at the time of disease onset. The median scores observed in our cohort 
showed a similar tendency but were lower; the median scores in the three groups 
were respectively 5.0 (IQR 2.0-11.0), 3.0 (IQR 1.0-9.0), and 2.0 (IQR 1.0-4.5). The 
trial data showed that, after adjusting for race, ACPA, disease duration, DAS, age, 
and sex, overweight patients had an odds ratio (OR) of 0.68 (95% CI 0.42- 1.08, 
p = 0.1) and obese patients an OR of 0.47 (95% CI 0.27-0.82, p = 0.008) for being in 
a higher BME quintile (Fig. 2). We performed the same analyses without adjusting 
for race because our study population consisted of 96% Caucasians, and without 
disease duration because all of our early arthritis patients were evaluated at their 
first presentation to the rheumatologic outpatient clinics. In our data, overweight 
patients had an OR of 0.42 (95% CI 0.23-0.79, p = 0.007) and obese patients had 
an OR of 0.30 (95% CI 0.14-0.64, p = 0.002) compared with low-normal weight 
patients (Fig. 2). Analyses of both data sets thus showed an inverse association 
between BMI and BME-scores.
BMI and regular measures of inflammation
The association of BMI with regular measures of inflammation was assessed in 
RA-patients and other arthritis patients. In RA-patients the median swollen joint 
count (SJC) in low-normal weight patients was 5 (IQR = 3-10), in overweight patients 
the median was 6 (IQR = 2-10), and in obese patients the median was 8 (IQR = 3-10; 
p = 0.69). The median CRP-levels in low-normal weight, overweight, and obese 
RA-patients were respectively 7 mg/L (IQR = 3-23 mg/L), 12 mg/L (IQR = 4-23 mg/L), 
and 10 mg/L (IQR = 4-24 mg/L; p = 0.39). In other arthritis patients the median 
of SJC in low-normal weight, overweight, and obese patients were respectively 3 
(IQR = 1-5), 3 (IQR = 2-5), and 4 (IQR = 3-7; p = 0.074). Lastly, the median CRP-level 
in the three groups were respectively 4 mg/L (IQR = 3-18 mg/L), 4 mg/L (IQR = 3-12 
mg/L), and 5 mg/L (IQR = 3-13 mg/L; p = 0.65). Therefore, in RA-patients and in other 
arthritis patients, BMI was neither associated with swollen SJC nor with CRP-levels.
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BMI and ACPA in RA-patients
The influence of BMI on MRI-detected inflammation in ACPA-positive or ACPA-neg-
ative RA-patients was assessed separately. Although the subgroups became 
small (n = 107 and n = 88 respectively), the effect size of the association between 
BMI and MRI-detected inflammation remained unchanged (respectively β = 0.97, 
p = 0.071 and β = 0.97, p = 0.12 for ACPA-positive RA and ACPA-negative RA in the 
univariable analyses and respectively β = 0.97, p = 0.097 and β = 0.96, p = 0.011 for 
the analyses adjusted for age and gender).
Furthermore, the association between ACPA level and BMI was assessed with the 
Spearman rank test in all RA-patients. ACPA levels were not correlated with BMI 
(ρ = −0.33, p = 0.65) and did not differ between the three BMI categories (p = 0.38; 
Additional file 6).
Discussion
An increased BMI is associated with higher inflammatory markers in the general 
population [1], and a higher risk for RA-development.[2] A high BMI within RA, 
however, is associated with less severe radiographic joint damage.[3-6] Because 
joint destruction is the result of persistent inflammation, the present cross-sectional 
study assessed the association between BMI and MRI-detected inflammation and 
showed that RA-patients with a high BMI had less MRI-detected inflammation. More 
specifically, patients had less severe synovitis and BME. This inverse association 
was not observed in early arthritis patients with other inflammatory diagnoses and 
in asymptomatic volunteers. This suggests that the inverse association between 
BMI and local joint inflammation is confined to RA and may explain the previously 
reported observation of less severe radiographic progression in obese RA-patients.
The mechanism underlying this inverse association is unknown. It can be specu-
lated that adipocytokines play a role. It could be that the composition of the adipo-
cytokines is different between various diseases; for example, the balance between 
low molecular weight versus high molecular weight adiponectin might be different. 




cells is different within RA compared with other diseases. However, we have no 
data to support these speculations and further studies are needed to unravel the 
biologic mechanism underlying our observation.
To the best of our knowledge RA is the only disease in which obese patients have 
less severe inflammation and progression. Also, the effect of obesity for RA is two-
fold. Despite the association with less severe MRI-detected inflammation and less 
severe radiographic progression, obesity has been associated with a higher risk 
for developing RA and a lower risk for reaching persistent remission.[2, 12] Fur-
thermore, a lower chance to achieve a low disease activity has also been observed 
in RA-patients that use synthetic DMARDs and biological DMARDs.[13-15] Of note, 
when evaluating the components of the disease activity score, the effect was only 
present for subjective measures (tender joint count and patient global assessment) 
and not for objective measures of inflammation (CRP, erythrocyte sedimentation 
rate, and swollen joint count).[13]
Also in the present study we observed no association between BMI and either the 
CRP-levels or the number of swollen joints. This illustrates that local inflammation 
is different from systemic inflammation and also underlines that MRI is a more 
sensitive method to detect local inflammation than physical examination of joints. 
Apparently the less severe radiographic progression in RA is paralleled by less 
severe local inflammation, which is detected when local inflammation is measured 
using a sensitive method. As such, the results of the present study suggest that 
MRI is not only valuable as an outcome measure in clinical trials but that MRI-stud-
ies may also help to increase our pathophysiological understanding of RA.
In line with recommendations of the ESSR [16], BME was evaluated on T1 Gd, which 
is different from the RAMRIS methodology using T2. Our scan protocol omitted T2 
because previous studies have shown that these sequences perform equally well in 
the depiction of BME [17, 18] and the T1 Gd sequence allows a shorter imaging time 
for the patients. The present finding of similar effects of BMI in BME as observed in 
two different studies in which BME was assessed on different sequences (Baker et 
al.[3] used short tau inversion recovery (or T2 precontrast) sequences) support the 
notion that the findings are not influenced by the sequence used to depict BME.
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This study has limitations. The BMI was used as an estimate of the adipose tissue, 
but differences in BMI are not only caused by differences in adipose tissue but also 
by differences in, for instance, muscle mass. There are methods that could make 
more accurate estimations in this respect, such as waist circumference, bioelec-
trical impedance, or computed tomography. Another important limitation is that 
long-term follow-up was not yet available for the RA-patients who had undergone 
MRI. Therefore we could not assess whether our findings at disease presentation 
might explain the association of BMI with less severe radiographic joint progres-
sion. In addition we could not determine the association of BMI with other disease 
outcomes, such as persistent remission.
Conclusions
The association between BMI and MRI-detected inflammation differs in patients 
with RA compared with patients with other inflammatory diagnoses and with 
asymptomatic controls. Within RA a higher BMI is associated with less severe 
MRI-detected inflammation, and this may explain the finding that obese RA- 
patients have less severe radiographic progression.
Supplementary material





 1  Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. ELevated Creactive protein levels in 
overweight and obese adults. JAMA. 1999;282: 2131-5.
 2  Qin B, Yang M, Fu H, Ma N, Wei T, Tang Q, et al. Body mass index and the risk of rheumatoid 
arthritis: a systematic review and dose-response meta-analysis. Arthritis Res Ther. 2015;17:86.
 3  Baker JF, Østergaard M, George M, Shults J, Emery P, Baker DG, et al. Greater body mass 
independently predicts less radiographic progression on X-ray and MRI over 1-2 years.  
Ann Rheum Dis. 2014;73:1923-8.
 4  van der Helm-van Mil AHM, van der Kooij SM, Allaart CF, Toes REM, Huizinga TWJ. A high body 
mass index has a protective effect on the amount of joint destruction in small joints in early 
rheumatoid arthritis. Ann Rheum Dis. 2008;67:769-74.
 5  Westhoff G, Rau R, Zink A. Radiographic joint damage in early rheumatoid arthritis is highly 
dependent on body mass index. Arthritis Rheum. 2007;56: 3575-82.
 6  Kaufmann J, Kielstein V, Kilian S, Stein G, Hein G. Relation between body mass index and 
radiological progression in patients with rheumatoid arthritis. J Rheumatol. 2003;30:2350-5.
 7  Nieuwenhuis WP, van Steenbergen HW, Stomp W, Stijnen T, Huizinga TWJ, Bloem JL, et al.  
The course of bone marrow edema in early undifferentiated and rheumatoid arthritis;  
a longitudinal MRI-study on bone level. Arthritis Rheumatol. 2016;68:1080-8.
 8  de Rooy DPC, van der Linden MPM, Knevel R, Huizinga TWJ, Mil AHM van der H. Predicting arthritis 
outcomes—what can be learned from the Leiden Early Arthritis Clinic?  
Rheumatology. 2011;50:93-100.
 9  Mangnus L, van Steenbergen HW, Reijnierse M, van der Helm-van Mil AHM. MR-detected features 
of inflammation and erosions occur in symptom-free persons from the general population. 
Arthritis Rheumatol. 2016. doi:10.1002/art.39749.
 10  Østergaard M, Edmonds J, McQueen F, Peterfy C, Lassere M, Ejbjerg B, et al. An introduction to the 
EULAR-OMERACT rheumatoid arthritis MRI reference image atlas.  
Ann Rheum Dis. 2005;64 Suppl 1:i3-7.
 11  Haavardsholm EA, Østergaard M, Ejbjerg BJ, Kvan NP, Kvien TK. Introduction of a novel magnetic 
resonance imaging tenosynovitis score for rheumatoid arthritis: reliability in a multireader 
longitudinal study. Ann Rheum Dis. 2007; 66:1216-20.
 12  Ajeganova S, Andersson ML, Hafström I, for the BARFOT Study Group. Association of obesity with 
worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term followup 
from disease onset. Arthritis Care Res. 2013;65:78-87.
 13  Sandberg MEC, Bengtsson C, Källberg H, Wesley A, Klareskog L, Alfredsson L, et al. Overweight 
decreases the chance of achieving good response and low disease activity in early rheumatoid 
arthritis. Ann Rheum Dis. 2014;73: 2029-33.
 14  Gremese E, Carletto A, Padovan M, Atzeni F, Raffeiner B, Giardina AR, et al. Obesity and reduction 
of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a 
personalized medicine. Arthritis Care Res. 2013;65:94-100.
111
BMI and MRI-detected inflammation
5
 15  Heimans L, van den Broek M, le Cessie S, Siegerink B, Riyazi N, Han KH, et al. Association of 
high body mass index with decreased treatment response to combination therapy in recent-onset 
rheumatoid arthritis patients. Arthritis Care Res. 2013;65:1235-42.
 16  Sudoł-Szopińska I, Jurik AG, Eshed I, Lennart J, Grainger A, Østergaard M, et al. Recommendations 
of the ESSR Arthritis Subcommittee for the use of magnetic resonance imaging in musculoskeletal 
rheumatic diseases. Semin Musculoskelet Radiol. 2015;19:396-411.
 17  Stomp W, Krabben A, van der Heijde D, Huizinga TWJ, Bloem JL, Mil AHM van der H, et al. Aiming 
for a shorter rheumatoid arthritis MRI-protocol: can contrast-enhanced MRI replace T2 for the 
detection of bone marrow oedema? Eur Radiol. 2014;24:2614-22.
 18  Mayerhoefer ME, Breitenseher MJ, Kramer J, Aigner N, Norden C, Hofmann S. STIR vs. T1-weighted 
fat-suppressed gadolinium-enhanced MRI of bone marrow edema of the knee: computer-assisted 
quantitative comparison and influence of injected contrast media volume and acquisition 




Table 1  Characteristics of early rheumatoid arthritis patients, early arthritis 




Arthritis patients with 





Female, N (%) 119 (66) 80 (52) 136 (70)
Age, mean (SD) 55.9 (14.6) 54.3 (17.2) 50.7 (z)
Symptom duration (months), 
median (IQR)
3.2 (1.8-6.8) 3.0 (1.0-6.2)  - 
Current smokers, N (%) 38 (24) 29 (23) 17 (9)
BMI (kg/m2), median (IQR) 26.4 (23.7-29.4) 25.5 (22.9-27.9) 24.1 (22.3-26.3)
WHO BMI classification, N (%)
Low-normal weight  
(BMI 18.5-24.9) (%)
75 (38) 66 (42) 115 (60)
Overweight  
(BMI 25.0-29.9) (%)
79 (41) 70 (44) 61 (32)
Obesity  
(BMI ≥ 30) (%)
41 (21) 23 (14) 17 (9)
CRP (mg/L), median (IQR) 9.8 (3.7-23.0) 4.0 (3.0-15.1)  NA
ACPA positivity, N (%) 107 (55) 6 (4)  NA
RF positivity, N (%) 120 (62) 27 (17)  NA
Three (2%) RA-patients had a low weight (BMI < 18.5 kg/m2), no patients with other arthritides had a 
low weight, and two (1%) asymptomatic volunteers had a low weight.
Gender was missing in 11 RA-patients; within early arthritis patients with other arthritides, gender, 
ACPA positivity and RF positivity was missing in respectively six, two, and three patients.
NA, not assessed;
WHO, World Health Organization;
BMI, body mass index;
CRP, C-reactive protein;
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Table 2  Association of BMI with MRI-detected inflammation in patients with 
RA, early arthritis patients with other arthritides, and asymptomatic 
volunteers
Rheumatoid arthritis  
(n = 195)
Other arthritides  
(n = 159)
Asymptomatic  
volunteers (n = 193)
 β (95%CI) p β (95%CI) p β (95%CI) p
Univariable
BMI 0.97 (0.94-1.00) 0.024 1.082 (1.041-1.13)  < 0.001 1.029 (1.001-1.057) 0.040
Multivariable
Model 1
BMI 0.96 (0.94-0.99) 0.005 1.036 (1.00-1.075) 0.054 1.022 (1.001-1.044) 0.040
Age 1.025 (1.017-1.033)  < 0.001 1.033 (1.024-1.041)  < 0.001 1.031 (1.025-1.036)  < 0.001
Gender 1.13 (0.89-1.44) 0.30 0.88 (0.67-1.15) 0.34 1.010 (0.84-1.21) 0.92
Model 2
BMI 0.96 (0.94-0.99) 0.003 1.039 (1.001-1.078) 0.043 NA
Age 1.022 (1.014-1.030)  < 0.001 1.030 (1.021-1.039)  < 0.001 NA
Gender 1.12 (0.89-1.41) 0.35 0.93 (0.71-1.23) 0.62 NA
CRP 1.007 (1.003-1.012) 0.001 1.002 (0.998-1.006) 0.29 NA
ACPA positivity 0.96 (0.77-1.20) 0.72 1.55 (0.75-3.20) 0.24 NA
Total inflammation scores were log-transformed for regressions.
Regression coefficients presented are back-transformed (10β and 1095% CI). Therefore, the effect size 
(β) can be interpreted as the fold increase in MRI-detected inflammation per point increase in BMI. 
Thus, an effect size of < 1 means a decrease in MRI-detected inflammation per unit increase in BMI and 
an effect size of  > 1 means an increase in MRI-detected inflammation per unit increase in BMI. The raw 
beta coefficients are presented in Additional file 3.
BMI, body mass index;




ACPA, anti-citrullinated protein antibody.
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Introduction: Moderate alcohol consumption is protective against rheumatoid 
arthritis (RA)-development and associated with lower levels of systemic inflamma-
tion in RA and in the general population. We therefore hypothesized that moderate 
alcohol consumption is associated with less severe local inflammation in joints 
in RA, detected by MRI. Since asymptomatic persons can have low-grade MRI- 
detected inflammation [1,2], we also hypothesized that alcohol consumption is 
associated with the extent of MRI-inflammation in asymptomatic volunteers.
Methods: 188 newly presenting RA-patients and192 asymptomatic volunteers 
underwent a unilateral contrast-enhanced 1.5T MRI of MCP, wrist and MTP-joints. 
The MRIs were scored on synovitis, bone marrow edema and tenosynovitis; the 
sum of these yielded the MRI-inflammation score. MRI-data was evaluated in 
relation to current alcohol consumption, categorized: non-drinkers, consuming 1-7 
drinks/week, 8-14 drinks/week, and > 14 drinks/week. Association between C-re-
active protein-level and alcohol was studied in 1070 newly presenting RA-patients.
Results: Alcohol consumption was not associated with the severity of MRI-detected 
inflammation in hand and foot joints of RA-patients (p = 0.55) and asymptomatic 
volunteers (p = 0.33). A J-shaped curve was observed in the association between 
alcohol consumption and CRP-level, with the lowest levels in patients consuming 
1-7 drinks/week (p = 0.037).
Conclusion: Despite the fact that moderate alcohol consumption has been shown 
protective against RA, and our data confirm a J-shaped association of alcohol 
consumption with CRP-levels in RA, alcohol was not associated with the severity 
of joint inflammation. The present data suggest that the pathophysiological mech-






In the general population moderate alcohol consumption has been associated with 
lower levels of systemic inflammation, as several studies have shown that alcohol 
consumption is associated with levels of C-reactive protein (CRP) in a J-shaped or 
U-shaped manner.[1,2] Individuals with an alcohol consumption of 1-2 drinks daily 
had the lowest CRP-levels.
In rheumatoid arthritis (RA), the influence of alcohol consumption on the risk of 
developing RA has been studied extensively. Moderate alcohol consumption has 
been associated with a decreased risk on developing RA.[3-5] The risk of devel-
oping RA was lowest in persons who consumed approximately 1 unit of alcohol 
per day.[3] In RA-patients, alcohol consumption was associated with lower levels 
of inflammatory markers (e.g., CRP and erythrocyte sedimentation rate (ESR) 
soluble tumor necrosis factor receptor II, Interleukin-6 (IL-6)).[6-8] For IL-6 levels a 
U-shaped association was also observed, with the lowest IL-6 levels in RA-patients 
that consumed 1 unit of alcohol per day.[6]
Within RA the effect of alcohol on local inflammation in joints has been studied once 
using the swollen joint count (SJC) and no evident association between alcohol 
consumption and the number of swollen joints was observed in 1238 RA-patients.
[9] Because magnetic resonance imaging (MRI) is more sensitive than the swollen 
joint count to detect local inflammation [10], we anticipated that MRI is useful to 
detect an effect of alcohol on the severity of local inflammation in RA.
Furthermore, as the effect of alcohol on markers of systemic inflammation is also 
present in the general population [1] and since some asymptomatic persons of 
the general population also have low-graded MRI-detected inflammation [11,12], 
an association between alcohol and joint inflammation might not be confined to 
RA-patients, but even be present in asymptomatic volunteers.
Therefore, we hypothesized that moderate alcohol consumption is associated 
with less inflammation in hand and foot joints, visualized by MRI, both in patients 







The RA-patients studied were consecutively included in the Leiden Early Arthritis 
Clinic (EAC). This is an inception cohort that includes patients with ≥ 1 swollen joint 
and a symptom duration of < 2 years. When patients presented at the outpatient 
clinic, questionnaires were obtained that included a self-reported average number 
of alcohol consumptions per week (current consumption). Furthermore, physical 
examination was performed and blood samples were obtained.[13] RA was defined 
as fulfilling the 1987 ACR-criteria during the first year of follow-up. From 1993 to 
2016 1244 RA-patients were included in the EAC cohort. The association between 
alcohol consumption and CRP was assessed in all RA-patients of whom alcohol 
consumption was available (1070 RA-patients). From 2010 onwards MRI was added 
to the study protocol [10] and the association between alcohol and MRI-detected 
inflammation was assessed in 188 consecutive RA-patients who underwent an MRI 
at baseline (See Supplementary Figure 1 for a flowchart).
The asymptomatic volunteers were recruited between November 2013 and Decem-
ber 2014, and were described earlier.[12] Volunteers were recruited via adver-
tisements in local newspapers and websites. Volunteers had no history of RA or 
other inflammatory rheumatic diseases, no joint symptoms during the last month 
and no clinically detectable arthritis at physical examination. Questionnaires 
were obtained, including self-reported alcohol consumption. CRP-levels were not 
assessed in these volunteers. 193 volunteers underwent an MRI; in one of these 
persons no data on alcohol consumption was obtained. The volunteers received a 
voucher of 20€ to compensate for their time and travel costs and did not receive a 
report of the MRI. Therefore, volunteers had no/limited benefit from participating.
The medical ethics committee of the Leiden University Medical Center approved 
this study and all participants have given a written informed consent.
MRI-protocol and scoring
A contrast-enhanced MRI was performed of the unilateral metacarpophalangeal 




the most painful side was scanned or in case of equally severe symptoms at both 
sides the dominant side was scanned. In asymptomatic volunteers the dominant 
side was scanned. An ONI-MSK-extreme 1.5T extremity MRI-scanner (GE, Wisconsin, 
USA) was used. The scan protocol is described in more detail in the Supplementary 
methods. Briefly, T1-weighted sequences (T1) were acquired. After intravenous 
contrast administration (gadoteric acid, Guerbet, Paris, 0.1 mmol/kg) T1-weighted 
sequences with fat saturation (T1Gd) were performed. The foot was scanned with 
T2-weighted fat saturated (T2) and T1 sequences in the first 106 RA-patients and 
with T1Gd in the last 82 RA-patients. Scoring of synovitis and bone marrow edema 
(BME) was done according to the RA MRI score (RAMRIS) method in the MCP, 
wrist and MTP joints.[14] Tenosynovitis was scored according to Haarvardsholm 
et al. in the MCP and wrist.[15] The total MRI-inflammation score was calculated 
by summing the synovitis, BME and tenosynovitis scores, and ranged between 0 
and 189. MRI-scoring was done independently by trained readers, the RA-patients 
were scored by two readers (WPN and ECN) and the asymptomatic volunteers were 
scored by two readers (HWvS and LM). Readers were blinded for any clinical data. 
Furthermore, to exclude observer bias introduced by knowledge that persons had 
no symptoms, MRI images of asymptomatic volunteers were mixed with MRI images 
of RA-patients and patients with arthralgia without clinical synovitis (n = 99). The 
within-reader intraclass correlation coefficients (ICC) of the readers were all greater 
than 0.93 and the between reader ICCs of the four readers were all above 0.91. The 
mean scores of two readers were used for the analyses.
Analyses
Alcohol consumption was categorized into 4 groups: non-drinkers, participants 
that consume 1-7 drinks/week, 8-14 drinks/week and > 14 drinks/week, this corre-
sponded to no, 1, 2 and more drinks daily as used is some previous studies.[3-6] 
Groups were compared with the Kruskal Wallis test and the Mann-Whitney U-test 
when appropriate. The association of alcohol consumption with MRI-detected 
inflammation was analysed using univariable and multivariable linear regressions 
adjusted for age, gender, smoking status, and anti-citrullinated protein antibody 




linear regression in the asymptomatic volunteers was adjusted for age, gender, 
and smoking status. In the linear regression analyses MRI inflammation scores 
were log10-transformed (log10(score+1)) to approximate a normal distribution. To 
analyse whether a J-shape existed in the association between alcohol consump-
tion and CRP-levels, a linear regression with a piecewise linear spline on 1 alcohol 




Baseline characteristics are presented in table 1. Sixty-four % (n = 121) of the RA- 
patients that underwent MRI (See Supplementary Figure  1 for a flowchart), con-
sumed alcohol at baseline, with a median consumption of 6 drinks/week (IQR 3-11). 
Of the asymptomatic volunteers, 70% (n = 135) consumed alcohol with a median 
consumption of 7 drinks/week (IQR 4-14). The RA-patients consumed on average 
one alcohol consumption less than the asymptomatic volunteers, this difference 
did not reach statistical significance (p = 0.14).
The association of MRI-detected inflammation with alcohol 
consumption in RA-patients
The extent of MRI-detected inflammation was first compared in 4 categories of 
alcohol consumption. The median MRI-detected inflammation in RA-patients did 
not significantly differ between the 4 categories; RA-patients who did not drink 
alcohol had a median MRI inflammation score of 14.8 (IQR = 7.0-26.5), RA-patients 
consuming ≤ 7 drinks/week had a median of 16.5 (IQR = 7.0-27.5), RA-patients con-
suming 8-14 drinks/week had a median of 16.8 (IQR = 8.5-26.5),and RA-patients 
consuming > 14 drinks/week median of median of 15.0 (IQR = 12.0-40.5), p = 0.53 
(Figure 1A). When analysing BME, synovitis, and tenosynovitis separately similar 




Figure 1  The association between alcohol consumption and the severity of 
MRI-detected inflammation in hand and foot joints of RA-patients (A), 





















































The lines presented in the figure represent median values. MRI-detected inflammation does not differ 
significantly between the 4 groups in RA-patients and asymptomatic volunteers (respectively p = 0.53 




Figure 2  The association between alcohol consumption and the severity of 




























































The lines presented in the figure represent median values. Synovitis, BME, and tenosynovitis scores 





Figure 3  The association between alcohol consumption and the severity of 

























































The lines presented in the figure represent median values. Synovitis, BME, and tenosynovitis scores 
did not differ significantly between the 4 groups in asymptomatic volunteers (respectively p = 0.81, 




The association between alcohol and MRI-detected inflammation was also eval-
uated with the number of alcohol consumptions on a continuous scale, also 
showing no association (β = 1.011, 95%CI = 0.992-1.030, p = 0.36). To exclude the 
possibility of non-significance due to the presence of confounders, the analysis was 
subsequently adjusted for age, gender, smoking, and ACPA. Also this showed no 
association between alcohol and inflammation in hand and foot joints. (β = 0.994, 
95%CI = 0.975-1.013, p = 0.53).
The association of MRI-detected inflammation with alcohol 
consumption in asymptomatic volunteers
In asymptomatic volunteers, the extent of MRI-detected inflammation was also 
compared in 4 categories of alcohol consumption. The median MRI-detected 
inflammation did not significantly differ between the 4 categories; asymptomatic 
volunteers who did not drink alcohol had a median MRI inflammation score of 1.5 
(IQR = 0.5-4.0), ≤ 7 drinks/week 1.5 (IQR = 0.5-4.0), 8-14 drinks/week 2.5 (IQR = 1.0-
4.0), > 14 drinks/week 3.5 (IQR = 1.0-5.0), p = 0.33 (Figure 1B). Analysing BME, syno-
vitis, and tenosynovitis separately revealed similar results (see Figure 3).
Assessing alcohol consumption on a continuous scale an association was observed 
in univariable analysis (β = 1.018, 95%CI = 1.002-1.034, p = 0.025). However, after 
adjusting for age, the association disappeared (β = 1.003, 95%CI = 0.99-1.016, 
p = 0.62), and also after adjusting for age, gender, and smoking status no associa-
tion was observed (β = 1.002, 95%CI = 0.99-1.015, p = 0.76).
Association of alcohol consumption and CRP in RA-patients
Because of the negative findings done thus far, we searched for a positive control 
and we wished to verify if the previously observed association between alcohol 
consumption and CRP was present in our cohort of RA-patients. In a total of 1070 
RA-patients 58% consumed alcohol with a median consumption of 6 drinks/week 
(IQR 2-11). The median CRP-level in nondrinkers was 16 mg/L (interquartile range 
(IQR) = 6-37 mg/L), in patients that consume ≤ 7 drinks/week the median was 
11 mg/L (IQR = 5-29 mg/L), in patients that consume 8-14 drinks/week the median 




median was 19 mg/L (IQR = 6-41 mg/L). The median CRP-levels between these four 
groups differed significantly (p = 0.043). Evaluation by eye suggested the presence 
of a J-shaped effect with the lowest CRP in the group that consumes ≤ 7 drinks/
week. Indeed comparing this group with the non-drinkers revealed a significant 
difference (p = 0.011, Figure 4). To further confirm this J-shape, a piecewise linear 
spline regression was used. The regression was divided into 2 regression co -
efficients of the J-curve (e.g. the left decreasing part and the right increasing part 
with the lowest CRP-level on 1 drink/week). CRP-level decreased significantly with 
increasing alcohol consumption up until a maximum of 1 drink/week (β = 0.80, 
95%CI = 0.68-0.93, p = 0.003). In patients consuming > 1 drink/week, CRP-levels 
increased significantly (β = 1.015, 95%CI = 1.004-1.025, p = 0.006). Hereby, the 
J-shaped association was confirmed. In a multivariable analyse adjusting for 
Figure 4  The association between alcohol consumption and the association 





















The lines presented in the figure represent median values. CRP does not differ significantly between 




age, gender, smoking and ACPA status, the downward part of the J-curve was still 
present (β = 0.85, 95%CI = 0.73-0.99, p = 0.039) but the upward part of the J-curve 
lost its significance (β = 1.007, 95%CI = 1.00-1.017, p = 0.214). A beta of 1.007 indi-
cates that for every drink/week increase in alcohol consumption there is an 1.007-
fold increase in CRP-level, thus in patients consuming > 1 drink/week higher alcohol 
consumption was associated with a higher CRP-level.
Discussion
Moderate alcohol consumption has been associated with less severe systemic 
inflammation (generally measured using CRP-levels), in the general population.
[1,2] Also within RA-patients, it has been shown repeatedly that moderate alcohol 
consumption lowers the risk of developing RA and is associated with less severe 
systemic inflammation [3,4] Because of these findings, we hypothesized that mod-
erate alcohol consumption might also be associated with less severe inflammation 
in joints, which can be sensitively detected with MRI. The current data revealed no 
association between alcohol consumption and the severity of local inflammation 
in hand and foot joints on MRI. Thus, though moderate alcohol consumption is 
associated with lower levels of systemic inflammation and a lower risk to develop 
RA, based on the present findings it is not associated with less severe inflamma-
tion in joints.
The pathophysiological mechanism underlying the association between alcohol 
consumption and inflammation is unknown. Different studies explored the immuno-
regulatory effects of alcohol and various results have been observed. High alcohol 
consumption has been reported to be associated with depleted cell- mediated and 
humoral immune responses [16], whereas other data suggest that low alcohol con-
sumption has a stimulatory effect on the cellular immune response.[17]
Distinguishing high alcohol consumption from moderate alcohol consumption has 
several pitfalls. In this study, assessment of alcohol consumption is based on ques-
tionnaires and could therefore deviate from the true alcohol consumption. Also, 




size and type of the alcohol consumption and variability in the period in which 
alcohol is used. Nonetheless, the fact that the association of alcohol consumption 
and CRP-levels in this study resemble the associations found in the literature [1] 
supports the validity of the data on alcohol consumption.
Alcohol consumption is part of a lifestyle and might therefore be a proxy for other 
factors associated with lifestyle. So, the association of alcohol on joint inflam-
mation might have been influenced by other factors. Multivariate analyses were 
performed to adjust for some of these factors (amongst others age, smoking), but 
this did not majorly influence the study results.
The lack of association between alcohol consumption and the extent of local joint 
inflammation on MRI found in this study might have been caused by an inadequate 
power to detect an effect of alcohol on joint inflammation on MRI, especially as the 
previously observed effect of alcohol on systemic inflammatory markers, such as 
CRP-levels, was generally observed in very large studies.[1] MRI is more time-con-
suming and more expensive to perform than e.g. CRP-level measurements; making 
an MRI-study within thousands of RA-patients infeasible. In our view there was not 
even a trend towards an association between alcohol and local inflammation, this 
makes it unlikely that the present finding is falsely negative.
The present study in early RA had a cross-sectional study design. This allowed 
to perform the measurements before disease modifying treatment was initiated. 
A longitudinal study is needed to evaluate the association between alcohol and 
long-term outcome of RA, but current treatments and treat-to-target strategies may 
mask an effect of alcohol (if it is present) on the course of RA.
According to the European Society of musculoSkeletal Radiology (ESSR) recom-
mendations, BME was evaluated on T1Gd. The RAMRIS method suggest to use T2, 
but a T2 was omitted from our scan protocol since previous studies have shown 
that these sequences preform equally well to depict BME [18,19] and a T1Gd has 
already been used to assess synovitis and tenosynovitis. This allowed a shorter 
imaging time for the participants.
Healthy, asymptomatic volunteers can also have some subclinical inflammation in 
hand and foot joints, especially at higher age. The nature of this inflammation is 




the origin is incompletely known, we speculated that a potential effect of alcohol 
on joint inflammation might also be present in persons without RA. But similar as 
to within RA, alcohol did not influence the severity of subclinical inflammation in 
hand and foot joints of asymptomatic volunteers.
Conclusions
Moderate alcohol consumption has been shown to have a beneficial effect on the 
risk of RA-development and inflammatory markers, and the present study con-
firmed a J-shaped association between alcohol and CRP, we observed no associa-
tion between alcohol and the extent of local inflammation in joints. Therefore the 
present data suggest that the pathophysiological mechanism underlying the effect 
of alcohol consists of a systemic effect that might not involve joints.
Supplementary material
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Table 1  Baseline characteristics of RA-patients and asymptomatic volunteers 
in which hand and foot MRIs were performed and RA-patients in which 
CRP was analysed
RA-patients  








Age in years, mean (SD) 56 (14) 50 (16) 56 (15)
Female, n (%) 121 (64.4) NA 717 (67.0)
Symptom duration in weeks, 
median (IQR)
15.4 (7.9-29.6) NA 18.4 (9.1-35.6)
CRP in mg/L, median (IQR) 10.0 (3.8-23.5) NA 14.0 (6.0-33.0)
ACPA positivity, n (%) 102 (54.3) NA 550 (52.6)
RF positivity, n (%) 116 (61.7) NA 604 (56.9)
Curernt smokers, n (%) 50 (28.4) 17 (8.8) 271 (25.7)
Patients consuming alcohol, n (%) 121 (64.4) 135 (69.9) 621 (58.0)
Units/week, median (IQR) 6.0 (3.0-10.5) 7.0 (4.0-14.0) 6.0 (2.0-10.5)
Of RA-patients with an MRI smoking status was missing in 12 RA.
In RA-patients with a CRP measurement smoking status, RF and ACPA status was missing in 
respectively 17, 9, and 24 RA-patients.
NA, not assessed.
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Chapter 7: Bone mineral density loss  
in clinically suspect arthralgia is  
associated with subclinical 
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Introduction: Peripheral bone mineral density (BMD) can be decreased in early 
rheumatoid arthritis but it is unknown if BMD-loss emerges already before arthritis 
is clinically apparent. We aimed to study if BMD-loss occurs in patients with clini-
cally suspect arthralgia (CSA), if it is associated with progression to clinical arthritis 
and if it is associated with MRI-detected subclinical inflammation.
Methods: Patients with CSA had arthralgia for < 1 year and were suspect to progress 
to RA according to their rheumatologists. At baseline a 1.5T MRI was performed 
of unilateral MCP, wrist and MTP-joints and scored on synovitis, bone marrow 
edema and tenosynovitis;. summing these features yielded the MRI-inflamma-
tion score. Digital X-ray radiogrammetry (DXR) was used to estimate BMD on two 
sequential conventional hand radiographs (mean interval between radiographs 
4.4 months). The change in BMD was studied; BMD-loss was defined as decrease 
of ≥ 2.5 mg/cm2/month. Patients were followed on arthritis development for 
median 18.4 months.
Results: In CSA-patients (n = 108) change in BMD was negatively associated with 
age (β = -0.03, p = 0.007). Within CSA-patients BMD-loss was associated with 
arthritis development (adjusted for age HR = 6.1, 95%CI = 1.7;21.4) and was most 
frequently estimated in the months before clinical arthritis development. The 
MRI-inflammation scores were associated with the change in BMD (adjusted for 
age β = -0.05, p = 0.047). The MRI-inflammation score and BMD-loss were both 
independently associated with arthritis development (HR = 1.1 95%CI = 1.1;1.2 and 
HR = 4.6 95%CI = 1.2;17.2 respectively).
Conclusion: In CSA-patients BMD-loss is associated with MRI-detectable subclini-
cal inflammation and with progression to clinical arthritis.
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Introduction
Processes that underlie the development of rheumatoid arthritis (RA) are already 
active in the symptomatic phase before arthritis is clinically evident. In this phase 
pro-inflammatory cytokines can be elevated, and auto-antibodies and subclinical 
inflammation can be present.[1,2] Whether bone metabolism is changed in the 
phase preceding clinical arthritis is less clear, but it has previously been reported 
that several biomarkers of bone and cartilage metabolism (cartilage oligomeric 
matrix protein, N-terminal telopeptide of type I procollagen and osteoprotegerin) 
were altered.[3,4]
BMD-loss of the hands (metacarpal bones II-IV) can be estimated with digital 
X-ray radiogammetry (DXR).[5] Previous studies revealed that the association with 
radiographic progression of BMD estimated by DXR is stronger than that of BMD 
measured by dual energy X-ray absorptiometry (DEXA) of periarticular metacarpal 
bones.[6] BMD-loss has not only been associated with radiographic progression in 
early RA (7), but also with RA-development in patients presenting with undifferen-
tiated arthritis.[8]
Clinically Suspect Arthralgia (CSA) patients have no clinical arthritis and are prone 
to progress towards RA.[2,10] This study aimed to address if BMD-loss is present 
in CSA and if so, whether BMD-loss is preferentially present in CSA-patients that 
progress to clinically detectable arthritis. Second, as MRI-detected subclinical 
inflammation in CSA has been strongly associated with progression to RA (2,11), 




Patients were included in the Leiden Clinically Suspect Arthralgia (CSA)-cohort 
between April 2012-Augustus 2014. As described previously (10) this inception 




emerges. Inclusion criteria were the presence of arthralgia of small joints for < 1-year 
and an increased risk to progress to RA according to the clinical expertise of the 
rheumatologists.[2,10] Patients were not included when clinically detectable 
arthritis was present or when another explanation for arthralgia was more likely. 
Patients had a visit at baseline and after 4, 12 and 24 months. If indicated, patients 
were seen in between visits to evaluate arthritis development. At all scheduled 
visits physical examination was performed, radiographs were made and blood 
samples obtained. MRI was performed at the baseline visit. Follow-up ended at 24 
months or earlier when clinical arthritis had developed. This outcome was evalu-
ated in medical files until December 24, 2014. The medical ethics committee of the 
Leiden University Medical Center approved this study. All patients provided written 
informed consent.
Digital X-ray radiogrammetry
Radiographs of both hands, performed in posteroanterior position (baseline and 
the first consecutive visit), were used to estimate BMD with DXR. Briefly, DXR is 
an automated analysis of the cortical bone at the centres of metacarpal bones 
II-IV, this technique is described in detail previously.[5] The mean BMD change of 
both hands was calculated as the difference per month between 2 radiographs 
(mg/cm2/month) as described previously.[8,9] BMD change was analysed as a 
continuous measure and was dichotomized; with a change of BMD of  ≤ -2.5 mg/
cm2/month defined as BMD-loss.[8,9]
MR imaging and scoring
At baseline contrast-enhanced MRIs was made of unilateral metacarpophalangeal 
(MCP)2-5 joints, wrist joints and metatarsophalangeal (MTP)1-5 joints as described 
earlier.[10] A detailed scan protocol is provided in the Supplementary methods. 
The most painful side was scanned or, in case of equally severe symptoms at both 
sides, the dominant side. An ONI-MSK-extreme 1.5T extremity-MRI-scanner (GE, 
Wisconsin, USA) was used.
Scoring of inflammation (synovitis, bone marrow edema (BME) and tenosynovitis) 
was done according to the RA MRI-scoring system (RAMRIS).[13,14] Synovitis and 
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BME were scored in MCP, wrist, and MTP-joints and tenosynovitis in the MCP and 
wrist-joints. The total MRI-inflammation score was calculated by summing the BME, 
synovitis and tenosynovitis-scores of all scored joints. The mean MRI-scores, per-
formed by 2 trained independent readers (HWvS and LM) blinded for any clinical 
data, were used. For the total MRI-inflammation score the within-reader intraclass 
correlation coefficient (ICC) was 0.98 and 0.99, and the between-reader ICC 0.96.
Analyses
Unpaired t-test, Mann-Whitney U test and the chi-squared test were used as appro-
priate. Univariable and multivariable linear regression models were used to study 
associations of inflammation with BMD change. Univariable and multivariable 
Cox proportional hazard regression analyses were used to determine associations 
with arthritis development. To prevent overfitting of the data the multivariable 
Cox  regression contained only age as an adjustment factor. Data were analyzed 
using IBM SPSS statistics version 20.
Results
Patients
162 patients were consecutively included in the CSA-cohort. Of these, 116 patients 
had conventional radiograph at baseline and follow-up (mean time interval 
4.4 months (SD 1.3)). Radiographs of 8 patients could not be studied by DXR due 
to settings when acquiring the images. Therefore, DXR results were obtained from 
108 CSA-patients in total. The 108 CSA-patients that were studied and the 54 CSA- 
patients that were excluded did not differ in baseline characteristics (Table  1). 
Median follow-up of the studied patients was 18.6 months (IQR = 15.6-21.6).
BMD change and age
A higher age was associated with a larger decrease in BMD (β = -0.03, p = 0.007, 
Figure  1A). No statistically significant difference in BMD change was observed 




Figure 1  Association between age and change in BMD (A) and the development 
of clinical arthritis in CSA-patients with and without increased BMD-
loss (B)






































Ad Figure 1A.The correlation coefficient of age with BMD-loss was -0.03 (p = 0.007).  
Ad Figure 1B. BMD-loss was defined as a decrease in BMD of ≥ 2.5 mg/cm2/month.
139
Bone mineral density in clinically suspect arthralgia
7
RF-positive = -0.89, RF-negative = -0.079, p = 0.06) and ACPA-status (median 
ACPA-positive = -0.23, ACPA-negative = -0.09 p = 0.58).
MRI-detected inflammation and BMD change
The total MRI-inflammation score at baseline was associated with BMD change 
during the first months of follow-up (β = -0.07, p = 0.018, Table 2); β = -0.07 indi-
cates that per point increase in total MRI-inflammation, the BMD decreased with 
0.07 mg/cm2/month. After adjustment for age, the association remained present 
(β = -0.05, p = 0.047). Studying the MRI-detected inflammatory features separately 
revealed that synovitis and tenosynovitis-scores were associated with BMD-loss 
(β = -0.18, p = 0.008 and β = -0.19, p = 0.006 respectively), in contrast to the BME-
score (β = -0.03, p = 0.63).
In a sub-analysis, the association between BMD-loss in one hand and MRI-inflam-
mation of metacarpal bones of the same metacarpals was studied (See supple-
mentary figure 1). This analysis revealed similar results as presented above (see 
Supplementary table 1).
BMD-loss and progression to clinical arthritis
Twenty (19%) CSA-patients developed clinically apparent arthritis after a median 
interval of 1.7 months (range = 0.4-15.0) and15 fulfilled the 1987-criteria for RA. 
BMD-loss was present in 4.6% (n = 5) of the CSA-patients, out of which 3 devel-
oped arthritis. BMD-loss was more often present in CSA-patients that progressed 
to clinically apparent arthritis than in CSA-patients that did not progress (hazard 
ratio (HR) = 4.94, 95%CI = 1.44;16.97, Figure 1B). After adjustment for age, the HR 
of BMD-loss was 6.01 (95%CI = 1.72;21.38, Table 3). Furthermore, the association 
of BMD-loss and arthritis development was independent of MRI-inflammation 
(HR = 4.62, 95%CI = 1.24-17.20, Table 3).
Six patients converted to clinical arthritis one month after inclusion in the CSA- 
cohort and these patients had the second radiograph made 2-3 months after 
arthritis development. In a sensitivity analysis, these patients were excluded; this 





Studying patients with arthralgia at risk for RA can increase the understanding 
of the processes that are active in the earliest symptomatic phase of RA. In this 
light, this study evaluated BMD-loss, estimated at the metacarpals using DXR. 
We observed that BMD-loss was present in CSA, that BMD-loss was more often 
present in the CSA-patients that progressed to arthritis than in patients that did 
not progress, and that MRI-detected subclinical inflammation was associated with 
a decrease in BMD.
BMD-loss was mostly estimated using radiographs taken in the months preceding 
the development of clinical arthritis. Therefore, our study mainly evaluated the last 
preclinical phase and does now allow conclusions on the presence of bone loss in 
earlier, asymptomatic, preclinical phases.
We showed that MRI-detected subclinical inflammation was associated with a 
decrease in BMD and that BMD-loss was associated with arthritis development. 
A multivariable analysis showed that MRI-detected inflammation and BMD-loss 
were both independently associated with progression to clinical arthritis, suggest-
ing that both are markers of processes that are active in a very early phase of RA.
This study is the first assessing BMD-loss in CSA-patients. Only a part of the CSA- 
patients progressed to arthritis and most patients did not progress. This explains 
why the average decrease in BMD observed in this study is lower than previously 
reported in RA.[8,9]
The cut-off value for BMD-loss that we used was suggested by the manufacturer 
and based on data from studies in RA; age was not included in this cut-off. A very 
recent study assessed variation in BMD in the general population and established 
age and sex-adjusted reference values.[14] Applying these cut-off values revealed 
that 46% (n = 50) of the CSA-patients had BMD-loss, but that BMD-loss was equally 
present in CSA-patients that did not progress to arthritis and in those that did 
progress (HR 0.99 (95%CI = 0.41-2.38, p = 0.98). Hence this did not increase the 
discriminative ability in the present population.
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The most important limitation of this study is the sample size. A small part of 
patients progressed to clinical arthritis during the follow-up period and BMD-loss 
was also infrequent. Further studies are therefore needed to confirm the present 
findings.
In conclusion, BMD-loss is increased in CSA-patients progressing to clinical arthri-
tis and is associated with MRI-detectable subclinical inflammation in CSA.
Supplementary material
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Table 1 Baseline characteristics of included and excluded CSA-patients
CSA-patients 
analyzed (n = 108)
CSA-patients 
excluded (n = 54) p-value
Age (years), mean (SD) 44.5 (12.9) 40.4 (12.3) 0.057
Female, N (%) 81 (75) 39 (72) 0.70
TJC, median (IQR) 5.0 (3.0-10.0) 5.5 (3.0-8.0) 0.92
CRP, median (IQR) 0.0 (0.0-4.6) 0.0 (0.0-4.3) 0.98
RF positive, N (%) 24 (22) 13 (24) 0.79
ACPA positive, N (%) 14 (13) 12 (22) 0.13
Total MRI-inflammation, 
median (IQR) 
2.0 (1.0-5.5) 2.0 (0.5-4.9) 0.43
Total synovitis score, 
median (IQR)
1.0 (0.0-2.5) 1.0 (0.0-2.8) 0.67
Total BME-score,  
median (IQR)
0.5 (0.0-1.5) 1.0 (0.0-1.5) 0.81
Total tenosynovitis score, 
median (IQR)
0.0 (0.0-2.0) 0.0 (0.0-1.0) 0.33
TJC, tender joint count;
CRP, C-reactive protein;
RF, rheumatoid factor;
ACPA, Anti-citrullinated protein antibody.
Table 2  Association between MRI-detected inflammation at baseline and 
change in BMD
BMD β (95%CI) p
Univariable
Total MRI-inflammation score -0.07 (-0.12;-0.01) 0.018
Total BME-score -0.03 (-0.16;0.10) 0.63
Total synovitis score -0.18 (-0.32;-0.05) 0.008
Total tenosynovitis score -0.19 (-0.32;-0.05) 0.006
Multivariable   
Age -0.03 (-0.05;-0.01) 0.015
Total MRI-inflammation score -0.05 (-0.11;0.00) 0.047
BME, Bone marrow edema;
Total MRI-inflammation is the sum of all scored synovitis, BME and tenosynovitis in one hand and foot.
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Table 3  The association of BMD-loss and progression from CSA to clinical 
arthritis in univariable and multivariable Cox regression analyses
HR (95%CI) p
Univariable
BMD-loss * 4.94 (1.44;16.97) 0.011
Multivariable
Model A
BMD-loss * 6.07 (1.72;21.38) 0.005
Age 0.97 (0.94;1.00) 0.076
Model B
BMD-loss * 4.62 (1.24;17.20) 0.023
Age 0.96 (0.93;0.99) 0.016
Total MRI-inflammation score 1.12 (1.05;1.19)  < 0.001
* BMD-loss is defined as decrease of ≥ 2.5 mg/cm2/month.

Chapter 8:  




This thesis focussed on inflammation observed on magnetic resonance imaging 
(MRI) in the early phases of rheumatoid arthritis (RA) and was divided into two 
parts. In the first part we explored the prevalence of inflammation and erosions 
detected on MRI in the general population. In the second part, we studied the early 
phases of RA and assessed factors which could be associated with radiographic 
joint damage or local inflammation detected on MRI.
Part I:  Inflammation and erosions detected on MRI 
in the general population
In chapter 2, a systematic literature search, we summarized the prevalence of 
MRI-detected inflammation and erosions in an asymptomatic population. Though 
MRI is generally considered to be of value in the diagnostic process of RA and is 
also sensitive in the early detection of structural damage (1), the prevalence of 
inflammation and erosions detected on MRI in the general population (e.g. the 
specificity of MRI in the diagnostics of RA) was unknown. MRI-findings in asymp-
tomatic volunteers were evaluated in 31 studies. Both inflammation and erosions 
detected on MRI were present in asymptomatic volunteers. However, the frequency 
of MRI-detected findings varied widely between the different studies. This was most 
likely caused by the fact that the data were heterogeneous. Most of the studies were 
not designed to determine MRI-findings in asymptomatic volunteers and they were 
mainly used as a control population; consequently the number of included healthy 
subjects was small. Furthermore, methodologies differed between studies and the 
healthy control groups were not well described. Often, baseline characteristics as 
age, body mass index (BMI), or medical history were lacking and in- and exclusion 
criteria were poorly described, if described at all. Therefore, we concluded that the 
data summarized in the review suggested that inflammation and erosions were 
present in an asymptomatic population, but that a large scale study with the main 
goal to assess the prevalence of MRI-detected findings in the general (asymptom-
atic) population was lacking.
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In chapter 3 we assessed the prevalence of inflammation and erosions detected on 
MRI in a study population of 193 volunteers, recruited from the general (asymptom-
atic) population. We aimed to include volunteers without joint symptoms. There-
fore inclusion criteria were: age 18 years or older, no history of RA or other inflam-
matory rheumatic diseases, no joint symptoms during the previous month, and no 
clinically detectable arthritis on physical examination. All volunteers underwent a 
contrast enhanced MRI of the dominant metacarpophalangeal (MCP), wrist, and 
metatarsophalangeal (MTP) joints on a 1.5T extremity scanner. Scoring was done 
independently by 2 readers and, to prevent observer bias, MRIs of symptom-free 
individuals were mixed with MRIs of RA-patients and patients with arthralgia 
without clinical synovitis.[2,3] Scoring was done according to the RA MRI-scoring 
(RAMRIS) method for synovitis and bone marrow edema (BME) in the MCP, wrist, 
and MTP joints (4) and tenosynovitis was scored according to Haavardsholm et al 
in the MCP and wrist.[5] Synovitis, BME and tenosynovitis was summed into an 
inflammation-score.
Inflammation and erosions detected on MRI were frequently observed. An inflam-
mation score of ≥ 1 was present in 72% of volunteers and an erosion score of ≥ 1 was 
present in 78% of the volunteers. These findings were primarily low-grade accord-
ing to RAMRIS (a score of 1), and severe findings were very rare. BME and synovitis 
were more often observed compared to tenosynovitis. The prevalence of detected 
inflammation and erosions increased with a higher age. Therefore, the findings 
observed could be degenerative in nature, even though we did exclude volunteers 
with symptomatic osteoarthritis.
To evaluate if asymptomatic osteoarthritis caused the observation of more severe 
inflammation at higher age, we performed a sub-analysis in which we excluded 
both volunteers with any sign of asymptomatic osteoarthritis but also locations 
known to be predilection sites for osteoarthritis. Also in this analysis, we found 
a positive association with the prevalence of MRI-detected findings and age. 
Although it cannot be excluded that degenerative processes underlie the obser-
vation on age, the findings of this study are not solely explained by asymptomatic 




The locations in which MRI-detected findings were most frequently seen in the 
asymptomatic volunteers were MCP II, MCP III, wrist and the MTP I joint. Inter-
estingly, these locations are remarkably similar to the locations in which RA is 
regularly presented and where the most radiographic joint damage is seen during 
RA.[6] Therefore, it can be hypothesised that in these locations certain stressors, 
for instance mechanical stress, are more abundant compared to other joints and 
thereby could elicit processes which eventually lead to inflammation and/or 
erosions. Future research should assess whether indeed the minor MRI-findings 
detected in an asymptomatic population are due to certain stressors (e.g. mechan-
ical) and whether these minor findings could elucidate the appearance of RA in 
these joints.
In the last decades, MRI is increasingly used in RA-research. Along with the 
increased use of MRI, there was a need to increase the comparability between 
studies. Therefore, a scorings methodology on MRI was developed, the RA MRI 
score (RAMRIS).[4] Erosions, BME and synovitis were incorporated in this method, 
and later a scorings method for tenosynovitis was developed and added.[5] Even 
though the comparability between studies increased by the use of one scorings 
method, the use of RAMRIS has several disadvantages. The scorings method was 
developed for the follow-up of patients in clinical trials and was therefore not 
developed for a single time point measurement. The RAMRIS method therefore may 
be suboptimal for use as a diagnostic instrument.
Thus in conclusion, the prevalence of inflammation and erosions in asymptomatic 
volunteers is higher than anticipated. This has consequences for the use of MRI 
in the early detection of RA since ignorance of the observations done in a control 
population could lead to false positive test results.
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Part II:  Association with MRI-detected inflam-
mation and radiographic joint damage
In chapter 4-7 we studied the early phases of RA, both with regards to the severity 
of MRI-detected inflammation at disease onset and the severity of radiographic 
damage over time.
In chapter 4 we first assessed the association between age of onset and radio-
graphic joint damage progression. This was done in 5 cohorts including 1,875 
RA-patients. We observed that a higher age of onset was associated with more 
severe radiographic joint damage. This association was seen on baseline and the 
effect remained similar during 7 years follow-up.
In the second part of this article we tried to improve the understanding of the 
mechanisms which may have been involved in this association. These analyses 
were performed in the Leiden early arthritis cohort (EAC) in which 698 RA-patients 
were included with 7 years of follow-up. As MRI was added to the EAC-cohort 
protocol 56 RA-patients had an MRI performed and had a minimum of 1 year of 
follow-up, including conventional radiographs. Firstly, we tried to assess whether 
the increase of radiographic joint damage with an increase in age was due to 
degeneration. Therefore, we assessed whether the increase in the radiographic 
joint damage was due to a disproportional increase in the joint space narrowing 
(JSN) score, reflecting degenerative changes. We observed an increase in both the 
erosion score as well as the JSN-score with age. Furthermore, we analysed bones 
and joints that are known to be predilection sites for osteoarthritis separately from 
other scored joints and bones. In this analyse we also observed an increase in 
all sites analysed. These findings suggest that degeneration insufficiently explains 
the association between age and radiographic joint damage.
Secondly, mediation analyses were performed in which we assessed whether 
age has an indirect relationship with radiographic joint damage. In this cohort 
we explored whether symptom duration, anti-citrullinated-peptide-antibodies 




and inflammation detected on MRI had an effect on the association between age 
and radiographic joint damage. We hypothesized that older persons with joint 
complaints present at a later point in time and therefore have more severe radio-
graphic joint damage. However, symptom duration, ACPA, RF, SJC and CRP did not 
mediate the association between age and radiographic joint damage. We observed 
that older patients have more MRI-detected inflammation and that MRI-detected 
inflammation partially explains the association between age and radiographic 
joint damage. Thus, we observed partial mediation of MRI-detected inflammation. 
In sum, a higher age at inclusion was associated with more severe radiographic 
joint damage, and this could be partially explained by MRI-detected inflammation. 
However, this last conclusion should be replicated within a larger cohort since our 
analysis was only performed in a small subgroup of patients.
In chapter 5 we assessed the association of BMI with inflammation detected on 
MRI. Previously it has been observed, in a population based study, that BMI is 
associated with increased inflammatory markers (7). Intriguingly, several studies 
within RA had shown that a high BMI is associated with less progression of 
radiographic joint damage.[8-11] We assessed whether there was an association 
between BMI and MRI-detected inflammation in 195 RA-patients, 159 patient with 
other inflammatory arthritides and in 193 asymptomatic volunteers. When assess-
ing the association between BMI and MRI-detected inflammation in patients with 
other inflammatory arthritides and in asymptomatic volunteers, a higher BMI is 
associated with more severe MRI-detected inflammation. This is in line with the 
previously observed association between increased inflammatory markers and 
BMI in the general population.[7] However, within the RA-patients, a higher BMI 
was associated with less inflammation detected on MRI, this is in line with the 
association between BMI and radiographic joint damage which was previously 
observed. These findings are intriguing as a higher BMI is generally associated with 
a worse outcome in RA-patients (e.g. function and disease activity).[12] Similarly, 
RA-patients with a higher BMI seems to have a decreased treatment response (13), 
and have a decreased chance on reaching remission.[14] This might be caused by 
the fact that functional ability, and partially disease activity and clinical remission 
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are dependent on subjective measurements as well as objective measurements. 
Indeed a high BMI has been shown to be associated with higher subjective mea-
surements (e.g. tender joint count, patient global assessment) but with similar 
objective measurements (e.g. C-reactive protein, erythrocyte sedimentation rate 
and 28-swollen joint count) compared to RA-patients with a low BMI.[15]
Altogether a high BMI is associated with lower MRI-detected inflammation but with 
higher subjective measurements. Whether this latter issue has consequences for 
the clinical practise has to be investigated (e.g. differences in medication due to 
differences in DAS-scores).
In sum this study illustrated the paradox of BMI in RA compared to patients with 
other inflammatory arthritides and in asymptomatic volunteers. A high BMI is asso-
ciated with less severe local inflammation and less severe joint destruction. A par-
adoxical effect of BMI has also been observed in relation to mortality; RA-patients 
with a high BMI had a lower mortality than thinner patients.[16]
In chapter 6 we assessed whether there was an association between alcohol 
consumption and inflammation detected on MRI in RA-patients. Moderate alcohol 
consumption has been shown to be beneficial as it is associated with a decrease in 
inflammatory markers and a decreased risk of RA-development.[17-20] Therefore, 
we first assessed whether we could replicate the association between moderate 
alcohol consumption and C-reactive protein (CRP-) level as a marker for inflamma-
tion in 1070 RA-patients. We indeed observed that moderate alcohol consumption 
(1 consumption per week) is associated with the lowest CRP-level. Subsequently 
we wanted to assess whether moderate alcohol consumption was also beneficial 
for MRI-detected inflammation. We therefore assessed the association between 
alcohol consumption and MRI-detected inflammation in 188 RA-patients and in 
192 asymptomatic volunteers. Unexpectedly, we did not observe an association 
between alcohol consumption and MRI-detected inflammation in RA-patients or 
asymptomatic volunteers.
In conclusion, moderate alcohol consumption is associated with a lower systemic 
inflammation but there was no association between alcohol consumption and joint 




A decreased BMD can be observed in patients with early RA.[21-23] In RA- patients, 
BMD-loss has been associated with more radiographic joint damage. Also, in 
patients with UA (22), BMD-loss is a predictor for the development of RA.[23] 
However, it is unknown to what extent BMD changes are present in the phase 
before arthritis is clinically evident. Therefore, in chapter 7 we assessed BMD in 
the clinically suspect arthralgia (CSA) cohort consisting out of 108 CSA-patients. An 
MRI was performed at baseline and digital X-ray radiogrammetry on two sequential 
conventional hand radiographs was used to estimate BMD. This change was stan-
dardized by calculating the mean difference per month. We observed that BMD-
loss (defined as a decrease of ≥ 2.5 mg/cm2/month) was seen in a small proportion 
of CSA-patients. Furthermore, we observed that with more severe inflammation 
detected on MRI at baseline, a higher decrease in BMD was seen in the months 
following the MRI. Together with the previous findings on changed bone markers 
in the preclinical phase of RA[24,25], the data suggest that the bone metabolism 
is altered in some patients in the symptomatic phase preceding clinical arthritis.
Conclusions and future perspectives
In the current thesis it was shown that the prevalence of inflammation and ero-
sions in the general, asymptomatic population, are highly dependent on age and 
location. The RAMRIS method does not take into account these factors. In clinical 
practice, radiologists that assess an MRI for diagnostic purposes already take 
into account the age of the patient and the location of the lesion(s). But apart 
from these factors, radiologists also take into account other factors such as the 
pattern of inflammation. These differences between the RAMRIS method and the 
assessment by a radiologist in clinical practise highlights the disadvantages of the 
use of the RAMRIS score in the diagnostics of RA. This illustrates the need for the 
development of another scorings methodology which incorporates factors such as 
age, location, pattern, and the level of inflammation in the general population. The 
value of this scorings method in the diagnostic process of RA has still to be derived 
and validated in longitudinal cohorts of patients.
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In addition, if MRI-data of asymptomatic volunteers would be used as a reference, 
even larger data-sets of controls might be required to ensure that sufficient patients 
are available in the different age categories.
Apart from MRI, several other imaging techniques could be helpful to assess joint 
inflammation in the clinical practise such as ultrasonography, positron emission 
tomography (PET), and single photon emission computed tomography (SPECT).[26] 
In clinical practise ultrasound is more easily available and is often performed by 
the treating rheumatologist. However, ultrasound cannot detect BME and is oper-
ator dependent.[26] In the future the additional value to ultrasound above MRI or 
vice versa should be assessed in a head to head comparison, as a diagnostic tool 
for the clinical practise of RA. Similarly, the value of SPECT and PET in the detection 
of early inflammation during RA should be assessed. In all of these studies the 
specificity of findings will be important. A first study on ultrasonography findings 
in symptom-free persons was published recently (27), but more effort is needed 
here as well.
Apart from accurate prognostication, it remains to be determined how early RA 
should be treated. The early detection of RA is very important as starting treat-
ment in an early, clinically apparent, phase of the disease improves the clinical 
outcome.[28] Imaging techniques may contribute to the detection of inflammation 
at an earlier time point as compared to the current diagnostics resulting in the pos-
sibility to start treatment at even earlier time points (thus in pre-arthritis phases). 
At present it is unknown whether starting treatment this early is indeed beneficial 
and results in better outcomes than when treatment is started in the early clinical 
phase.
In the literature, a higher age of onset of RA is associated with more severe radio-
graphic joint damage.[29-34] Likewise, in chapter 3 we have observed a higher 
prevalence of MRI-detected erosions at higher age. Although these MRI-detected 
erosions are asymptomatic and mostly small, these erosions could be prone for 
the development of radiographic joint damage. Indeed, previous studies showed 
that bones with MRI-detected erosions are more prone to develop erosions on 




have more MRI-detected erosions, radiographic joint damage might develop more 
easily in older RA-patients. This hypothesis should be addressed in future studies.
With respect to the findings on BMI and the severity of joint inflammation in RA, 
further studies are needed to determine the biological mechanisms that underlie 
this effect. A recent study in mice suggested that arthritis has an earlier onset in 
obesity, amongst others due to an increased neutrophil recruitment, but also that 
when arthritis was evident obesity had no influence anymore as leucocytes, T-cell 
population and chemoattractants did not differ between lean and obese mice.[36] 
The severity of joint damage was not assessed here. In conclusion, the mecha-
nisms underlying the obesity paradox in RA is not yet elucidated.
There has been a lot of debate about the pros or cons of drinking 1 or 2 alcohol 
beverages a day. The preventive effects of moderate alcohol consumption have 
been advocated for several diseases (e.g. cardiovascular disease). However the 
data presented in this thesis may imply that moderate alcohol consumption has 
no beneficial effect on the joints of RA-patients. However, we only evaluated the 
association on the local level of joints, which is presumably different from systemic 
effects.
All studies investigating bone metabolism in the preclinical phase of RA performed 
so far have a small sample size. To validate the altered bone metabolism in the 
symptomatic phase preceding clinical arthritis, larger studies are needed. At the 
moment, cohorts of arthralgia patients are still increasing in size and therefore, 
these studies could be started in the nearby future.
RA is considered to be a multifactorial disease, resulting from genetic and envi-
ronmental factors.[37,38] The best known environmental factor, smoking, has 
been studied extensively in the past.[39] The relation of RA-development with 
other factors, such as BMI and alcohol consumption, is less clear.[19,20,40] In this 
thesis, we addressed two of these factors, namely BMI and alcohol. We tried to 
elucidate whether these factors were associated with inflammation detected on 
MRI. A limitation of our studies is the cross-sectional study design. Even though 
we found BMI to be associated with inflammation on MRI, longitudinal studies are 
needed to confirm that lower inflammation in obese patients is indeed associated 
with less radiographic progression.
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Furthermore longitudinal studies following symptomatic patients without clinically 
detectable arthritis are of particular interest. In these cohorts patients could be 
followed and the sequence of these events can be assessed in relation to envi-
ronmental factors. Thereby the influence of different factors can be assessed on 
the development of RA. For example, it can be assessed whether losing weight 
has any effect on MRI-detected inflammation and may prevent progression to RA. 
In addition, it can be explored if alcohol consumption in the symptomatic phase 
is still of influence on further progression to clinical arthritis. Finally, longitudi-
nal studies may also increase the understanding on the biological mechanisms 
underlying some of the associations assessed in part II of this thesis. To better 
understand the pathophysiology in the earliest phases of RA future research is 
needed to elucidate biologic mechanisms underlying the associations assessed 
in this thesis (e.g. immunosenescence, inflammatory properties of adipose tissue, 
bone metabolism).
In conclusion, the current thesis showed that inflammation detected on MRI 
is frequently seen in an asymptomatic population. This is essential to take into 
account during the assessment of MRIs for diagnostic purposes or for determining 
remission of RA. Furthermore, age, BMI and BMD are associated with inflamma-
tion detected on MRI. These factors, amongst others, should be subject of future 
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In dit proefschrift hebben we ontsteking, gevonden op magnetic resonance imaging 
(MRI) in de vroege fases van reumatoïde artritis (RA), bestudeerd. Dit proefschrift 
bestaat uit twee delen. In het eerste deel is de prevalentie van lokale ontstekingen 
in de algemene bevolking bestudeerd. In het tweede deel hebben we bekeken of 
verschillende factoren een associatie vertoonden met radiografische gewrichts-
schade of lokale ontsteking. In dit proefschrift hebben we lokale ontsteking af -
gebeeld en onderzocht middels MRI.
Deel I:  Ontsteking en erosies, gevonden op MRI in 
de algemene bevolking
Hoofdstuk 2 is een systematisch literatuuronderzoek waarin we de prevalentie 
van ontsteking en erosies, gevonden op MRI, in een bevolkingsgroep zonder 
gewrichtsklachten hebben beschreven. MRI wordt beschouwd als een belangrijke 
modaliteit in het diagnostische proces van RA en is sensitief bij het vroeg-detecte-
ren van structurele gewrichtsschade.[1] De prevalentie van ontsteking en erosies, 
gevonden middels MRI, in de algemene bevolking (de specificiteit van MRI in de 
diagnostiek van RA) is echter onbekend. Bevindingen op MRI in asymptomatische 
vrijwilligers zijn onderzocht in 31 studies. Hieruit kwam naar voren dat zowel ontste-
king als erosies aanwezig waren op MRI bij asymptomatische vrijwilligers. Echter, 
de frequentie van de bevindingen op MRI varieerden vrij veel tussen verschillende 
studies. Dit kan hoogstwaarschijnlijk toegeschreven worden aan het feit dat de 
data heel heterogeen was. De meeste studies hadden niet als doel om MRI-bevin-
dingen in asymptomatische vrijwilligers op te sporen. De vrijwilligers waren vooral 
bedoeld als een controlepopulatie waardoor het aantal geïncludeerde gezonde 
vrijwilligers erg laag was. Daarnaast verschilde de methodologie tussen de studies 
en waren de controlegroepen over het algemeen niet goed omschreven. Zo ont-
braken vaak meerdere persoonskarakteristieken zoals leeftijd, body mass index 
(BMI) of medische voorgeschiedenis maar waren ook in- en exclusiecriteria slecht 




steking als erosies aanwezig zijn in een asymptomatische populatie. Echter, een 
groot opgezet onderzoek met als hoofddoel om de prevalentie van bevindingen op 
MRI in de algehele (asymptomatische) populatie te onderzoeken ontbrak.
In hoofdstuk 3 hebben we hierom de prevalentie van ontsteking en erosies op 
MRI bekeken in de algehele (asymptomatische) bevolking. Hiervoor hebben we 
193 vrijwilligers geïncludeerd. Deze vrijwilligers werden geïncludeerd als ze vol-
deden aan de inclusiecriteria (ouder dan 18 jaar, geen voorgeschiedenis van RA of 
andere inflammatoire reumatische ziekten, geen gewrichtsklachten in de maand 
voorafgaand aan het onderzoek en geen klinisch aanwezige gewrichtsontsteking 
(artritis) bij lichamelijk onderzoek). Vrijwilligers mochten dus wel een medische 
voorgeschiedenis hebben, als deze maar vrij was van reumatologische en aanver-
wante ziekten.
Alle vrijwilligers kregen een MRI met contrast van de dominante metacarpophalan-
geale (MCP), pols en metatarsophalangeale (MTP) gewrichten. De MRI’s werden 
door twee onafhankelijke beoordelaars gescoord. De MRI’s van asymptomatische 
vrijwilligers werden gemengd met MRI’s van patiënten met RA en patiënten met 
gewrichtsklachten zonder klinische synovitis (ontsteking van het gewrichtskapsel) 
om beïnvloeding van de beoordeling te voorkomen.[2,3] Voor het scoren werd de 
RA MRI (RAMRIS) methode (bedoeld voor het scoren van synovitis en beenmerg-
ontsteking (BME)) gebruikt in de MCP, pols en MTP gewrichten.[4] Tenosynovitis 
(ontsteking van peesschedes) in de MCP en polsgewrichten werd gescoord volgens 
de methode beschreven door Haavardsholm et al.[5] De scores van de synovitis, 
BME en tenosynovitis werden opgeteld tot een totale ontstekingsscore.
Ontsteking en erosies werden frequent gevonden op de MRIs. Een ontstekings-
score van ≥ 1 werd gevonden bij 72% van de vrijwilligers, voor erosies had 78% van 
de vrijwilligers een score van ≥ 1. De meeste van deze bevindingen waren klein en 
hadden een RAMRIS score van 1. Ernstige bevindingen waren zeldzaam. BME en 
synovitis werden vaker gezien dan tenosynovitis. De prevalentie van ontsteking en 
erosies nam toe met de leeftijd. Daarom zouden deze bevindingen ook wel dege-
neratief van aard kunnen zijn, ook al hadden we vrijwilligers met symptomatische 




We hebben een sub-analyse uitgevoerd om te kijken of asymptomatische artrose 
een verklaring van dit leeftijdsverschil kan zijn. Hierbij hebben we niet alleen vrij-
willigers met enige aanwijzingen voor een asymptomatische artrose uit de analy-
ses gelaten, maar ook alle locaties die vaak aangedaan zijn bij artrose. Ook in deze 
analyse vonden we een positieve associatie tussen de prevalentie van bevindin-
gen op MRI en leeftijd. Hoewel niet uitgesloten kan worden dat het degeneratieve 
processen zijn die hieraan ten grondslag liggen, kunnen de bevindingen van deze 
studie niet enkel verklaard worden door degeneratie gevonden middels anamnese 
en lichamelijk onderzoek.
In asymptomatische vrijwilligers werden vooral MRI afwijkingen gevonden in MCP 
II, MCP III, de pols en het MTP I gewricht. Opmerkelijk genoeg zijn deze locaties 
nagenoeg gelijk aan de locaties waarin RA zich normaal presenteert en waarin 
tevens de meeste radiografische schade wordt gevonden bij RA-patiënten.[6] Het 
zou kunnen dat op deze locaties bepaalde stressoren (bijvoorbeeld mechani-
sche stress) meer aanwezig zijn in vergelijking met andere gewrichten. Hierdoor 
zouden deze gewrichten vatbaarder kunnen zijn voor processen die uiteindelijk 
leiden tot ontsteking en/of erosies. Toekomstig onderzoek moet uitwijzen of deze 
MRI afwijkingen bij asymptomatische vrijwilligers inderdaad veroorzaakt worden 
door bepaalde stressoren en of deze vervolgens de ontwikkeling van RA kunnen 
uitlokken.
In de laatste decennia wordt MRI in toenemende mate gebruikt voor het onderzoek 
naar RA. Tegelijk met de toename van het gebruik van de MRI was er ook een toe-
nemende behoefte om deze onderzoeken met elkaar te kunnen vergelijken. Hier-
voor werd een scoringsmethode voor de MRI ontworpen, de RA MRI score (RAMRIS).
[4] Deze scoringsmethode omvatte in eerste instantie erosies, BME en synovitis, 
later werd er nog een scoringsmethode voor tenosynovitis aan toe gevoegd.[5] 
Hoewel de vergelijkbaarheid tussen de studies inderdaad toenam door het gebruik 
van de RAMRIS, heeft het ook enkele nadelen. De scoringsmethode is van oor-
sprong ontwikkeld om ontsteking en erosie te vervolgen in de tijd, maar niet voor 
een enkele meting. Het gebruik van de RAMRIS voor een enkel scoringsmoment of 




Concluderend is er een hogere prevalentie van ontsteking en erosies in asympto-
matische vrijwilligers dan verwacht. Dit heeft consequenties voor het gebruik 
van de MRI bij de vroege detectie van RA, omdat het kan leiden tot vals-positieve 
beoordelingen.
Deel II:  Associaties met ontsteking gevonden op 
MRI en radiografische gewrichtsschade
In hoofdstukken 4 t/m 7 hebben we gekeken naar associaties tussen facto-
ren (leeftijd, BMI, alcohol, botdichtheid (BMD) in de vroege fases van RA en in 
de sympto matische fase voordat artritis klinisch evident is) en radiografische 
gewrichtsschade of bevindingen op MRI.
In hoofdstuk 4 hebben we de invloed van leeftijd op radiografische gewrichts-
schade onderzocht. We hebben dit gedaan in 5 cohorten waarin in totaal 1875 
RA-patiënten zaten. Hierin vonden we dat een hogere leeftijd geassocieerd was 
met meer radiografische gewrichtsschade. Deze associatie werd gevonden op 
baseline, maar het effect bleef gelijk gedurende de 7 jaar follow-up.
In het tweede deel van dit artikel hebben we geprobeerd om meer te begrijpen van 
de mechanismen die ten grondslag zouden kunnen liggen aan deze asso ciatie. 
Deze analyses werden uitgevoerd in het Leiden early arthritis cohort (EAC), dat 698 
RA-patiënten bevat met een follow-up van 7 jaar. MRI werd pas later toegevoegd 
aan het EAC-cohort protocol. Hierdoor hadden 56 RA-patiënten een MRI met een 
minimum van 1 jaar follow-up waarin tevens conventionele röntgenfoto’s gemaakt 
werden.
Als eerste hebben we onderzocht of de toename van radiografische gewrichts-
schade met het toenemen van de leeftijd het gevolg van degeneratie was. Hiervoor 
hebben we gekeken of de toename in radiografische gewrichtsschade geassocieerd 
was met een disproportionele toename in de gewrichtsspleetsvernauwings-score 




We vonden een toename in zowel de erosiescore als in de JSN-score. Verder 
hebben we botten en gewrichten, die bekend staan als locaties waar osteoartritis 
zich ontwikkelt, apart onderzocht van de andere botten en gewrichten. Ook in deze 
analyse vonden we een toename met de leeftijd op alle onderzochte locaties. Deze 
bevindingen suggereren dat degeneratie alléén een onvoldoende verklaring is voor 
de associatie tussen leeftijd en een radiografische gewrichtsschade.
Vervolgens hebben we een mediatie-analyse uitgevoerd waarin we onderzochten 
of leeftijd een indirecte relatie heeft met radiografische gewrichtsschade. In dit 
cohort onderzochten we of symptoomduur, anti-citrullinated-peptide-antibodies 
(ACPA), reumafactor (RF), het aantal gezwollen gewrichten (SJC), C-reactive-protein 
(CRP) en ontsteking gevonden op MRI, een effect hadden op de associatie tussen 
leeftijd een radiografische gewrichtsschade. Een van onze hypotheses was dat 
oudere personen met gewrichtsklachten zich later melden en daarom ernstigere 
radiografische schade hebben bij binnenkomst. Echter, symptoomduur, ACPA, RF, 
SJC en CRP hadden geen invloed op de associatie tussen leeftijd en radiografische 
gewrichtsschade. We vonden dat oudere patiënten meer MRI-gedetecteerde ont-
steking hebben en dat MRI-gedetecteerde ontsteking deels de associatie tussen 
leeftijd en radiografische gewrichtsschade verklaart. MRI-gedetecteerde ontste-
king verklaart dus voor een deel de associatie tussen leeftijd en radiografische 
gewrichtsschade.
Een hogere leeftijd bij inclusie is dus geassocieerd met ernstigere radiografische 
gewrichtsschade, en dit kan deels verklaard worden door MRI-gedetecteerde ont-
steking. Echter, deze laatste conclusie zal herhaald moeten worden in een groter 
cohort, aangezien onze analyse slechts uitgevoerd is in een kleine subgroep 
patiënten.
In hoofdstuk 5 hebben we de associatie tussen body mass index (BMI) en MRI- 
gedetecteerde ontsteking onderzocht. Een toename van BMI is geassocieerd met 
toegenomen ontstekingsmarkers.[7] Bijzonder genoeg zijn er verschillende studies 
waarin een hoger BMI geassocieerd is met minder progressie van radiografische 
gewrichtsschade in RA.[8-11] Wij hebben derhalve onderzocht of er een associatie 




ten met andere inflammatoire artritiden en in 193 asymptomatische vrijwilligers. 
Een hoger BMI was inderdaad geassocieerd met ernstigere MRI- gedetecteerde 
ontsteking bij patiënten met andere inflammatoire artritiden en in asymptomati-
sche vrijwilligers. Dit is conform de eerder gevonden associatie van toegenomen 
ontstekingsmarkers en BMI in de algehele populatie.[7] Echter, bij RA-patiënten 
is een hogere BMI geassocieerd met minder ernstigere MRI-gedetecteerde ontste-
king. Dit is conform de eerder gevonden associatie tussen BMI en radiografische 
gewrichtsschade. Deze bevindingen zijn intrigerend, aangezien een hoger BMI 
over het algemeen geassocieerd is met een slechtere uitkomst bij RA-patiënten 
(functie en ziekte-activiteit).[12] Ook hebben RA-patiënten met een hogere BMI een 
verminderde respons op behandeling,[13] en hebben ze een verminderde kans dat 
ze weer klachtenvrij worden.[14] Dit zou veroorzaakt kunnen worden door het feit 
dat functioneel vermogen – en voor een deel ook ziekte-activiteit – afhankelijk 
zijn van zowel subjectieve als objectieve maten. Inderdaad blijkt een hoger BMI 
geassocieerd te zijn met hogere subjectieve maten (aantal pijnlijke gewrichten, 
patient global assessment) maar met gelijke objectieve maten (CRP, bezinking en 
aantal gezwollen gewrichten) in vergelijking met RA-patiënten met een lagere BMI.
[15] Dus, een hogere BMI is geassocieerd met lagere MRI-gedetecteerde ontsteking 
en andere objectieve maten, maar met hogere subjectieve maten. Of dit conse-
quenties heeft voor de kliniek moet nog onderzocht worden (bijvoorbeeld andere 
behandeling middels medicatie, andere of meer fysieke activiteiten).
Concluderend laat deze studie de BMI-paradox zien bij RA-patiënten in vergelij-
king met patiënten met andere inflammatoire artritiden en asymptomatische 
vrijwilligers. Een hoge BMI is geassocieerd met minder ernstige lokale ontsteking 
en minder ernstige gewrichtsdestructie. Een paradoxaal effect van BMI wordt ook 
gezien in het kader van mortaliteit; RA-patiënten met een hoge BMI hebben een 
lagere mortaliteit dan patiënten met een lagere BMI.[16]
In hoofdstuk 6 onderzochten we de associatie tussen alcoholconsumptie en MRI-ge-
detecteerde ontsteking in patiënten met RA. Matige consumptie van alcohol lijkt 
een positief effect te hebben en is geassocieerd met een afname van ontstekings-




we bekijken of we de associatie tussen matige alcoholconsumptie en CRP-con-
centraties (als maat voor ontsteking) konden repliceren in 1070 RA-patiënten. We 
vonden inderdaad dat matige alcoholconsumptie (1 glas per week) ge associeerd 
was met de laagste CRP-concentraties. Vervolgens wilden we bekijken of matige 
alcoholconsumptie eveneens een positief effect had op MRI-gedetecteerde ontste-
king, dit deden we in 188 RA-patiënten en 192 asymptomatische vrijwilligers. Tegen 
de verwachtingen in, vonden we geen associatie tussen alcohol en MRI-gedetec-
teerde ontsteking in zowel de RA-patiënten als de asymptomatische vrijwilligers.
Matige alcoholconsumptie is dus positief geassocieerd met een lagere systemi-
sche ontsteking maar niet met MRI-gedetecteerde ontsteking.
Een afname in botdichtheid (BMD) wordt gezien bij patiënten die net gediagnosti-
ceerd zijn met RA.[21-23] Bij patiënten met RA is BMD-verlies ook wel geassocieerd 
met ernstigere radiografische gewrichtsschade. In patiënten met UA[ref  23] is 
BMD-verlies een voorspeller voor de ontwikkeling van RA (23). Echter, het is on-
bekend in welke mate BMD veranderingen aanwezig zijn in de fase voordat artritis 
klinisch aanwezig is. Dit hebben wij onderzocht in hoofdstuk 7, in het Clinically 
Suspect Arthralgia (CSA) cohort, bestaande uit 108 CSA-patiënten. In deze groep 
werd een MRI gemaakt bij aanvang en digitale X-ray radiogrammetry op twee 
opeenvolgende conventionele röntgenfoto’s van de handen werd gebruikt om de 
BMD te bepalen. Deze BMD-veranderingen werd gestandaardiseerd naar BMD- 
verlies per maand. We zagen dat BMD-verlies (gedefinieerd als een verlies van ≥ 2.5 
mg/cm2/maand), gevonden werd in een klein deel van de CSA-patiënten. Tevens 
zagen we dat bij een ernstigere MRI-gedetecteerde ontsteking bij aanvang, een 
groter BMD-verlies werd gevonden in de maanden volgend op de MRI. Samen met 
de bevindingen van veranderde botmakers in de preklinische fase van RA,[24,25] 
suggereren deze data dat het botmetabolisme veranderd is bij sommige patiënten 





In deze thesis hebben we aangetoond dat de prevalentie van ontsteking en erosies 
in de algehele, asymptomatische bevolking, erg afhankelijk is van leeftijd en 
de locatie van de laesie(s). De RAMRIS-methode houdt geen rekening met deze 
factoren. In de praktijk nemen radiologen, bij de beoordeling van een diagnosti-
sche MRI, al verschillende factoren mee in de beoordeling (leeftijd, locatie van de 
 laesie(s)). Maar naast deze factoren neemt een radioloog ook nog andere factoren 
mee, zoals het patroon van de ontsteking. Het verschil tussen de RAMRIS-methode 
en de daadwerkelijke beoordeling van een radioloog benadrukt de nadelen van 
het gebruik van de RAMRIS-methode in de diagnostiek van RA. Er is dus behoefte 
aan een andere scoringsmethode die deze verschillende factoren (bijvoorbeeld 
leeftijd, locatie, patroon, mate van afwijkingen in de algehele populatie) wel mee-
neemt in de beoordeling. De waarde van deze scoringsmethode voor de diagnos-
tiek van RA moet uiteraard nog wel gevalideerd worden in longitudinale cohorten 
van patiënten.
Tevens, als MRI-data van asymptomatische vrijwilligers gebruikt gaat worden als 
een referentie, dan zullen controles met grotere groepen nodig zijn om er zeker 
van te zijn dat er voldoende personen zijn in de verschillende leeftijdscategorieën.
Naast MRI zijn er ook nog andere beeldende technieken die een toevoeging kunnen 
zijn bij de beoordeling van ontsteking in gewrichten in de kliniek. Je kan hierbij 
denken aan echografie, positron emission tomografie (PET) en single photon emis-
sion computed tomografie (SPECT).[26] In de kliniek is echografie goed beschik-
baar. Echter, echografie kan bijvoorbeeld geen BME detecteren en de beoordeling 
is erg afhankelijk van degene die de echografie uitvoert.[26] De additionele waarde 
van echografie of MRI als een diagnostisch middel bij de beoordeling van RA zal 
derhalve onderzocht moeten worden in een directe vergelijking tussen deze twee 
methoden. Tevens zou de waarde van SPECT en PET bij de detectie van vroege 
ontsteking bij RA moeten worden onderzocht. Bij al deze studies is het van belang 
om te kijken naar de specificiteit. Hoewel er recent een onderzoek is gepubliceerd 
waarin gekeken is naar bevindingen op echografie in asymptomatische vrijwilli-




Afgezien van een accurate prognose, is het nog onbekend hoe vroeg het nuttig 
is om RA te behandelen. De vroeg-detectie van RA is erg belangrijk, aangezien 
behandeling in een vroege klinische fase van de ziekte de klinische uitkomst aan-
zienlijk verbetert.[28] Beeldende technieken zouden aanzienlijk kunnen bijdragen 
aan de vroege detectie van ontsteking op een eerder tijdspunt in vergelijking met 
de huidige diagnostische middelen. Hierdoor zou behandeling eerder, zo mogelijk 
zelfs in een pre-artritis fase, gestart kunnen worden. Echter, het is onbekend of 
de behandeling in zó’n vroege fase daadwerkelijk leidt tot betere klinische uit-
komsten in vergelijking met het starten van de behandeling bij de eerste klinisch 
detecteerbare artritis.
In de literatuur is een hogere leeftijd geassocieerd met ernstigere radiografische 
gewrichtsschade.[29-34] Ook wij vonden in hoofdstuk 3 een hogere prevalentie van 
MRI-gedetecteerde erosies op een hogere leeftijd. Hoewel deze laesies asympto-
matisch en vaak klein waren, kunnen dit wel plekken zijn waar zich radiografische 
gewrichtsschade ontwikkelt. Eerdere studies wijzen inderdaad uit dat botten met 
MRI-gedetecteerde erosies vatbaarder zijn voor de ontwikkeling van erosies op 
conventionele röntgenfoto’s.[35] Dus, omdat oudere personen meer MRI-gedetec-
teerde erosies hebben in vergelijking met jongere personen, zou radiografische 
gewrichtsschade zich sneller kunnen ontwikkelen in oudere RA-patiënten. Deze 
hypothese zou getoetst moeten worden in toekomstig onderzoek.
In het kader van de bevindingen van de invloed van BMI op de ernst van gewrichts-
schade bij RA-patiënten, zijn er aanvullende onderzoeken nodig om de achterlig-
gende biologische processen te ontrafelen. De uitkomsten uit een recente studie 
bij muizen suggereren dat artritis eerder begint bij overgewicht door neutrofiele 
rekrutering. Echter, zodra RA evident aanwezig is, blijkt overgewicht geen invloed 
meer te hebben omdat op dat punt er geen verschil meer is in leukocyten, T-cel 
populatie en chemoattractanten tussen slanke muizen en muizen met overgewicht.
[36] De ernst van de gewrichtsschade is niet onderzocht in deze studie.
Er is veel discussie over de voor- en nadelen van het drinken van een tot twee 
alcoholische consumpties op een dag. De positieve effecten van matige alcohol-




hart- en vaatziekten). Echter, onze data laten zien dat matige alcoholconsumptie 
geen positieve invloeden heeft op de gewrichten van RA-patiënten.
Alle studies die tot dusverre onderzoek hebben gedaan naar botmetabolisme in 
de preklinische fase van RA, bestonden slechts uit kleine aantallen deelnemers. 
Om het veranderde botmetabolisme daadwerkelijk te valideren in de symptomati-
sche fase voorafgaand aan klinisch evidente artritis, zijn groter opgezette studies 
nodig. De cohorten met artralgie-patiënten groeien echter gestaag en daarom zal 
dit onderzoek in de nabije toekomst al mogelijk zijn.
RA is een multifactoriële ziekte, waarbij genetische en omgevingsfactoren van 
invloed zijn.[37-38] De best bekende omgevingsfactor, roken, is uitgebreid onder-
zocht in het verleden.[39] De relatie tussen de ontwikkeling van RA en andere 
factoren zoals BMI en alcoholconsumptie is echter minder bekend.[19,20,40] In 
dit proefschrift hebben we twee van deze factoren nader onderzocht, (BMI en 
alcoholconsumptie). We hebben onderzocht of deze factoren van invloed waren 
op MRI-gedetecteerde ontsteking. Een limitatie van deze onderzoeken is de cross- 
sectionele opzet van de studie. Hoewel hieruit naar voren kwam dat BMI geassoci-
eerd was met MRI-gedetecteerde ontsteking, zijn longitudinale studies nodig om 
inderdaad te bevestigen dat een lagere ontsteking bij patiënten met overgewicht 
inderdaad geassocieerd is met minder radiografische progressie.
De follow-up van symptomatische patiënten zonder klinisch detecteerbare artritis 
in longitudinale studies zou zeer waardevol kunnen zijn. In deze cohorten zouden 
de patiënten opgevolgd kunnen worden waardoor de volgorde van gebeurtenissen 
gevolgd kan worden in relatie tot omgevingsfactoren. Hierbij kan de invloed van 
deze omgevingsfactoren op de ontwikkeling van RA nader onderzocht worden. Zo 
zou bijvoorbeeld onderzocht kunnen worden of gewichtsverlies enig effect zou 
kunnen hebben op MRI-gedetecteerde ontsteking en of dit mogelijk zelfs de pro-
gressie naar RA zou kunnen afremmen. Tevens zou de invloed van alcohol beter 
onderzocht kunnen worden. De longitudinale studies zouden ons begrip over de 
biologische mechanismen, die ten grondslag liggen aan een aantal associaties 
die we onderzocht hebben in deel II van dit proefschrift, doen toenemen. Om de 
pathofysiologie in de vroege fasen van RA beter te begrijpen is toekomstig onder-




sche mechanismen (bijvoorbeeld immunosenescence, inflammatoire eigenschap-
pen van vetweefsel of botweefsel) die ten grondslag liggen aan, onder andere, de 
associaties gevonden in dit proefschrift.
Concluderend laten de onderzoeken uit dit proefschrift zien dat MRI-gedetecteerde 
ontsteking vaak gezien wordt in een asymptomatische populatie. Dit is van belang 
om mee te nemen bij de beoordeling van diagnostische MRI's of voor het bepalen 
van het al dan niet in remissie zijn van RA. Verder is aangetoond dat leeftijd, BMI 
en BMD geassocieerd zijn met MRI-gedetecteerde ontsteking. Deze, en andere 
beïnvloedende factoren, zouden het onderwerp moeten zijn van toekomstig onder-
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